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1  Summary 
Cellular homeostasis and function, including the controlled interaction with the environment, not 
only depends on the genetic code but also and primarily on the epigenetic information contained in 
histone tail modifications and DNA methylation. Histone modifications are most prominently 
acetylation or methylation of specific residues in the histone tails whereas cytosine on the DNA can 
be methylated to form 5-methylcytosine (5mC) (Bernstein et al., 2007; Kouzarides, 2007; Nicholson 
et al., 2015). Virtually all cells from a multicellular organism contain the same genetic code; the 
epigenetic system shapes the nuclear organisation of chromatin and DNA accessibility, determining 
gene expression programs in development to facilitate lineage commitment into specific tissue types. 
Thereby, patterns of epigenetic modifications change dramatically as cells undergo functional and 
morphological determination during differentiation and de-differentiation, including cancerous 
transformation (Bernstein et al., 2007; Cedar and Bergman, 2011; Dambacher et al., 2013). Genetic 
mutations as well as aberrations of epigenetic modifications are hallmarks of cancer, but may also be 
the driving force of cancerogenesis. Acute leukaemia is characterised by high abundance of 
progenitor cells and they often have alterations in genes encoding epigenetic modifiers (Greenblatt 
and Nimer, 2014; Ntziachristos et al., 2013). Hence, mutations in epigenetic modifiers in leukaemia 
and the blocked differentiation of progenitor cells may indicate a defect in the epigenetic control of 
differentiation. Additionally, epigenetic programming in differentiating cells is sensitive to 
disturbance by environmental factors (Feil and Fraga, 2011; Jaenisch and Bird, 2003; Mitchell et al., 
2016). Extremely-low-frequency electromagnetic fields (ELF-MFs) have been considered as one of 
these environmental factors, caused by modern life style. The ever increasing use of electronic 
appliances generating electromagnetic fields in the ELF-MF range of 50 Hz has raised concerns 
regarding potential risks for human health. Due to epidemiological studies, indicating a correlation of 
ELF-MF exposure with an increased risk for childhood leukaemia, ELF-MF was evaluated as being 
possibly carcinogenic to humans (group 2B) by the International Agency for Research on Cancer 
(IARC) (IARC, 2002). However, the molecular mechanisms underlying this correlation have remained 
elusive. The energy transmitted by ELF-MF is not sufficient to directly damage DNA (Adair, 1998) and 
thereby unlikely to induce cancer-promoting mutations, but whether or not it has the potential to 
influence the epigenetic program of genomes has not been systematically addressed. The aim of my 
PhD thesis was to evaluate the influence of ELF-MF on the epigenetic code as a potential molecular 
explanation of the implicated leukaemogenic activity. Therefore, we analysed ELF-MF effects on the 
epigenetic stability in leukaemic cells and on the epigenetic reprogramming during an in vitro 
haematopoietic differentiation into the neutrophilic lineage. Additionally, I investigated the 
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epigenetic dynamics of histone modifications and DNA methylation during neutrophilic 
granulopoiesis in a second part.  
Previous studies indicated a certain genotoxic potential of ELF-MF exposure (Duan et al., 2015; Focke 
et al., 2010; Mihai et al., 2014; Vijayalaxmi and Prihoda, 2009), although the energy content of 
ELF-MF is not high enough to induce structural damage to DNA. It is possible, however, that 
secondary effects such as changes in cell proliferation, cell cycle progression or apoptosis can 
account for the low levels of DNA breaks observed (Focke et al., 2010; Kim et al., 2010). On the other 
hand, the second layer of information superposed to the basic DNA sequence, the epigenetic code, 
has been hardly assessed with respect to ELF-MF exposure. There are a few studies indicating that 
the epigenome can be modified by ELF-MF exposure (Baek et al., 2014; Liu et al., 2015), but the 
potential of ELF-MF exposure to destabilize epigenetic modifications in general and in a cancer-
relevant manner in particular has not been addressed systematically. We examined the influence of 
ELF-MF exposure on the chromatin landscape of the leukaemic Jurkat cell line by analysing the 
alterations of histone modifications. Furthermore, we studied the impact of ELF-MF exposure on the 
dynamics of histone modifications and DNA methylation during the epigenetic programming of 
human cord blood stem cells, differentiating into the neutrophilic lineage. We generated genomic 
profiles of the activating histone mark H3K4me2 and the repressive histone mark H3K27me3 as well 
as of DNA cytosine methylation. We report that ELF-MF exposure has no significant and consistent 
influence on epigenetic modifications in differentiated leukaemic cells as well as during 
haematopoietic differentiation. However, our data showed a consistent effect of ELF-MF exposure on 
the reproducibility of these histone and DNA modification profiles, indicating that ELF-MF may 
influence the robustness of histone modifications and DNA methylation most pronounced in the 
course of global reorganization of chromatin in the neutrophilic differentiation process. Moreover, 
our results indicate that ELF-MF exposure may stabilize the epigenetic features that are associated 
with open chromatin during differentiation as regions marked by H3K4me2, losing H3K27me3 or CpG 
demethylation. Our data suggest a stochastic effect of ELF-MF exposure on the chromatin landscape 
of individual cells. 
Acute myeloid leukaemia (AML) is the most common leukaemia in adults (80%). It is characterized by 
high accumulation of progenitor stages mainly neutrophilic progenitors and alterations in modifiers 
of epigenetic modifications (Greenblatt and Nimer, 2014; Seiter, 2016; Zenhäusern et al., 2003). To 
understand the potential contribution of aberrant epigenetic programming in differentiation to 
carcinogenesis, it is important to understand the physiological epigenetic pattern established during 
the differentiation process. As the dynamic epigenetic programming during human neutrophilic 
granulopoiesis has not been addressed systematically, we investigated the reorganization of histone 
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modifications (H3K4me2 and H3K27me3) and DNA cytosine methylation during in vitro neutrophilic 
granulopoiesis at genome scale. The results show a fundamental reorganisation of the chromatin 
landscape most pronounced at lineage commitment at the transition of human cord blood stem cells 
into the neutrophilic lineage, shaping an overall more compact chromatin. We observed that 
epigenetic repression of pluripotency and developmental genes with a poised chromatin state in 
human cord blood stem cells occurred through a gain of H3K27me3 alone or with concomitant de 
novo DNA methylation, but rarely with DNA methylation alone. By contrast, our data indicate that 
epigenetic activation of neutrophil-specific genes preferentially appeared through DNA 
demethylation without simultaneous alterations in histone modifications. Our data suggest a specific 
regulatory role of DNA demethylation in lineage restriction of neutrophils. 
This work was part of the European Commission funded project “Advanced Research on Interaction 
Mechanisms of electromagnetic exposure with Organisms for Risk Assessment” (ARIMMORA), 
evaluating possible pathways to explain the association between ELF-MF exposure and childhood 
leukaemia. I contributed to the final risk assessment applying an IARC Monograph evaluation scheme 
to hazard identification of ELF-MF. The ARIMMORA consortium concluded that the relationship 
between ELF-MF and childhood leukaemia remains consistent with the classification by IARC that 
ELF-MFs are possibly carcinogenic to humans (Group 2B). The risk assessment was published in a 
peer-reviewed comment (Schuz et al., 2016). 
Taken together, in collaboration with others, I was able to elucidate and describe alterations of 
epigenetic modifications during an in vitro differentiation and induced by an environmental factor. As 
a proof-of-concept, I showed that ELF-MF, as an environmental factor, is able to influence the 
epigenetic code of histone modifications and DNA methylation. ELF-MF effects are subtle and 
stochastic rather than deterministic; the analysis of epigenetic patterns in cell populations showed 
altered reproducibility between replicate samples. These effects suggest that ELF-MF affects the 
robustness of epigenetic reprogramming by stabilizing epigenetic modifications associated with open 
chromatin. These observations will support further mechanistic studies analysing the contribution of 
ELF-MF exposure to cancerogenesis. Additionally, my data of the epigenetic programming during 
neutrophilic granulopoiesis provided novel insights into the regulatory role of DNA methylation and 
histone modifications in lineage restriction and cell plasticity, revealing a specific epigenetic pattern 
for activated and repressed genes during differentiation. These data may support further studies 
investigating chromatin epigenetic regulators as targets for leukaemia induced differentiation 
therapy.  
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2 Introduction 
2.1 The genome and its epigenetic modifications 
The genome and its genetic code are identical in virtually all cells of human body and stored in the 
DNA. The epigenetic code of each cell, however, can differ, contributing to distinct cell type-specific 
gene expression programs. The epigenome contains modifications of histone tails (e.g. acetylation or 
methylation) and DNA methylation of cytosine residues generating 5-methylcytosine (5mC) 
(Bernstein et al., 2007). Epigenetic features, once established, are relatively stable maintained, yet, 
they are flexible and capable to adapt to changing developmental or environmental conditions, 
resulting in reorganisation of the chromatin structure and DNA accessibility. Different enzymes are 
involved in the regulation of epigenetic modifications; they establish (writers), remove (erasers) or 
interpret and bind (readers) histone modifications or DNA methylation (Nicholson et al., 2015; Shen 
and Laird, 2013). The pattern of epigenetic modifications changes dramatically as cells undergo 
differentiation, establishing mainly three main classes of transcriptionally relevant chromatin states: 
transcriptionally active, repressed or poised chromatin. Active chromatin comprising highly 
expressed genes is occupied by histone 3 lysine 4 trimethylation (H3K4me3), histone 3 lysine 27 
acetylation (H3K27ac) and non-methylated cytosine, whereas chromatin correlating with gene 
repression is characterized by trimethylated histone 3 lysine 27 (H3K27me3) and histone 3 lysine 9 
trimethylation (H3K9me3) as well as 5mC. Transcriptionally poised chromatin is occupied by active as 
well as repressive epigenetic features including H3K4 di- and trimethylation and H3K27me3 
modifications, and is preferentially located at developmental genes in stem cells (Boland et al., 
2014). Thus, the epigenome represents a second dimension of genomic information, controlling a cell 
type-specific gene expression. Alterations in the epigenome are hallmarks of cancer (You and Jones, 
2012) and may also be a driving force for cancerogenesis. The following chapters will introduce the 
genome and its epigenetic modifications  
 
2.1.1 The genome and its organisation 
Deoxyribonucleic acid (DNA) is the carrier of genetic information, which is transferred to each 
daughter cell and encodes the building blocks of all organisms. The DNA contains coding regions 
transcribed in mRNA and further translated into proteins fulfilling their function in each cell, but as 
well non-coding regions, including regulatory elements (e.g. promoter, enhancer), introns or repeat 
sequences. The DNA consists of four different nucleotides including a purine base adenine (A), 
guanine (G) or a pyrimidine base cytosine (C) or thymine (T) as well as a sugar-phosphate group. The 
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sequential arrangements of these four nucleotides build the genetic code. Methylation of cytosine at 
the C5 position (5-methylcytosine, 5mC), generating a fifth DNA base, adds an additional gene 
regulatory layer onto the DNA sequence, without changing the coding property. Two antiparallel 
DNA strands are built of nucleotides connected by the sugar-phosphate backbone that are 
complementary of each other and linked by hydrogen bonds according to the Watson-Crick base 
pairing model, connecting adenine to thymine and guanine to cytosine forming a right handed 
double-helical structure. The DNA structure facilitates replication, continued gene expression and 
packaging (Shabalina and Spiridonov, 2004; Travers and Muskhelishvili, 2015; Watson and Crick, 
1953). 
 
Figure 1: DNA condensation into chromatin structures. DNA double helix is wrapped around histones to form 
nucleosomes further compacted into chromatin fibers and coiled into chromatid of chromosome (adapted 
from Pierce, 2012). 
Each cell of the human body has about 2 meters of DNA inside the nucleus, which is approximately 
10 µm in diameter. Several steps of compaction are necessary to fit this amount of DNA inside this 
tiny space; still keeping it accessible for reading the genetic code (Figure 1). In total, the human 
genome is packed in 46 chromosomes. The primary structure of DNA is organized in nucleosomes 
where about 147 bp of the negatively charged DNA is wrapped 1.7 times around a core histone (H) 
octamer. These histone octamers consist of two H3-H4 and two H2A-H2B histone dimers. 
Nucleosome core particles are connected together by linker DNA (20 – 80 bp) forming a linear array 
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of repetitive 200 bp elements, also known as the 10 nm fiber, originally named ‘beads on a string’. 
The linker DNA is occupied by the histone protein H1 (Maeshima et al., 2014). The 10 nm fiber, also 
bound by various non-histone proteins, forms the chromatin. The next compaction step is a 30 nm 
chromatin fiber, as indicated by in vitro studies from isolated nucleosomes, were the nucleosomes 
are folded in a higher order helical fiber in a solenoid or a zig-zag way (Finch and Klug, 1976; 
Woodcock et al., 1984). Beside these two favoured models, other ways of chromatin compactions in 
30 nm fibers were suggested, but the precise structure of these fibers still remains elusive. However, 
recent in vivo studies using the chromosome conformation capture method do not support the 
existence of a stable 30 nm fiber in interphase cells, rather suggesting a more dynamic, highly 
disordered, interlinked chromatin state (Nishino et al., 2012). The chromatin fiber is further folded to 
finally form mitotic chromosomes from large interphase chromatin fibers (Hubner et al., 2013; 
Maeshima et al., 2010; Maeshima et al., 2016).  
Chromatin state H3K4me2/3 H3K27me3 H3K9me3 Transcription 
Euchromatin + - - active 
Euchromatin + + - poised 
Facultative heterochromatin - + +/- silenced 
Constitutive heterochromatin - - + permanently silenced 
Table 1: Transcriptional activity of euchromatin and heterochromatin occupied by the histone modifications 
H3K4me2/3, H3K27me3 or H3K9me3. 
Eukaryotic chromatin is not equally distributed in the nucleus; there are more compacted regions 
(heterochromatin) and open regions (euchromatin), inaccessible and accessible for transcription, 
respectively (Table 1). The compact heterochromatin comprising inactive genes is preferentially 
located at the nuclear periphery associated with the nuclear lamina. Two different heterochromatic 
regions are known: facultative and constitutive heterochromatin. Genes that become silent during 
development and differentiation are located in facultative heterochromatic regions and they are 
mainly occupied by H3K27me3 and H3K9me3 modifications (e.g. the X chromosome inactivation 
within mammalian female cells). Constitutive heterochromatin contains permanently silenced genes 
mainly occupied by H3K9me3 modifications and is mostly associated with centromeric and telomeric 
regions. By contrast, euchromatin regions are relaxed open environments that carry most of the 
active genes, undergo cyclic relaxation during cell cycle allowing transcription and fill the internal 
nucleoplasm. Regions of euchromatin are characterized by different compositions of histone 
modifications. Active enhancers are occupied by H3K4 monomethylation (H3K4me1) whereas active 
genes harbour H3K4me2/3 marks on their promoter (for more details on histone modifications see 
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2.1.2). Additionally, regions of euchromatin can be transcriptionally poised by co-occupancy of active 
and repressive histone marks H3K4me2/3 and H3K27me3, respectively, and they are located 
preferentially at developmental genes in stem cells (Boland et al., 2014). Regions in the chromatin, 
which are separating heterochromatin from euchromatin, are bound by specific ‘boundary elements’ 
like the insulator binding protein CTCF, preventing spreading of heterochromatin into neighbouring 
euchromatic regions (Bannister and Kouzarides, 2011; Felsenfeld and Groudine, 2003; Kouzarides, 
2007; Pueschel et al., 2016).  
Several processes such as DNA replication, DNA repair, and activation or silencing of transcription 
involve alterations of chromatin structures. In principle, there are three ways to change the 
chromatin organisation: (i) with the help of chromatin remodelling complexes, (ii) through exchange 
of core histones with histone variants and (iii) through alterations of epigenetic modifications. For 
instance to initiate transcription, specific transcription factors have to bind to their target sequence 
on the DNA. However, if the region is occupied by nucleosomes, transcription factors recruit 
chromatin-remodelling complexes to the DNA. They move the histone core complexes in a ATP-
dependent manner over a short distance without disturbing the general chromatin structure, 
allowing the transcription factor to bind the DNA (Felsenfeld and Groudine, 2003). Additionally, core 
histones can be replaced by histone variants. For instance, an important histone variant of H2A is 
H2AX that has an important role in the DNA damage response as it gets phosphorylated following 
DNA repair. Moreover, histone variants of H3 are H3.3 and H3.2, where H3.3 was found to be 
associated with active chromatin, whereas H3.2 correlates with a repressive chromatin state (Hake 
and Allis, 2006; Kraushaar and Zhao, 2013; Snyers et al., 2014). The third way to induce chromatin 
reorganisation is through epigenetic modifications contained in histone modifications and DNA 
methylation (Figure 2). These epigenetic modifications shape the chromatin landscape and DNA 
accessibility by affecting directly the nucleosome structure, introducing chemical groups recognised 
by regulatory proteins or by disrupting directly the higher chromatin organisation (Felsenfeld and 
Groudine, 2003). Acetylation and methylation of specific residues in the histone tails are the most 
prominent histone modifications whereas the epigenetic modifications of DNA comprises methylated 
cytosine (5mC) mainly in a cytosine-guanine (CpG) context (Bernstein et al., 2007; Nicholson et al., 
2015). In mammals, around 50% of all genes are transcriptionally repressed in a cell type-specific 
manner by epigenetic mechanism to assure heritability without changes of the DNA sequence (Cedar 
and Bergman, 2011; Sashida and Iwama, 2012). Therefore, epigenetic information undergoes 
fundamental changes during cellular differentiation, resulting in silencing of pluripotency genes 
through H3K27me3, H3K9me3 and stabilised by DNA methylation (5mC), and activation of lineage-
specific genes through H3K4me3, leading to a cell type-specific gene expression pattern (Bernstein et 
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al., 2007). Dynamic epigenetic programming in differentiating cells is sensitive to disturbance by 
environmental factors. Several studies indicated that epigenetic features, particularly DNA 
methylation, can be altered through exposure to environmental factors (e.g. Aspirin, endocrine 
disruptive chemicals) (Damdimopoulou et al., 2012; Feil and Fraga, 2011; Noreen et al., 2014).  
 
Figure 2: Cytosine methylation and histone modifications in mammals are part of the epigenetic code. (A) 
Methylation of the lysine at the fourth position (K4) of the N-terminal tail of histone H3 is associated with 
active genes (green), whereas H3K27 methylation is present in transcriptionally silenced regions (orange). In 
CpG rich regions, methylation of cytosine at the C5 position (5-methylcytosine, 5mC) is present in repressed 
regions, whereas non-methylated cytosine is enriched in transcriptionally active regions. (B) The N-terminal of 
histone H3 is subject to various post-translational modifications as methylations, phosphorylations and 
acetylations (adapted from Bernstein et al., 2007). 
 
2.1.2 Histone modifications and their regulation 
Important features of the epigenome are histone modifications of the amino-terminal histone tails as 
well as the octamer core histone body. More than 100 distinct posttranslational modifications of 
histones are known, including acetylation, methylation, phosphorylation, ubiquitination, 
sumoylation, ADP-ribosylation and deamination, mainly occurring at the histone tails of the four 
histone subunits (H2A, H2B, H3 and H4). The biological function of some of these modifications such 
as acetylation and methylation is well described. However, the role of other modifications is less 
clear (Bannister and Kouzarides, 2011; Bernstein et al., 2007; Kouzarides, 2007). Histone 
modifications can be dynamic, appearing and disappearing within minutes of external stimuli (Anink-
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Groenen et al., 2014; Meagher, 2014; Waterborg, 2002), allowing for a rapid change of the 
epigenetic information. Two main functions of histone modifications are known; they can impact the 
setting up of the global chromatin organisation by altering the charge of the histone tail resulting in 
the separation into heterochromatin and euchromatin and, secondly, they are involved in the 
recruitment of non-histone proteins to the DNA (Kouzarides, 2007). Histone acetylation and 
methylation are described in more details, introducing the enzymes catalysing these modifications 
and the factors that recognise them.  
Histone acetylation  
Acetylation of lysine residues on histone tails neutralizes the positive charge of the lysine, indicating 
a potential to decrease the interactions between nucleosomes and the DNA, and resulting in a more 
open chromatin structure. However, there are different models explaining the correlation between 
histone acetylation and open chromatin, including that a decreased affinity of the lysine residue to 
the negatively charged DNA give rise to a more open chromatin structure or due to charge repulsion 
between nucleosomes and DNA, but it is not entirely clear how acetylation facilitates transcription. 
Hence, histone acetylation makes a locus more accessible for transcription factors and is associated 
with increased gene expression. Lysine acetylation marks are highly dynamic, the underlying histones 
are located mostly at promoters and enhancer of expressed genes (Nicholson et al., 2015). 
Acetylation of lysine residues appears in the tails of histone H3, H4, H2A and H2B and a few lysine 
residues can be either acetylated or methylated as for instance H3K9 (Rice and Allis, 2001). Several 
acetylation sites (e.g. H3K9ac, H3K56ac, H4K16ac) have been shown to be involved in DNA double-
strand break repair (Gong and Miller, 2013). Lysine acetylation is controlled by two classes of 
proteins: the histone acetyl-transferases (HATs) and the histone deacetylases (HDACs). HATs catalyse 
the transfer of an acetyl group to the ε-amino group of lysine side chains and are divided in two main 
classes: type-A and type-B HATs. Newly synthesised cytoplasmic histones that are not yet 
incorporated into the chromatin are acetylated mainly by type-B HATs. Type-A HATs modify mainly 
N-terminal tails of histones assembled in nucleosomes. By contrast, HDACs remove the acetyl group 
and restores the positive charge of the lysine residue, resulting in chromatin compaction and 
transcriptional repression (Bannister and Kouzarides, 2011).  
Histone methylation 
Unlike acetylation, histone methylation does not alter the charge of the histone tails; therefore, it 
has no impact on the overall chromatin organisation on its own. However, it has an important role in 
the recruitment of non-histone proteins so-called readers to the chromatin, at least for the best 
known histone modifications, including methylation of H3K4, H3K27 or H3K9. Histone methylation 
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occurs preferentially on lysine and arginine residues of histone tails and depending on the position 
and number of the methyl groups, histone methylation has an activating or a repressing influence on 
gene transcription. Arginine (R) can be mono-, asymmetrically or symmetrically dimethylated, 
whereas lysine (K) can be modified with one (monomethyl; me1), two (dimethyl; me2) or three 
(trimethyl; me3) methyl groups. The target amino acid and the number of methyl groups correlate 
with the transcriptional activity at nearby genes. For instance, H3K4, H3K36 or H3K79 methylations 
are associated with active transcription, while H3K27, H3K9 or H4K27 methylation is linked to 
repressive chromatin (Nicholson et al., 2015).   
As histone methylations at lysine residues, particularly H3K4me2 and H3K27me3, are a central part 
of my thesis, I will describe their regulation in details. Histone methylations at lysine residues are 
controlled by two classes of proteins: lysine methyltransferases (KMTs) and lysine demethylases 
(KDMs). KMTs methylate the ε-amino group of lysine residues in the histone tails, two major classes 
of KMTs are known, comprising or not having a SET domain. To date, there is only one KMT known 
not having a SET domain, which specifically modifies H3K79. In all other KMTs, the SET domain 
contains the enzymatic activity transferring a methyl group from S-adenosylmethionine (SAM) to the 
amino group of the lysine residue (Bannister and Kouzarides, 2011; Smith and Denu, 2009). By 
contrast, KDMs remove the methyl groups from lysine residues. Based on their catalytic activity, two 
types of KDMs can be distinguished. Members of the first group of KDMs, including LSD1 and LSD2, 
which demethylate mono- and dimethyl groups, contain a flavin adenine dinucleotide (FAD)-
dependent amine oxidase domain. LSD1 can demethylate H3K4, repressing transcription and has 
demethylation activity on H3K9 in combination with the androgen receptor, mediating 
transcriptional activation. The second class of KDMs, including JHDM1, KDM2 or JARID1, have a 
Jumonji C domain and is capable of removing mono-, di- and trimethyl groups by oxidation of the 
methyl groups requiring iron Fe(II) and α-ketoglutarate as cofactors (Black et al., 2012; Nicholson et 
al., 2015). Different KMTs and KDMs fulfil their specificity only on certain lysine residues. Exemplified 
in detail for the best descripted key activating and repressing histone marks H3K4 and H3K27 
methylation, respectively, as histone modifications are regulated by a complex interplay between 
many enzymes and protein complexes.  
H3K4 methylation marks are generally found at active genes; H3K4me1 is associated with active and 
poised enhancers, H3K4 dimethylation (H3K4me2) is linked to active and poised genes, whereas 
trimethylation of H3K4 is linked to promoters of transcriptionally active genes (Eissenberg and 
Shilatifard, 2010; Hon et al., 2009; Nicholson et al., 2015). Moreover, during cellular differentiation 
such as haematopoiesis, H3K4me2 is not only present at active genes, but also at transcriptionally 
silent lineage-specific genes and is localized at enhancers of developmental genes (Orford et al., 
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2008). Methylation of H3K4 is catalysed by trithorax-group (trxG) protein complexes containing not 
only KMTs but also HATs or HDACs. TrxG complexes are clearly associated with transcriptional 
activation. In mammals, several KMTs methylating H3K4 were identified, for example mixed lineage 
leukaemia (MLL) proteins (MLL1-4), hSET1A and B, and ASH1. MLL1, for instance, catalyses 
specifically H3K4 to H3K4me2, but is also able to trimethylate H3K4 with the help of association 
partners (RBBP5 and Ash2L) (Black et al., 2012; Dou et al., 2006; Hon et al., 2009; Lanzuolo and 
Orlando, 2012). KMTs from the trxG-MLL complex are associated with proteins having KDM activities 
in some genomic regions. For instance, MLL2 is present in a complex together with the H3K27me3-
specific demethylase UTX. This suggests that methylation and demethylation of different lysine 
residues regulating transcription in specific genomic regions is highly coordinated (Pasini et al., 2008).  
H3K27me2/3 marks, associated with gene repression, are catalysed by polycomb-group (PcG) 
proteins found in polycomb repressive complexes (PRCs). In mammals, two PRC complexes are 
known: PRC1 and PRC2. PRC2 consists of the subunits EED, SUZ12 and the histone methyltransferase 
EZH2, catalysing the H3K27 methylation. A variant form of the PRC2 complex exists, containing EZH1 
instead of EZH2, which occupies active chromatin and promotes gene expression (Xu et al., 2015). 
PRC2-EZH1 is present in dividing as well as differentiated cells, while PRC2-EZH2 is found only in 
actively dividing cells. On the other side, PRC1 mediates gene repression by binding to methylated 
H3K27 and subsequent ubiquitylation of K119 on H2A leading to chromatin compaction (Bernstein et 
al., 2007; Lanzuolo and Orlando, 2012; Pasini et al., 2008). Jarid1 proteins (Rbp2/Jarid1a) catalyse 
demethylation of H3K4me2/3 marks that are present at sites of PRC2 complexes, important for the 
repression of target genes (Pasini et al., 2008). 
 
2.1.3 DNA methylation and its regulation  
DNA methylation is the second main feature of the epigenetic code, contributing to the distinct cell 
type-specific gene expression. Cytosine residues in DNA can be methylated at their C5 position, 
generating 5mC while not disturbing the base pairing properties of the nucleotides. Methylation of 
cytosine is the mechanistically best-understood epigenetic modification and evolutionary conserved 
among plants and animals. In the mammalian genome, DNA methylation mainly occurs at CpG 
dinucleotides, which are underrepresented in the bulk genome but enriched at specific genomic 
regions called CpG islands (Deaton and Bird, 2011; Illingworth and Bird, 2009). Non-CpG methylation 
is found in mammals, but to a much lower extend and its biological function is not yet clear. In the 
human genome, 60-80% of CpGs are methylated and less than 10% of CpGs are located in CpG 
islands (Du et al., 2015; Smith and Meissner, 2013). DNA methylation at CpG-rich promoters results 
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in gene silencing, whereas DNA methylation in gene bodies correlates with gene expression 
(Nicholson et al., 2015). DNA methylation patterns are dynamically regulated through DNA 
methylation and DNA demethylation during development to establish tissue- and cell type-specific 
methylation patterns. 
DNA methylation is maintained and deposited by DNA methyltransferases (DNMTs). In mammals, 
three enzymatically active DNMTs are known: DNMT1, DNMT3a and DNMT3b. By flipping the 
cytosine residue out of the DNA helix, DNMTs catalyse and transfer a methyl group from the cofactor 
S-adenosyl-L-methionine (SAM) to the C5 position of cytosine, generating 5mC. Disruption of DNMT1 
or DNMT3b genes in mice is embryonic lethal and DNMT3a deficient mice die shortly after birth, 
indicating that DNA methylation plays an important role during development. In mammals, DNMT3a 
and DNMT3b are probably responsible for de novo methylation in combination with a homologous 
protein DNMT3L which is catalytic inactive. DNMT3L is unable to bind the cofactor SAM but 
stimulates the enzymatic activity of the others. DNMT3a and DNMT3b are able to de novo methylate 
hemimethylated and unmethylated DNA (Jurkowska et al., 2011). In addition to de novo methylating 
in a CpG context, DNMT3a and DNMT3b can catalyse methylation of non-CpG cytosines (Arand et al., 
2012). De novo methylation is important for the establishment of DNA methylation patterns in early 
development and in germ cells; de novo DNMTs are therefore highly expressed in embryonic stem 
cells (ESCs) and embryonic tissues, while downregulated in differentiated cells (Jurkowska et al., 
2011). On the other side, DNMT1 is mainly responsible for DNA methylation maintenance, occurring 
during S phase of the cell cycle shortly after DNA replication. When cell enters S phase, DNMT1 is 
very abundant and recruited to replication fork through interactions with PCNA and UHRF1. By using 
the methylated parental strand as a template, DNMT1 converts hemimethylated CpG into a fully 
methylated double DNA strand, restoring the original methylation pattern (Du et al., 2015; Smith and 
Meissner, 2013). DNMT1 moves along with replication fork to methylate the newly synthesised DNA 
strand before chromatin is reassembled (Jurkowska et al., 2011). Biochemical assays showed that 
unmethylated DNA is not recognized by DNMT1 and its preferred substrate is hemimethylated DNA, 
indicating that DNMT1 contributes little to de novo methylation (Li and Zhang, 2014). DNMT1 alone is 
not sufficient in maintaining global DNA methylation; knock-out studies showed that the presence of 
DNMT3a and DNMT3b is required especially to maintain DNA methylation in heterochromatic 
regions (Jones, 2012; Jurkowska et al., 2011). 
The mammalian genome is reprogrammed through active and passive demethylation processes. 
Passive demethylation occurs by diluting the 5mC mark during DNA replication due to inhibition of 
DNMT1 catalysed DNA maintenance methylation. In mammals, there is no DNA demethylase known 
yet. Active demethylation of 5mC is possible and occurs most likely through a family of DNA 
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hydroxylases called ten-eleven translocation (TET) proteins. The TET proteins TET1, TET2 and TET3 
convert 5mC by oxidation to 5-hydroxymethylcytosine (5hmC) in a 2-oxoglutarate-dependent 
manner (Li and Zhang, 2014). 5hmC can be oxidised further by the TET enzymes, generating 5-
formylcytosine (5fC) and 5-carboxylcytosine (5caC), both of which are substrates for the thymine 
DNA glycosylase (TDG) (He et al., 2011). TDG is able to excise 5fC and 5caC from the DNA and, 
through base excision repair (BER), the original cytosine residue is restored (Weber et al., 2016). 
Additionally, 5hmC, without further oxidation, can also be passively demethylated, as it is only poorly 
copied by DNMT1 (Ji et al., 2014; Shen and Zhang, 2013). Another protein shown to be involved in 
DNA demethylation during development is the activation-induced-deaminase (AID), able to 
deaminate 5mC to thymine that is recognised by DNA glycosylases and excised by the BER pathway 
(Seisenberger et al., 2013). Beside their important contribution in early development, DNA 
demethylation processes are also present and required in fully differentiated somatic cells, though to 
a lower extent. Site-specific DNA demethylation is involved in transcriptional responses to 
environmental changes, in oncogenic transformation or in aging, keeping the DNA methylation 
pattern dynamic through life (Li and Zhang, 2014). 
DNA methylation dynamics during development 
DNA methylation patterns are relatively stable throughout life and play an important role in 
determining cell fate. There are two points in the mammalian development where DNA methylation 
changes dramatically to allow nuclear reprogramming; during early embryogenesis as well as in 
primordial germ cells (PGCs) (Figure 3). During early development, the mammalian genome is 
reprogrammed through active and passive demethylation processes. After fertilization the DNA 
methylation pattern from the maternal and paternal genome is reprogrammed (Guo et al., 2014). 
The maternal genome is passively demethylated while the paternal genome undergoes a rapid, 
complete loss of DNA methylation through active enzymatic processes, before the first cell division. 
There is good evidence that TET3, the only TET protein present in early zygotes, oxidize 5mC residues 
generating 5hmC before DNA synthesis starts, and 5hmC is then serially diluted in each round of cell 
division. However, recent evidence also suggests that the early loss of paternal 5mC is independent 
of TET, and that 5hmC accumulation is uncoupled from the 5mC loss and dependent on de novo DNA 
methylation through DNMT3a and DNMT1 in the zygote (Amouroux et al., 2016). BER complexes 
including PARP1 and APE1 are as well enriched in zygotes and possibly involved in demethylation, but 
TDG seems to be absent (Hajkova et al., 2010). Further studies are necessary to determine the exact 
mechanism of the global demethylation during zygotic reprogramming. The global demethylation is 
followed by de novo methylation by DNMT3a and DNMT3b. The de novo methylation starts in the 
morula stage when cells located in the periphery separate to form the inner cell mass cells destined 
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to become the embryo. This separation results in the specific epigenetic features with low 
methylation levels in cells of the outer trophectoderm and re-establishing DNA methylation pattern 
of the inner cell mass cells (Schuermann et al., 2016; Seisenberger et al., 2013; Smith and Meissner, 
2013). 
 
Figure 3: DNA methylation dynamics during mammalian development. DNA methylation is changed in a 
global scale two times during mammalian development by active or passive DNA demethylation processes 
followed by de novo DNA methylation and results in the reprogramming of the DNA methylation pattern. The 
first demethylation occurs during early embryogenesis affecting both the maternal (red) and the paternal 
(blue) genome. The second methylation change happens in primordial germ cells (PGCs) and de novo 
methylation is sex specific (adapted from Seisenberger et al., 2013).  
The second demethylation step occurs in PGCs, the direct progenitors of sperm and oocytes, where 
the somatic epigenetic pattern of the epiblast state is changed into a germ cell state. This 
reprogramming step is important for the generation of gametes to erase the parental imprints before 
fertilisation and generating the next generation. In mice, most of the DNA methylation marks are 
reset in PGCs. Starting from embryonic day 8.5, DNA demethylation in PGCs consists of a passive 
demethylation processes through 5mC dilution followed by an actively regulated locus-specific DNA 
demethylation. Recent studies indicate that specific genomic regions as meiotic genes and imprints 
are demethylated by TET1 and the BER machinery (Kawasaki et al., 2014; Schuermann et al., 2016; 
Yamaguchi et al., 2013). After demethylation in early PGCs, the genome undergoes de novo 
methylation to achieve the higher methylation levels in mature gametes. In females, de novo 
methylation occurs in the growing oocyte after birth. By contrast, male PGCs gain their DNA 
methylation pattern between embryonic day 14.5 and 16.5. De novo DNMTs, DNMT3a and DNMT3b, 
with the help of DNMT3L catalyse the DNA methylation resulting in CpG methylation levels of about 
85% and 30% in sperm and oocytes, respectively (Seisenberger et al., 2013).  
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2.1.4 Epigenetic programming during cell differentiation 
Epigenetic modifications alter dramatically during a cell differentiation, shaping the nuclear 
organisation of chromatin and determining gene expression programs through development to 
facilitate lineage commitment into specific tissue types. Histone modifications in combination with 
DNA methylation change the overall chromatin structure during differentiation, establishing three 
main chromatin states at CpG rich regions: transcriptionally active, repressed and poised chromatin 
(Figure 4) (Boland et al., 2014). 
 
Figure 4: Epigenetic control at promoters of poised, active and repressed transcript genes. Involvement of 
histone tail modifications in the form of methylation and acetylation in combination with DNA methylation is 
illustrated. Contributions of the following chromatin associated proteins are indicated: DNMT (DNA 
methyltransferase), HAT (histone acetyltransferase), HDAC (histone deacetylase), PcG (polycomb group 
complex), POL II (RNA polymerase II), TET (ten eleven translocation dioxygenase), TF (transcription factor) and 
TrxG (trithorax group complex) (adapted from Boland et al., 2014). 
Active open chromatin contains highly expressed genes and enhancers. Active promoters occupied 
by trxG, HATs, RNA polymerase II and TET proteins, are characterised by the presence of H3K4me3 
and H3K27ac as well as non-methylated cytosine, but increased levels in 5hmC (Figure 4). Active 
enhancers are marked with H3K4me1, H3K27ac and are occupied by the mediator complex. Gene 
bodies of actively transcribed genes are defined by the presence of H3K36me3. Other modifications 
such as H3K79 methylation, H3K56 acetylation or H2B ubiquitination were also shown to be 
associated with active transcribed genes (Boland et al., 2014; Dambacher et al., 2013; Shilatifard, 
2012). By contrast, the repressed chromatin features are present mainly at compact heterochromatic 
regions and associated with repressive genes. H3K27me3 modifications and 5mC are prominent at 
repressed promoters, which are as well occupied by DNMTs and HDACs (Figure 4). Genes that are 
occupied with H3K9me3 marks are completely repressed. Repressed enhancers lost their specific 
active enhancer features (H3K4me1 and H3K27ac) and are instead enriched for H3K27me3 and 5mC 
(Boland et al., 2014; Dambacher et al., 2013). In the poised chromatin state, promoter regions are 
marked with a bivalent histone modification profile including the activation mark H3K4me3 and the 
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repressive one H3K27me3 (Figure 4). The presence of the trxG and PcG proteins together with the 
poised RNA polymerase II allows a rapid transcriptional activation or repression upon initiation of cell 
differentiation (Aloia et al., 2013; Cui et al., 2009; Kouzarides, 2007). The DNA in poised chromatin 
contains little 5mC, but is enriched for 5hmC. Poised state correlates with an open chromatin 
structure, but the genes are silenced or lowly transcript (Bernstein et al., 2006; Meissner et al., 
2008). Poised chromatin states at promoters are mainly present in pluripotent or multipotent stem 
cells such as ESCs or haematopoietic stem cells (HSCs) at genes that are important for development, 
morphogenesis and in cell signalling pathways. Poised enhancers are characterised by H3K4me1 and 
H3K27me3 and with the presence of the mediator complex as transcriptional coactivator and are 
associated with low transcription. The gene body of poised chromatin is covered with H3K27me3 and 
5mC (Bernstein et al., 2006; Boland et al., 2014).  
The rapid global change of chromatin and transcription during differentiation is resulting in stable 
silencing of pluripotency genes, activation of lineage-specific genes as well as the controlled 
activation and repression of progenitor-specific gene (Kraushaar and Zhao, 2013). There are on one 
site the pluripotent ESCs characterised by an open and highly dynamic chromatin landscape. Somatic 
cells, on the other hand, have more and larger genomic regions that are occupied by H3K27me3 
(around 40% of total genome versus 8% in ESCs) resulting in a more defined, compact and closed 
chromatin structure with a higher content of heterochromatic regions. Comparison of histone 
modifications and DNA methylation pattern between ESCs and differentiated cells showed that 
around one-third of the genome differs in chromatin structure (Hawkins et al., 2010; Zhu et al., 
2013). Extracellular signals (cytokines, growth factors or morphogens) and intracellular transcription 
factors drive the gene expression pattern required for cell differentiation and lineage specification 
(Kraushaar and Zhao, 2013). Differentiation in response to environmental cues activates chromatin 
marks through transcriptional responses. Additionally, chromatin stages can provide gene priming as 
a form of preparation for future needs and it is achieved by establishing bivalent or similar states 
(Dillon, 2012). Bivalent domains are preferentially present in stem cells (ESCs or adult stem cells) but 
as well at lineage-specific genes in more mature cell stages, at mature T-cells for instance. This 
poised chromatin state allows a fast transcriptional activation or repression by losing one of the 
histone modifications during differentiation into somatic cells (Bernstein et al., 2006; Cui et al., 2009; 
Kraushaar and Zhao, 2013). Beside the bivalent domains, other mechanisms of epigenetic priming 
have been suggested. For instance, regulatory elements for brain development are occupied by high 
levels of DNA methylation in ESCs; they get demethylated and associated with H3K4me1 during 
ectoderm formation, but kept methylated in other lineages. Additionally, it was suggested that CpG 
poor regions with high DNA methylation levels in ESCs, get demethylated and enriched with 
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H3K27me3 methylation during differentiation in a lineage-specific manner (Boland et al., 2014; 
Gifford et al., 2013). Other examples are the specific epigenetic priming of myeloid and lymphoid 
genes during haematopoietic differentiation. Myeloid-specific genes are occupied by DNA 
methylation whereas lymphoid-specific genes are associated with the H3K27me3 mark in ESCs, 
allowing a fast activation through DNA demethylation and loss of H3K27me3 during differentiation, 
respectively (Cedar and Bergman, 2011). These examples indicate that histone modifications as well 
as DNA methylation play an important role in cell-type specific epigenetic priming, illustrating their 
important role in lineage commitment and cell plasticity. For more details on epigenetic features 
during haematopoiesis see section 2.2.3.  
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2.2 Haematopoietic system 
The haematopoietic system is the most regenerative tissue in humans and around two-thirds of its 
activity produces neutrophils, the most abundant white blood cell in the circulation. During 
haematopoiesis, alterations of histone modifications and DNA methylation generate lineage-specific 
gene expression patterns. Yet, aberrations in epigenetic modifications as well as genetic mutations 
are a hallmark of cancer and may also be a driving force of leukaemogenesis. The following chapters 
will introduce haematopoiesis especially neutrophilic granulopoiesis and specific epigenetic 
alterations during haematopoiesis and in leukaemic cells.  
 
2.2.1 General overview of haematopoiesis 
One trillion (1012) new blood cells are generated every day in the adult human bone marrow, 
illustrating that blood is the most regenerative tissue in humans. Multipotent HSCs have the capacity 
of durable self-renewal and can differentiate into all mature blood cells. After differentiation, blood 
cells migrate out of the bone marrow and reside in tissues, lymph nodes or circulate in the blood 
stream (Murphy, 2008). HSCs are localized in specific niches generated by osteoblasts with little 
blood flow and low oxygen levels. The HSC niches are located in the endosteum near the interface 
between bone marrow and bone. This environment and the contact with osteoblast cells are 
important for HSC survival, self-renewal and contribution to long-term haematopoiesis (Borregaard, 
2010; Winkler et al., 2010). HSCs differentiate into all different mature blood cells through several 
progenitor cell stages, which are categorized into lymphoid or myeloid cells (Doulatov et al., 2012) 
(Figure 5). T, B and natural killer cells belong to the lymphoid lineage, whereas the myeloid lineage 
comprises the megakaryocytes giving rise to platelets, erythrocytes (red blood cells), granulocytes 
and macrophages. According to the current model of human haematopoiesis, myeloid and lymphoid 
lineages are already separated at an early progenitor stage. The common myeloid progenitor (CMP) 
can differentiate into all myeloid cell types, whereas the lymphoid cells are generated by the 
multipotent lymphoid progenitor (MLP). However, recent studies indicated that human MLPs are not 
only restricted to the lymphoid lineage. They can give rise to myeloid cells, but do not have the 
potential to differentiate into erythroid and megakaryocytic cells. Dendritic cells are generated from 
either CMPs or MLPs and cannot be clearly grouped into a myeloid or lymphoid cell type (Doulatov et 
al., 2012; Kondo, 2010).  
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Figure 5: Lineage determination of human haematopoiesis. All the different types of human blood cells are 
derived from multipotent haematopoietic stem cells (HSCs) in the bone marrow. Differentiation gives rise to 
two common progenitor cells; the common myeloid (CMP) and the multipotent lymphoid progenitor (MLP). 
They are differentiating further into lineage-committed progenitor cells developing in multiple steps into 
distinct blood cells. All the different progenitor stages are indicated as following: ETP (earliest thymic 
progenitors), GMP (granulocyte–macrophage progenitor), MEP (megakaryocyte–erythrocyte progenitor), MPP 
(multipotent progenitor) (adapted from Doulatov et al., 2012). 
 
2.2.2 Neutrophils, their development and homeostasis 
Neutrophilic granulocytes are key players and the most abundant cell type of the innate immune 
system, arriving as the first immune cells at the site of infection. The immune system protects 
humans from disease-causing microorganism or pathogens and is divided into the innate and the 
adaptive immune system. Innate immunity is provided by macrophages, neutrophils and natural 
killer cells that constitute a fast but incomplete protection against microbes and generate a short-
term memory. By contrast, the adaptive immunity is a specific immune response against a particular 
pathogen or their product, mediated by T and B lymphocytes, and evolves during exposure to the 
pathogen. Adaptive immunity is generating long-term memory (Murphy, 2008). 
Granulocytes also known as polymorphonuclear leukocytes, they are derived from the CMP and are 
separated into three different cell types: neutrophils (90%), eosinophils and basophils. As 
neutrophils are short-lived cells with a half-life between a few hours to a few days, they need to be 
constantly generated in the bone marrow. To maintain homeostasis, the daily production of 
neutrophils is around 1 to 2 x 1011 cells in humans (Amulic et al., 2012; Borregaard, 2010). Around 
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66% of the haematopoietic activity in the bone marrow produces monocytes/macrophages and 
granulocytes. Two types of neutrophilic granulopoiesis can be distinguished: the steady-state and the 
emergency granulopoiesis. The steady-state granulopoiesis occurs at normal no inflammatory 
conditions or when local infections are present without disseminations. After severe infections 
including disseminations, neutrophils are consumed in large numbers inducing the emergency 
granulopoiesis. 
 
Figure 6: Lineage determination of neutrophilic granulopoiesis. Step-wise differentiation into neutrophilic 
lineage and its most related lineage, to macrophages. HSCs differentiate through the GMP stage into 
myeloblast cells, further through promyelocytes, myelocytes and metamyelocytes into neutrophils. The 
different neutrophilic stages can be distinguished by the expression of the surface markers CD34, CD11b and 
CD16b (adapted from Rosenbauer and Tenen, 2007).  
Neutrophils are derived from HSCs through a regulated differentiation process generating the 
intermediate states of myeloblasts, promyelocytes, myelocytes and metamyelocytes. The different 
maturation stages are distinguishable by expression of different surface marker or by analysing the 
transcription profile. For instance, human HSCs and progenitors as such CMPs and granulocyte-
macrophage progenitors (GMPs) express cluster of differentiation 34 (CD34), whereas CD11b and 
CD16b are upregulated in myelocytes and metamyelocytes, respectively (Figure 6). The production of 
neutrophils from progenitors is controlled by the key regulator of neutrophil development the 
granulocyte-colony stimulating factor (G-CSF), which is produced by bone marrow stroma cells in 
response to interleukin (IL)-17A. During steady-state conditions without infection, the release of 
G-CSF is regulated most likely by a feedback loop. Apoptotic neutrophils are phagocytosed in the 
tissue by macrophages and dendritic cells, which thereby reduce their IL-23 expression. In turn, 
reduction of IL-23 results in less IL-17A production by T cells and natural killer cells. As IL-17A is the 
main stimulus of G-CSF production in stroma cells of the bone marrow, neutrophilic granulopoiesis is 
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reduced (Borregaard, 2010; Bugl et al., 2012). G-CSF activates the major transcription factor C/EBPα 
through the STAT pathway, initiating the expression of several key genes of normal neutrophilic 
differentiation (Manz and Boettcher, 2014). Fully mature and non-mitotic neutrophils leave the bone 
marrow and enter the blood circulation. When no systemic infection is present, only 1-2% of mature 
neutrophils are circulating in the blood (Bugl et al., 2012). 
During inflammation, neutrophils are recruited from the blood to the infected tissue, guided by 
endothelial cells (Borregaard, 2010; Carmona-Rivera and Kaplan, 2016). They are able to take up 
different types of microorganism by phagocytosis, destroying them in intracellular vesicles. Another 
mechanism neutrophils use to fight pathogens is netosis, which invokes the release of neutrophil 
extracellular traps formed by decondensed chromatin fibers decorated with antimicrobial factors, 
leading to cell death of neutrophils (Remijsen et al., 2011; Zawrotniak and Rapala-Kozik, 2013). After 
severe infections including disseminations, neutrophils are consumed in large numbers, inducing the 
emergency granulopoiesis. Emergency granulopoiesis is characterized by increased de novo 
production of neutrophils, accelerated cellular turnover and release of mature as well as immature 
neutrophils from the bone marrow into the blood. The levels of granulocytic cytokines as G-CSF or 
early cytokines like IL-3, IL-6 or FMS-like tyrosine kinase 3 (FLT3) ligand are up to 100 times higher 
during emergency granulopoiesis compared to steady-state conditions. The increased G-CSF receptor 
signalling through JAK and STAT3 activates the transcription factor C/EBPβ replacing C/EBPα and 
inducing enhanced myeloid progenitor proliferation and neutrophil generation (Bugl et al., 2012; 
Manz and Boettcher, 2014). In addition, there is some recent evidence that increased granulopoiesis 
can be induced independently of the presence of a microbial pathogen by chemical agents (e.g. 
thioglycollate or 5-fluoruracil), physical insults (e.g. trauma or ionizing radiation) or autoimmune 
disorders (e.g. rheumatoid arthritis). Further studies are needed to describe this ‘reactive’ 
granulopoiesis in more detail (Manz and Boettcher, 2014). 
 
2.2.3 Epigenetics of the haematopoietic system 
The cell-type specific gene expression pattern epigenetically established during haematopoiesis are 
not well understood and were investigated only recently by analysing different haematopoietic 
intermediates from the blood (Cedar and Bergman, 2011). Multipotent progenitors (MPPs) derived 
from HSCs differentiate into progenitor cells of the myeloid and the lymphoid lineage: CMPs and 
MLPs. There is evidence from mouse studies that different mechanisms of epigenetic priming are 
involved to mark specific genes required for myeloid and lymphoid development in HSCs and MPPs. 
Myeloid and lymphoid-specific genes are silent in HSCs but are activated cell type-specifically during 
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differentiation. Interestingly, the expression of myeloid- and lymphoid-specific genes is probably 
poised by two different mechanisms. Generally myeloid-specific genes are repressed by DNA 
methylation in HSCs and MPPs and undergo programmed active demethylation to initiate myeloid 
differentiation, especially in CMPs. DNMT1 deletion in HSCs resulted in an increase of myeloid 
progenitor cells, whereas TET2 depletion led to an impaired myeloid differentiation, illustrating the 
important role of DNA demethylation during myeloid differentiation (Cedar and Bergman, 2011; Ko 
et al., 2010; Trowbridge et al., 2009). By contrast, usually lymphoid-specific genes are marked by the 
polycomb (PRC2)-mediated, repressive H3K27me3 modification in HSCs and MPPs. Activation of 
lymphoid related genes is initiated by the removal of the polycomb complex. Deletion of BMI1, 
encoding a member of the polycomb repressive complex, resulted in an increase of lymphoid 
progenitors through the activation of EBF1 and Pax5 (Oguro et al., 2010). Hence two different 
epigenetic mechanisms regulate the process of haematopoietic gene priming and thereby proper 
lineage commitment and differentiation (Cedar and Bergman, 2011). In addition to those 
mechanisms, an H3K4me2-based process was described for a subset of lineage-specific genes. These 
genes are occupied by H3K4me2 and not by H3K4me3 marks at transcription start sites or regions 
important for transcription factor binding. They are not transcribed in HSCs, but can either be 
activated by methylating H3K4me2 to H3K4me3 in specific cell types or undergo H3K4 
demethylation, eventually leading to silencing in other blood cell types. One example is Gata1 which 
is an erythroid-specific gene occupied by H3K4me2 in HSCs. H3K4 trimethylation rises in erythrocytes 
whereas H3K4me2 is demethylated in other blood cell types (Orford et al., 2008).  
Similar to ESCs, HSCs are characterized by a large number of bivalent chromatin domains. A small 
fraction of cell type-specific genes is losing the H3K27me3 modification during haematopoiesis and 
gets activated, but most of them lose H3K4me3 methylation and are silenced. The bivalent marks in 
HSCs maintain the activation potential for the genes necessary for cell type-specific activation (Cedar 
and Bergman, 2011). Bivalent domains in murine HSCs are enriched at promoters of genes encoding 
regulators of embryonic developmental, key transcription factors and growth factors for 
haematopoiesis (Weishaupt et al., 2010). The small fractions of bivalent domains that are activated 
during differentiation are characterized by the presence of the H3K4me1 and H3K9me1 marks as well 
as H2A.Z and RNA polymerase II occupancy, indicating a transcriptionally poised state. By contrast, 
bivalent regions concomitantly marked by H3K9me3 stay silent throughout differentiation (Cui et al., 
2009). Notably, some bivalent domains are also present in later cell stages like mature T-cells, 
located at promoters of genes required for further differentiation into effector T-cells (Wei et al., 
2009).  
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During differentiation, epigenetic modifications of stem cells change into cell type-specific 
modifications of somatic cells, resulting in a unique pattern in each lineage. Two-thirds of the 
haematopoietic activity produces neutrophils and neutrophilic granulopoiesis is an important subject 
in my PhD thesis, hence, exemplified the epigenetic alterations during human granulopoiesis. Global 
DNA methylation is decreasing during myeloid differentiation, but increasing upon lymphoid 
commitment comparing isolated HSCs with mature blood cells (Ji et al., 2010). Comparison of DNA 
methylation profiles of isolated CD34+ progenitor cells (including HSCs, CMPs, GMPs) with mature 
blood granulocytes indicated a global DNA demethylation during granulopoiesis (Bocker et al., 2011). 
However, an increase of genome-wide DNA methylation was observed between isolated CMPs and 
GMPs probably associated with the progressive loss of stemness. After global gain of DNA 
methylation, a loss of genome-wide methylation was observed between GMPs and promyelocytes, 
and to a lower extent between promyelocytes and blood neutrophils, reflecting the activation of 
neutrophil-specific genes (Alvarez-Errico et al., 2015; Ronnerblad et al., 2014). Therefore, DNA 
methylation is dynamically regulated, and levels and patterns depend on the stage of differentiation. 
Additionally, human blood neutrophils are characterized by a high amount of heterochromatin 
containing different repressive histone modifications, including H3K9me3, H3K27me3 or H3K20me3, 
and low amounts of active histone modifications (e.g. H3K4me3 and H3K4me2) (Navakauskiene et 
al., 2014; Olins and Olins, 2005). By contrast, ESCs are characterised by an open and highly dynamic 
chromatin state (Hawkins et al., 2010). However, the mechanism of progressive chromatin change 
during neutrophilic granulopoiesis is poorly understood. Global chromatin compaction takes place in 
non-dividing but shape-changing nuclei during granulopoiesis and is associated with stages beyond 
myelocytes (Olins and Olins, 2005). In contrast to this extensive chromatin mediated gene silencing, 
the neutrophil-specific genes PU.1, MPO and CD11b, which are kept in a poised state in human HSCs, 
are activated during an in vitro differentiation of 14 days into neutrophilic lineage, accompanied by 
high H3K4me3, low H3K27me3 and low H3K9me3 levels (Tang et al., 2014).  
 
2.2.4 Leukaemia 
Leukaemia is a haematopoietic malignancy also known as blood cancer, characterized by an 
accumulation of immature, non-functional malignant blood cells. According to the haematopoietic 
linage affected and mode of disease progression, four types of leukaemia are distinguished: acute 
myeloid (AML), chronic myeloid (CML), acute lymphocytic (ALL) and chronic lymphocytic (CLL) 
leukaemia. Acute leukaemia has a rapid progression with highly enriched immature cells, whereas 
chronic leukaemia is characterize by a slow progression in combination with high numbers of mature 
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cells. ALL is the most common type of leukaemia in children with around 80% of all acute cases in 
Switzerland (USA 75%), whereas AML is the most diagnosed type of acute leukaemia in adults (80% 
in Switzerland) (Florean et al., 2011; Krebsliga, 2016). 
ALL is characterized by an accumulation of leukaemic lymphoblasts in the bone marrow and other 
tissues, displaying dysregulated proliferation and survival, as a consequence of genetic alterations in 
early B- and T-progenitor cells. The most common genetic alterations in ALL are chromosomal 
translocations, including t(9;22)/BCR-ABL, t(4;11)/MLL-AF4, t(12;21)/TEL-AML1 and t(1;19)/E2A-PBX 
(chromosomes affected/fusion genes, Table 2) (Mrozek et al., 2009). In childhood lymphoblastic 
leukaemia for instance, the most common genetic alteration generated by a chromosomal 
translocation between chromosomes 12 and 21 results in the fusion protein TEL-AML1 (also known 
as ETV6-RUNX1). The translocations found in childhood leukaemia have foetal origin. Nevertheless, 
the development of childhood lymphoblastic leukaemia requires the postnatal accumulation of 
additional chromosomal or genetic aberrations as proposed in the ‘two-hit’ model of childhood 
leukaemia (Greaves, 2002). Several environmental factors were postulated promoting childhood 
leukaemia as a second hit after birth, including magnetic field exposure, infections or certain 
chemical (e.g. benzene) (Greaves, 2002; IARC, 2002; Martin-Lorenzo et al., 2015). 
 chromosomal translocations 
mutations in epigenetic modifiers for 
DNA methylation histone modifications 
AML 
t(15;17)/PML–RARα 
t(8;21)/AML1–ETO 
Inv(16)/CBFb–MYH11 
11q23/MLL-fusion protein 
DNMT3a 
IDH1 
IDH2 
TET2 
ASXL1 
EZH2 
HAT domain of CBP 
MLL-fusion protein 
PRMTs 
UTX 
ALL 
t(9;22)/BCR-ABL 
t(4;11)/MLL-AF4 
t(12;21)/TEL-AML1 
t(1;19)/E2A-PBX 
Dnmt3a 
EZH2 
HAT domain of CBP 
HDAC 
MLL-fusion protein 
UTX 
Table 2: Acute leukaemia associated chromosomal translocations and epigenetic alterations. Genetic 
alterations and mutations in epigenetic modifiers are hallmarks of acute leukaemia, listed are the four most 
frequent chromosomal translocations and the best documented epigenetic modifiers with mutations in acute 
myeloid and lymphocytic leukaemia. The following epigenetic modifiers are indicated: DNMT3a (DNA 
methyltransferase 3a), IDH1/2 (isocitrate dehydrogenase 1/2), TET (ten eleven translocation dioxygenase), and 
ASXL1 (polycomb group protein additional sex comb like 1), EZH2 (polycomb group protein enhancer of zeste 
homolog 2), HAT (histone acetyltransferase), MLL (mixed lineage leukaemia protein a lysine 
methyltransferase), UTX (lysine-specific demethylase), and PRMTs (protein arginine methyltransferase). For 
chromosomal translocations: chromosomes affected/generated fusion genes (Florean et al., 2011; Greenblatt 
and Nimer, 2014; Martens and Stunnenberg, 2010; Mrozek et al., 2009; Xiao et al., 2016).   
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AML originates from blocked myeloid differentiation, resulting in rapid proliferation of immature 
myeloid progenitor cells in the bone marrow, which expand to other organs including liver and 
spleen (Mehdipour et al., 2015). The four most common AML associated chromosomal aberrations 
among more than 700 known ones are t(15;17)/PML–RARα, t(8;21)/AML1–ETO, Inv(16)/CBFb–
MYH11, 11q23 and mixed lineage leukaemia (MLL)-fusion proteins (Table 2) (Florean et al., 2011; 
Martens and Stunnenberg, 2010). A simple ‘two-hit’ model of acute myeloid leukaemia was 
proposed as most of them have mutations or gene arrangements of two different classes. The first 
class (class I) of genetic alterations, resulting in a proliferation or survival advantage of 
haematopoietic progenitor cells, includes mutations that constitutively activate various signalling 
pathways like PI3K or RAS-MAPK (Shih et al., 2012). The second class (class II) alters the 
transcriptional regulation of haematopoietic differentiation and includes mutations in the core 
binding factor, retinoic acid receptor alpha or MLL protein (Conway O'Brien et al., 2014; Kelly and 
Gilliland, 2002).  
Only about 60% of all AML patients have mutations in a signalling gene (class I mutation), indicating 
that not all AMLs can be explained by the two-hit model of AML (Cancer Genome Atlas Research, 
2013). In addition, somatic mutations in genes involved in development or signalling were found in 
only 20% of early T-cell precursor-ALL (Zhang et al., 2012). This suggests at least a third class of 
mutations is involved in the development of leukaemia. A prominent candidate appears to be 
mutations in genes encoding epigenetic modifiers, as recent studies showed that in AML as well as in 
ALL somatic mutations are present in genes encoding epigenetic modifiers important for DNA 
methylation and histone modifications, pointing to a role of epigenetics in leukaemogenesis (Table 2) 
(Greenblatt and Nimer, 2014). As proper regulation of epigenetic mechanisms is critical for 
haematopoiesis, epigenetic modifications appear to constitute a class of genomic alterations with an 
important role in the development of leukaemia. Alterations in DNA methylation (5mC) patterns are 
found in various human cancers including leukaemia. For instance, tumour suppressor genes are 
transcriptionally silenced by methylation in different leukaemic subtypes. Additionally, gain of CpG 
methylation at promoters of the homeobox (HOX) A4 and HOXA5 genes was found in AML and ALL, 
correlating with poor prognosis and suggesting an important role of these HOX genes in the 
development of human leukaemia (Strathdee et al., 2007). By contrast, loss of DNA methylation was 
shown to activate proto-oncogenes in leukaemia. Moreover, epigenetic modifiers for DNA 
methylation, including DNMTs and TETs, are found in different types of leukaemia. 22% of patients 
with AML for instance, have a DNMT3a mutation, mainly including patients with repetitive de-novo 
AML having a poor prognosis. Additionally, expression of DNMT1, DNMT3a and DNMT3b is increased 
in some AML accompanied by a gain of DNA methylation at specific genomic regions. IDH1 and IDH2 
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mutations disturbing function of TET2, amongst others, as well as TET2 mutations themselves are 
frequently found in AML patients, linking epigenetic control of gene expression with cancer 
metabolism (Florean et al., 2011). Beside alterations at DNA methylation, mutations in genes 
encoding epigenetic modifiers of histone modifications were found in leukaemic cells, including 
subunits of the polycomb or trithorax-group. The most common mutation in T-ALL (16-19%) is found 
in the methyltransferase EZH2, a subunit of PRC2 (Ntziachristos et al., 2012). Other genetic 
alterations affecting PRC1 and PRC2 were found in different kind of leukaemia, including loss-of-
function mutations, copy-number alterations or overexpression, indicating an important role of these 
complexes in the development of human leukaemia. Also, mutation in HATs, HDACs, HDMs and the 
trithorax MLL gene encoding the histone H3K4 methyltransferase occurs in leukaemia. Translocations 
of the MLL gene are found in AML (5-10%) and in ALL (70 % of childhood ALL), resulting in a poor 
prognosis for the patients (Greenblatt and Nimer, 2014). Moreover, the oncogenic character of some 
of the known fusion proteins is due to the recruitment of epigenetic partners to aberrant locations in 
the genome. This can result in silencing of tumour suppressor genes or activation of developmental 
genes promoting cancer development (Florean et al., 2011). In support of this notion, mutations in 
epigenetic modifiers of mice were shown to be critical for HSC self-renewal and differentiation, and 
to contribute but not to induce leukaemia. However, the early occurrence of epigenetic mutations in 
cancer and potentially reversibility of these modifications makes the usage of small inhibitory 
molecules able to target the epigenetic modifiers a promising strategy to add in leukaemic therapies 
(Greenblatt and Nimer, 2014). 
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2.3 Biological effects of extremely-low-frequency magnetic fields (ELF-MFs) 
Over the last decades, there have been increasing concerns about potential health risks from the use 
of electronic appliances emitting magnetic (MF) and electromagnetic fields (EMF). Exposure to EMFs 
is not a new phenomenon, but man-made sources have simultaneously increased with advanced 
technologies and changed social behaviour. Main sources of EMFs start from household appliances 
and powerlines to telecommunications and wireless technologies. Human epidemiological studies as 
well as studies in animal and cellular models were used to investigate potential biological effects of 
ELF-MF exposure, but with inconclusive results (IARC, 2002; SCENIHR, 2015; WHO, 2007, 2016). On 
the grounds of epidemiological associations between ELF-MF exposure and increased risk of 
childhood leukaemia, ELF-MF were categorised as “possibly carcinogenic” to humans by the 
International Agency for Research on Cancer (IARC) (IARC, 2002). Mechanisms underlying this 
correlation, however, have remained elusive. Until now, there are hardly any reliable and 
reproducible data that would point to a universal mechanism. Contradictory results were generated 
analysing different endpoints relevant for cancer development, including cell cycle progression, 
apoptosis or genomic integrity. Due to the use of different cell types, exposure equipment, applied 
fields (static, dynamic, frequency, intensity etc.) and exposure times, it is difficult to compare and 
integrate reported positive and negative outcomes into consistent and plausible mechanistic 
concepts. The following chapters introduce electromagnetic fields, their observed correlation to 
human health and investigations into mechanism underlying its contribution to carcinogenesis.  
 
2.3.1 Basic physical background of electromagnetic fields 
Connected with our modern lifestyle, magnetic as well as electric fields are present wherever 
electricity is generated, transmitted or consumed, i.e. in power lines or electric applicants. EMFs are 
generated by electric charges and their motion. The energy is transported in the form of waves 
through space, consisting of an electric and a magnetic field perpendicular to each other (Figure 7). 
Electric fields are produced by the strength of electric charges and are indicated as volt per meter 
[V m-1]. By contrast, magnetic fields result from the movement of the charge and are measured in 
Tesla [T]. The Maxwell’s equation describes the fundamental law of electromagnetic fields: moving 
magnetic fields generate moving electric fields and vice versa. However at extremely-low frequency 
EMFs of 3-3000 Hz, the magnetic and the electric fields can be measured separately and are 
considered to be physically uncoupled (IARC, 2002). Most man-made sources of electromagnetic 
radiation emit EMF waves with field strengths that vary sinusoidally with time, produced by 
alternating current (AC) of electric systems. The current moves not unidirectional but back and forth 
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with a specific frequency; the number of cycles per seconds are quantified in Hertz [Hz] and the 
distance between peaks in the wave is indicated as wavelength [] (IARC, 2013; WHO, 2007). By 
contrast, static magnetic fields do not vary over time; the direct current (DC) is flowing constantly in 
one direction and DC is used in some rail or subway systems as well as in batteries or in magnetic 
resonance imaging (SCENIHR, 2009).  
 
Figure 7: Schematic representation of an electromagnetic wave. Sinusoidally varying electromagnetic wave 
consisting of an electric (E) and a magnetic field (H) perpendicular to each other (IARC, 2013).  
Electromagnetic fields are separated in two different classes: ionizing and non-ionizing radiation 
(Figure 8). High frequency EMFs are classified as ionizing radiation including X-rays and gamma rays, 
capable of transferring energy level that are high enough to break atomic bonds of molecules, i.e. to 
damage DNA directly. By contrast, non-ionizing radiations in the low- to mid-frequency range 
including EMFs from powerlines, radio waves, microwaves, infrared radiation as well as visible light 
are not able to damage DNA directly, they are not transferring enough energy required to affect 
chemical bonds. Extremely low frequency magnetic fields (ELF-MFs) such as emitted from powerlines 
(50 Hz in Switzerland) have frequencies between 1 and 3000 Hz, whereas radiofrequency EMFs used 
in communication technology like mobile phones range from 30 kHz to 300 GHz (Blank and 
Goodman, 2011). In homes, the main sources of ELF-MFs are in-house power installations, household 
appliances and powerlines, generating an average exposure level between 0.025 and 0.07 µT in 
Europe and 0.055 and 0.11 µT in the United States (SCENIHR, 2015; WHO, 2007). The International 
Commission on Non-Ionizing Radiation provides guidelines for ELF-MF exposure limitations to protect 
humans against EMF exposure in the low frequency range. These guidelines are based on scientific 
evidence on ELF-MF effects on human health (see 2.3.2). The most recent guideline, published in 
2010, sets the emission threshold for general public areas to 200 µT for 50 Hz ELF-MFs (ICNIRP, 
2010). Currently, Switzerland has one of the strictest regulations for 50 Hz magnetic fields 
worldwide; the threshold is set to 100 µT for public areas and even 1 µT for areas where people 
spend most of their time like in living rooms, bed rooms or at work places. As a comparison, 
Germany has only a fixed one at 100 µT (Swissgrid, 2015).  
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Figure 8: Electromagnetic spectrum. Electromagnetic fields are illustrated from non-ionizing radiation at low 
frequency to ionizing ration at high frequency ELFs and some examples of application of the different 
frequency ranges (adapted from Kumer, 2014). 
 
2.3.2 Association of ELF-MF exposure with the risk of childhood leukaemia  
Epidemiological studies over the last three decades repeatedly showed a positive association 
between ELF-MF exposure and the occurrence of childhood leukaemia, but no association with other 
types of cancer was observed. Based on the results of these epidemiological studies, ELF-MF was 
categorised as being possibly carcinogenic to humans (Group 2B) by IARC in 2002 (IARC, 2002). As the 
categorisation in this risk assessment was primarily based on the results of epidemiological studies, 
there was scientific debate on the validity of the assessment, yet, the potential risk of ELF-MFs was 
recently confirmed (SCENIHR, 2007, 2015; Schuz et al., 2016).  
In Europe, a typical daily mean exposure level of children is below 0.1 µT, only 1-2% of children are 
exposed to ELF-MF daily means more than 0.3 µT. Latest epidemiological studies determined a 1.5 to 
2-fold increase in risk for childhood leukaemia at average exposure levels for 24 hours above 0.3 - 
0.4 µT, confirming the results from older studies. Yet, no significant correlation was determined at 
lower exposure levels (Ahlbom et al., 2000; Kheifets et al., 2010). Both studies were pooled analysis 
from several individual cohorts, including in total 3’247 cases of childhood leukaemia and 10’000 
children in the control group analysed by Ahlbom et al. (2000) and 10’818 leukaemia patients vs 
12’806 controls by Kheifets et al. (2010). Additionally, a recent study analysed childhood leukaemia 
data collected from 1962 until 2008 of 53’515 children together with matched controls, indicating an 
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association of leukaemia and ELF-MF exposure only before 1990 (Bunch et al., 2014). These suggest 
that changing population characteristics among those living near powerlines may play an additional 
role. Although despite the analysis of more than 20 epidemiological studies, the lack of supportive 
evidence of experimental studies and mechanistic data still raise concerns about the causality 
indicated by the results of the epidemiological studies. Due to participation bias for instance, as 
individual studies include small numbers of highly exposed children, different selection procedures of 
control children or low participation numbers in general. Additionally, methodological shortcomings 
of studies, including misclassifications of exposure levels, information bias, confounding or 
publication bias, are of concerns. Overall, the classification of ELF-MF as possibly carcinogenic 
remains valid. Hence, the current estimated risk of ELF-MF is that up to 2% of childhood leukaemia 
cases in Europa may be promoted by ELF-MF exposure (Schuz and Ahlbom, 2008).  
 
2.3.3 Effects of ELF-MF exposure on cell proliferation, cell cycle and cell viability 
Epidemiological studies determined a correlation of EMF and leukaemia, but the underlying cellular 
mechanisms are still elusive. The following three chapters will summarise results of in vitro studies 
dealing with possible EMF-induced effects, trying to explain the correlation of ELF-MF and increased 
risk for childhood leukaemia at the mechanistic level. However, the studies produced contradictory 
results, which is why it remains difficult to integrate all the reported negative and positive 
experimental outcomes into a global consistent mechanistic picture. Moreover, most animal studies 
failed to support evidence that magnetic fields can cause tumours, but a recent study indicated a 
significant carcinogenic effect in Spraque-Dawley rats exposed to sinusoidal 50 Hz magnetic field in 
combination with an acute low-dose γ-ray radiation (SCENIHR, 2015; Soffritti et al., 2016). Therefore, 
it is important to understand the ELF-MF induced cell damage or cell mis-programming and how it is 
related to cancer to be able to substantiate or decline the hypothesized causal relationship between 
exposure and leukaemia.  
Impact of ELF-MF on cell cycle and cell proliferation  
Cell cycle deregulation is a hallmark of tumour cells, contributing to unscheduled cell proliferation 
(Malumbres and Barbacid, 2009). Cell cycle is a regulated process controlled by cyclin-dependent 
kinases (CDKs), resulting in cell division and production of daughter cells. The mammalian cell cycle is 
separated into four phases: G1, S, G2 and M phase (Figure 9). Cellular growth takes place in growth 
phases G1 and G2. Non-cycling cells mostly rest in G1 phase, sometimes referred to as G0 phase. In 
the synthesis phase (S phase) the DNA is replicated and during mitotic phase (M phase) the 
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duplicated chromosomes are divided before the cellular division into daughter cells. Mitosis is 
separated in individual phases: prophase, prometaphase, metaphase, anaphase and telophase. 
During prophase, the duplicated chromosomes become decondensed and centrosomes are 
separated. The nuclear envelope disperses, and mitotic spindle are assembled and connected to the 
chromosomes during prometaphase. In metaphase, chromosomes are aligned at the spindle equator, 
while the centrosomes split, and chromatids separate and move towards the poles during anaphase. 
Reformation of nuclear envelope and DNA decondensation occurs during telophase followed by cell 
division into two daughter cells (Scholey et al., 2003; Verdaasdonk and Bloom, 2011; Walczak et al., 
2010).  
 
Figure 9: Mammalian cell cycle. DNA synthesis (S) phase, mitosis (M) phase including metaphase, and the two 
resting phases G1 and G2 are indicated. Checkpoint mechanisms control the cell cycle progression, including 
DNA damage, DNA replication, antephase and spindle assembly checkpoints (adapted from Chin and Yeong, 
2010). 
Checkpoint mechanisms ensure that cell cycle procedure occurs only by completion of all essential 
tasks in the processing cell phase. Activation of checkpoints induces cell cycle arrest allowing repair 
of the lesion. After successful repair, cells resume cell cycle progression, otherwise cells enter 
senescence or undergo apoptosis (Malumbres and Barbacid, 2009). Different checkpoints through 
the whole cell cycle coordinate DNA repair with chromosome metabolism and cell cycle transitions, 
including DNA damage, DNA replication, spindle damage and antephase checkpoints (Branzei and 
Foiani, 2008; Chin and Yeong, 2010). The DNA damage checkpoints detect and resolve DNA lesions 
during late G1, intro S and G2 phase, while the DNA replication checkpoint controls DNA damage in 
response to replication stress during S phase (Bertoli et al., 2013). The spindle assembly checkpoint 
controls the correct chromosome segregation and attachment of chromosomes to spindles during M 
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phase (Bertoli et al., 2013; Malumbres and Barbacid, 2009), and the antephase checkpoint prevents 
cell entering into M phase in the presence of stress conditions (Chin and Yeong, 2010). Notably, 
disturbed regulation of the cell cycle leads to altered cell proliferation and is often observed in 
cancerous cells (Bou Kheir and Lund, 2010; Gerard and Goldbeter, 2016; Santini et al., 2005).  
Many studies investigated the impact of ELF-MF exposure on cell cycle progression and cell 
proliferation, yielding contradictory results. For instance, an increase of cell proliferation was 
observed by Zhang et al. (2013) in human epidermal stem cells exposed to ELF-MF (50 Hz, 5 mT, 
30 min/day, 7 days), additionally they observed an increase of the percentage of cells in S phase and 
a decrease in G1 phase cells. Moreover, Mihai et al. (2014) found cell cycle effects of ELF-MF (100 Hz, 
5.63 mT, continuous and discontinuous, 45 min) in Vero cells (kidney epithelial cell). Cell cycle 
profiles analysed 48 h after exposure illustrated an increase of the frequency of cells in S phase. 
Similarly, Martinez et al. (2012) reported an increase in cell number and in percentage of cells in 
S phase in NB69 cells (neuroblastoma) upon an intermitted ELF-MF (50 Hz, 0.1  mT, 5’ on / 10’ off, 63 
h), effects which were absent when continuous ELF-MF exposure was applied. Further studies found 
increased cell proliferation upon ELF-MF (50 Hz, 0.1 mT, 3 h on and 3 h off, 45 h) in two human cell 
lines (neuroblastoma NB69 and hepatocarcinoma HepG2 cells), but decreased proliferation under MF 
exposure in the presence of all-trans-retinol (Martinez et al., 2016; Trillo et al., 2012; Trillo et al., 
2013).  
In addition, other studies observed a small cell cycle arrest upon ELF-MF exposure. For instance, 
ELF-MF exposure (50 Hz, 1 mT, 24-72 h, continuous) of all-trans-retinol-induced neuroblastoma 
BE(2)C cells resulted in an decreased cell number, seemingly, because of a higher proportion of cells 
in G0/G1 phase (Marcantonio et al., 2010). Additionally, Huang et al. (2014) observed an G1 arrest in 
human HaCaT cells (immortalized epidermal keratinocyte cell line) exposed to ELF-MF (60 Hz, 1.5 mT, 
144 h) but no effect on cell growth, cell proliferation and cell cycle distribution in primary normal 
human epidermal keratinocytes, indicating a cell type-specific effect of ELF-MFs in this case.  
There are many more studies describing effects of ELF-MF exposure on cell proliferation and cell 
cycle distribution, but with non-comparable results depending on cell type used and exposure 
conditions. One interesting observation is that several studies showed an effect upon ELF-MF 
exposure with an intermitted field, but no effect with continuous exposure (Focke et al., 2010; 
Ivancsits, 2002; Martinez et al., 2012). The dependency on intermitted ELF-MF remains elusive, but it 
may indicate a more complex biological response dependent on different processes in addition to 
cell cycle progression, including alteration of metabolic activity or induction of apoptotic cell death.  
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Impact of ELF-MF on cell viability 
Another important hallmark of cancerous cells is that they can resist cell death, resulting in unlimited 
cell proliferation (Hanahan and Weinberg, 2011). There are two major types of controlled cell death 
in mammals: apoptosis and necrosis. Apoptosis is a mechanism of regulated cell death to eliminate 
abnormal, non-functional or harmful cells generated upon cell damage or stress but as well during 
normal development and morphogenesis. Caspase activation through death receptor ligands or 
release of apoptotic mediators from the mitochondria initiates mitochondrial membrane 
permeabilization, chromatin condensation, global mRNA decay, nuclear and DNA fragmentation 
(Nikoletopoulou et al., 2013; Thomas et al., 2015). These processes lead to the generation of 
apoptotic bodies (membrane-enclosed vesicles), which are removed by phagocytic cells such as 
neutrophils, macrophages or dendritic cells without inducing an immune response (Edinger and 
Thompson, 2004; Nikoletopoulou et al., 2013). By contrast, necrotic death is characterized by the 
alteration and degradation of organelles, resulting in cellular swelling followed by a rapid release of 
the whole cell content inducing an inflammatory response. Necrosis does not occur during normal 
development, but is important in inflammatory reactions or plays a role in cancer development. 
During inflammation for instance, necrosis can be triggered by biomolecules able to initiate an 
immune response, including the cytokine tumor necrosis factor or lipopolysaccharide present at 
pathogens (Nikoletopoulou et al., 2013; Wallach et al., 2016; Zong and Thompson, 2006).  
Again, there are inconsistent results reported for the impact of ELF-MF exposure on induction of 
apoptosis, but also a great heterogeneity in the experimental conditions (cell type, ELF-MF field, 
exposure time, controls etc.) as well as the evaluation of apoptosis. A decrease of apoptotic cells 
upon ELF-MF exposure was observed in a study of Brisdelli et al. (2014). They investigated the effect 
of ELF-MF (50 Hz sinus, 1 mT) on apoptosis induced by different compounds (vinblastine, etoposide, 
quercetin and resveratrol) in human K562 chronic myeloid leukaemia cells. In quercetin treated cells 
after 48 h of ELF-MF exposure, they observed a significant reduction in the percentage of apoptotic 
cells as well as in caspase-3 activity. These effects were accompanied with an increased expression of 
the anti-apoptotic proteins Bcl-2 and Hsp70. The authors concluded that the ELF-MF exposure may 
modulate pro-survival mechanisms in K562 cells. Basile et al. (2011) observed no impact of ELF-MF 
exposure (50 Hz, 30 A/m, 6 h) on levels of stress-related Hsp70 protein and cell apoptosis but an 
increase in the anti-apoptotic protein BAG in two melanoma cell lines. On the other side, many other 
studies indicated either an induction of apoptosis or no effect by ELF-MF exposure. Garip and Akan 
(2010) reported that exposure of K562 human leukaemic cells with ELF-MF (50 Hz, 1 mT, 3 h) in 
combination with co-exposure to H2O2 increased the percentage of apoptotic cells compared to cell 
treated with H2O2 only. Moreover, human lymphoblast cells exposed for 72 h to ELF-MF (50 Hz, 60 
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µT) showed a two-fold increased rate of apoptosis (Mangiacasale et al., 2001). Tofani et al. (2001) 
described increased apoptosis after ELF-MF (50 Hz, 3 mT, 20 min) in two transformed cell lines (WiDr 
human colon adenocarcinoma and MCF-7 human breast adenocarcinoma) but no change in non-
transformed cell line (MRC-5 embryonal lung fibroblast). Notably, no alteration in cell viability after 
ELF-MF exposure was reported in several additional studies (e.g. Giorgi et al., 2014; 2015). 
 
2.3.4 Effects of ELF-MF exposure on genomic integrity 
Based on elementary physical principles, the energy content of ELF-MFs is not high enough to 
directly alter chemical bonds of biomolecules, including DNA (Adair, 1998). ELF-MF is therefore 
unlikely to directly induce mutagenic DNA damage in cells, and increase the mutation rate in a way 
that could explain the putative cancerogenic effect. Yet, there are occasional reports indicating a 
genotoxic potential of ELF-MF exposure (e.g. Duan et al., 2015; Focke et al., 2010; Mihai et al., 2014; 
Vijayalaxmi and Prihoda, 2009). But, secondary effects that may give rise to DNA structural 
alterations such as changes in cell proliferation and cell cycle progression or apoptosis have in many 
cases not been excluded. Different studies evaluated the genotoxic potential of ELF-MF exposed cells 
by performing comet assays, sister chromatid exchange analysis and micronucleus formation, or by 
evaluating single- or double-strand break formation as well as chromosomal alterations. 
A meta-data analysis compared 87 separate studies from 1990-2007 analysing genetic damage in 
mammalian somatic cells exposed to ELF-MF. The most prominently used condition was 50 Hz 
ELF-MF at a flux density of 1 mT (Vijayalaxmi and Prihoda, 2009). The analysis showed that in 46% of 
the studies no ELF-MF dependent increase in DNA damage were observed, whereas in 22% of them, 
a genotoxic potential was apparent and 32% had inconclusive results. The pooled analysis revealed a 
small significant increase in the genotoxic potential of ELF-MF exposure. More recent studies 
reported for instance, that ELF-MF exposure (100 Hz, 5.6 mT, continuous and discontinuous, 45 min) 
of the kidney epithelial cell line Vero resulted in an increase of cells with highly damaged DNA 
measured 48 hours after exposure (Mihai et al., 2014). Furthermore, primary human fibroblasts 
exposed to ELF-MF (50 Hz, 1 mT, 5’ on/10’ off) for 15 hours had a significant increase in DNA damage 
(Focke et al., 2010). Treatments with H2O2 indicated that these increased genotoxicity in fibroblasts 
upon ELF-MF exposure was unlikely to be due to increased levels of oxygen radical species. 
Disturbance of S phase associated DNA transactions and induction of apoptosis in a subpopulation of 
ELF-MF exposed cells was proposed as a possible explanation. Additionally, a genotoxic effect of 
ELF-MF (50 Hz, 5’ on/10’ off) was observed in mouse spermatocyte-derived GC-2 cells at a flux 
density of 3 mT but not at 1 mT or 2 mT (Duan et al., 2015). These results are in line with other 
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studies, which could not confirm the genotoxic effect of ELF-MF at lower flux densities. For instance, 
human blood cells exposed to ELF-MF (50 Hz, 1 mT) for 2 h showed no difference in DNA damage 
compared to control cells and co-exposure with ionizing radiation had no synergistic effect (Stronati 
et al., 2004). 
Other studies investigated the potential of ELF-MF to induce nuclear foci of γH2AX. The 
phosphorylation of the histone variant H2AX generating γH2AX is a response to DNA strand 
interruptions and stress (Kuo and Yang, 2008). For instance, γH2AX levels as well as γH2AX foci 
formation was found to be increased in human lung fibroblasts and human lung epithelial L132 cells 
after ELF-MF exposure (60 Hz, 2 mT, 6 h). However, no difference was detected after exposure to a 
50 Hz, 1 mT ELF-MF, consistent with a dose-dependent effect (Yoon et al., 2014). Furthermore, Giorgi 
et al. (2014) determined the γH2AX formation upon ELF-MF exposure (50 Hz, 1 mT, pulsed; 1 h, 24 h, 
48 h or 72 h) in the presence of a genotoxic oxidative agent (H2O2) in human neuroblastoma and did 
not observe alteration of the DNA damage response following magnetic field exposure. Burdak-
Rothkamm et al. (2009) found no significant change in DNA or chromosomal damage in ELF-MF 
(50 Hz, 0.5-1 mT, 5’on/10’off, 15 h) exposed fibroblasts, analysed by γH2AX formation, comet assay, 
sister chromatid exchange and micronuclei detection. 
Several studies investigated the potential of ELF-MF exposure to affect DNA damage levels initiated 
by other genotoxic reagents, such as ionising radiation, H2O2 or menadione. Indeed, some authors 
reported increased genotoxicity of the carcinogen after co-exposure with ELF-MF, whereas others 
found no such effects. Luukkonen et al. (2014) found that human SH-SYSY neuroblastoma cells 
exposed to ELF-MF (50 Hz, 0.1 mT, 24 h) followed by a 3 hours menadione treatment have an 
increase in micronuclei formation 8 and 15 days after exposure. Additionally, they observed an 
increase in levels of reactive oxygen species directly after exposure as well as 15 days later. 
Moreover, DNA strand break and micronuclei induction were analysed in human peripheral blood 
lymphocytes by Cho et al. (2014) after. Cells were exposure to ELF-MF (60 Hz, 0.8 mT, 48 h) in 
combination with gadolinium, a contrast agent used for magnetic resonance imaging, reporting an 
increased genotoxic effect of gadolinium when exposed with ELF-MF. In another study, human 
fibroblasts and two epithelial cell lines exposed to ELF-MF (60 Hz, 1 mT, 4 h or 16 h) in the presence, 
or absence of different carcinogens (ionising radiation, H2O2), showed no difference in DNA damage 
formation when ELF-MF exposed (Jin et al., 2014). All in all, ELF-MF exposure was associated with 
increase DNA single- and double-strand break formations in some studies but not in others. This may 
indicate that the genotoxicity of ELF-MF is cell type-specific.  
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2.3.5 Effects of ELF-MF exposure on cellular differentiation and development 
During differentiation, cell specialisation is accompanied by changes in gene expression and 
stabilised by epigenetic modifications. These processes are triggered by developmental and 
environmental cues and are therefore particularly sensitive to environmental conditions. Recently, 
several studies investigated the influence of ELF-MF exposure on cell differentiation, mainly in the 
context of neuronal development. For instance, Jung et al. (2014) differentiated the rat neuroblastic 
cell line PC12 in vitro for 5 days under ELF-MF exposure (50 Hz sinus, 1 mT, continuous). They 
observed an increased percentage of cells with neuronal outgrowth as well as longer neurites after 
ELF-MF exposure concomitant with an overall reduction of cell proliferation, presumably due to 
more differentiated cells. In another study, embryonic neural stem cells induced to differentiate 
under ELF-MF (50 Hz, 1 - 2 mT, 5’ on / 10’ off, 72 h) by Ma et al. (2014) showed altered expression of 
specific key regulators of early neuronal development; without, however, affecting the 
differentiation into neurons and astrocytes notably. Yet, the same group found in a more recent 
study that embryonic neuronal stem cells exposed to ELF-MF (50 Hz, 1 mT, 4 h per 24 h for 72 h) 
enhance cell proliferation, neuronal differentiation and the neurite outgrowth (Ma et al., 2016). Also, 
Marcantonio et al. (2010) measured increased expression of several differentiation markers during 
all-trans-retinol induced differentiation of neuroblastoma BE(2) cells when exposed to ELF-MF (50 Hz, 
1 mT, 24 -72 h). Additionally, four independent studies illustrated that ELF-MF (50 Hz, 1-5 mT, 192 – 
288 h) exposure of bone marrow-mesenchymal stem cells induces neuronal differentiation without 
the addition of a growth factor, resulting in the appearance of specific cellular structures and also 
electrophysiological properties of neurons (Bai et al., 2013; Cho et al., 2012; Kim et al., 2013; Seong 
et al., 2014). Early growth response protein 1 was described as one of the key transcription factors of 
ELF-MF induced neuronal differentiation (Seong et al., 2014). These reported ELF-MF effects on 
neuronal differentiation could suggest that ELF-MF indeed can influence the dynamics and efficiency 
of cellular differentiation processes.  
The epigenetic code is reorganized during cellular differentiation and prone to be affected by 
environmental factors. Whether or not ELF-MF exposure has the potential to alter epigenetic 
patterns in a way that could drive cancerogenesis has not been assessed. There is evidence, however, 
that ELF-MF exposure (50 Hz, 1, 2 or 3 mT, 5’on/10’ off, 72 h) may alter genome-wide DNA 
methylation (Liu et al., 2015). The observation that ELF-MF exposure at a flux density of 1 mT (50 Hz, 
5’on/10’ off, 72 h) a decreased global methylation levels along with the expression of DNMT1 and 
DNMT3b, whereas DNA methylation as well as DNMT1 and DNMT3b expression was increased 
following ELF-MF at a flux density of 3 mT (50 Hz, 5’on/10’ off, 72 h). Another study investigated the 
chromatin conformation changes after low dose ELF-MF exposure (50 Hz, 20 µT, 1 h) of human 
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lymphocytes (Sarimov et al., 2011). Analysing the viscosity of chromatin, the authors found that 
relaxed chromatin becomes more condensed and compact chromatin more open, suggesting a 
convergence of chromatin states in response to ELF-MF exposure. Moreover, a paper was published 
recently by Baek et al. (2014), reporting that ELF-MF exposure (50 Hz sinus, 1 mT, 360 h) increases 
the reprogramming efficiency of somatic cells, involving the upregulation of the histone lysine 
methyltransferase Mll2, which triggers an enrichment of H3K4me3 in pluripotency genes.  
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3 Aims of the Thesis 
Aberrations of the epigenome are a hallmark of human cancers including leukaemia, and indicate a 
loss of cellular identity (Bernstein et al., 2007). An overrepresentation of haematopoietic progenitor 
cells harbouring genetic aberrations in epigenetic modifiers is often observed in leukaemia, 
suggesting that defect in epigenetic mechanism contribute to leukaemogenesis (Greenblatt and 
Nimer, 2014). ELF-MF exposure was associated with an increased risk of childhood leukaemia, and 
therefore classified as “possibly carcinogenic” to humans (group 2B) (IARC, 2002). However, the 
underlying biophysical mechanisms have been remaining elusive. ELF-MF is unlikely to directly 
damage DNA (Adair, 1998; Focke et al., 2010) and thereby to induce cancer-promoting genetic 
aberrations. Yet, epigenetic stability can be affected by environmental factors, especially during 
differentiation-associated dynamic epigenetic programming (Feil and Fraga, 2011). Whether or not, 
ELF-MF can cause alterations of the epigenome has not been addressed. The first aim of my PhD 
thesis was to evaluate the influence of ELF-MF exposure on the establishment and the stability of key 
epigenetic modifications in haematopoietic cells. I - in collaboration with others, investigated the 
impact of exposure on the stability of key active (H3K4me2) and repressive (H3K27me3) histone 
modifications at genome scale in the leukaemic cell line Jurkat as well as on the cell type-specific 
genome-wide H3K4me2, H3K27me3 and DNA methylation pattern in in vitro differentiating human 
cord blood cells into the neutrophilic lineage. The results and expertise from this work were brought 
into a risk assessment workshop, which took place at the IARC in Lyon, France and confirmed the 
classification of ELF-MF as “possibly carcinogenic” to humans.  
Acute myeloid leukaemia, the most common leukaemia in adults is characterized by an 
overrepresentation of neutrophilic progenitors and mutations in genes encoding epigenetic 
modifiers (Florean et al., 2011; Greenblatt and Nimer, 2014). To understand the underlying 
disturbance in cell differentiation and its contribution to leukaemogenesis, it is important to 
understand the physiological epigenetic changes established during differentiation. Previous studies 
investigated histone modifications and DNA methylation in isolated mature neutrophils and 
neutrophilic progenitors, respectively (Olins and Olins, 2005; Ronnerblad et al., 2014), and therefore 
did not provide information on the dynamics of these epigenetic modifications in the differentiating 
cell population. A second aim of my PhD thesis was to evaluate alterations of the epigenome during 
in vitro neutrophilic granulopoiesis. To this end, I - in collaboration with others, determined the 
regulatory role of alterations in DNA methylation and histone modifications at genome scale during 
lineage restriction of human neutrophils.   
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4 Results 
The following section summarizes the results presented in the manuscripts provided in the appendix 
as well as supplementary results not included in the manuscripts.  
 
4.1 ELF-MF exposure affects robustness of epigenetic programming during 
granulopoiesis (Appendix I) 
ELF-MF is a widespread man-made environmental agent, brought forth by the increasing use of 
electronic appliances emitting MF at frequency around 50 Hz. Addressing public concerns about 
possible health effects, epidemiological studies pointed to a correlation between ELF-MF exposure 
and an increased risk of childhood leukaemia. This evidence lead to classification of ELF-MF as being 
"possibly carcinogenic" to humans (group 2B) (IARC, 2002). Studies in animal and cellular models 
were used to investigate the biological effects of ELF-MF exposure, but with inconclusive outcome 
(IARC, 2002; SCENIHR, 2015). Hence, the mechanism underlying a potential cancerogenic effect 
remained elusive. A number of studies indicated a genotoxic potential of ELF-MF exposure (Duan et 
al., 2015; Focke et al., 2010; Mihai et al., 2014), although based on theoretical consideration, the 
energy content of ELF-MF is not high enough to directly damage the DNA (Adair, 1998). As epigenetic 
alterations are known to be sensitive to environmental conditions (Feil, 2006; Feil and Fraga, 2011), 
we reasoned that ELF-MF exposure may affect the epigenome, rather than the genome, and thereby 
induce cancer promoting alterations.  
To address whether ELF-MF influences the chromatin landscape of cancerous cells, we exposed the T 
cell lymphoma cell line Jurkat in exponential growth to ELF-MF (50 Hz sinus, 1 mT, 5’ on/10’ off) or a 
sham control (< 7 µT residual field) for 72 h and performed chromatin immunoprecipitation (ChIP) 
followed by next generation sequencing (ChIP-seq) of the histone modifications H3K4me2 and 
H3K27me3 (Appendix I, Supplementary Figure S1a). Additionally, we analysed the histone profiles of 
Jurkat cells treated with a low, sub-toxic dose of the histone deacetylase trichostatin A (10 nM TSA) 
for 72 h to assess the impact of a known epigenetic modulator. The results with low dose TSA 
provided a proof of concept that histone modifications H3K4me2 and H3K27me3 can be altered 
(Appendix I, Figure 1a, b). By contrast, we observed no significant difference when comparing ELF-MF 
and sham-exposed Jurkat cells, indicating that the genome-wide profiles of H3K4me2 and H3K27me3 
marks is not significantly altered upon ELF-MF exposure in this leukaemic cell line (Appendix I, Figure 
1c). In parallel and as a control we monitored health parameters of the cells as previous studies 
indicated an effect of ELF-MF exposure on cellular growth rates, cell cycle and cell viability (Brisdelli 
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et al., 2014; Focke et al., 2010; Santini et al., 2005), which may themselves affect histone 
modifications. However, ELF-MF exposure did not alter any of these parameters in the Jurkat cell line 
exposed for 72 h (Appendix I, Supplementary Figure 2).  
The dynamic epigenetic changes occurring during cellular differentiation are likely to be particularly 
sensitive to disturbance by environmental factors (Feil and Fraga, 2011; Jaenisch and Bird, 2003; 
Noreen et al., 2014), and interference with the proper shaping of the chromatin landscape in this 
situation may lead to the loss of cell identity and development of cancer. To investigate whether 
ELF-MF influences the establishment of histone modifications and DNA methylation during the 
chromatin reorganisation in differentiating cells, we in vitro differentiated CD34+ cord blood cells 
into the neutrophilic linage under ELF-MF (50 Hz powerline, 1 mT, 5’ on/10’ off), parallel sham or no 
exposure (Appendix I, Supplementary Figure S1b). During this process, CD34+ cells differentiate into 
promyelocyes and later on into myelocytes and metamyelocytes. We found that neither the 
differentiation efficiency nor the cell proliferation was affected by ELF-MF exposure (Appendix I, 
Supplementary Figure 6). We noticed in ELF-MF exposed neutrophilic progenitors after 4 days a small 
but significant increase of apoptotic cells and a trend for a reduction of G1 and an increase of S phase 
cells, indicating a minor positive selection effect of the ELF-MF exposure (Appendix I, Figure 2a,b). 
We performed ChIP-seq for H3K4me2 and H3K27me3 before and after five days of differentiation, 
which produced high quality datasets clearly separating epigenetic pattern of different maturation 
stages (Appendix I, Figure 2c, Supplementary Figure S9 and S10). Yet, although the cells underwent a 
global epigenetic reorganisation in the differentiation process, we were not able to identify a single 
genomic region, showing a statistically significant alteration in the patterns of H3K4me2 or 
H3K27me3 during ELF-MF exposure (Appendix I, Figure 2d,e). Additionally, we addressed weather 
ELF-MF exposure alters the pattern of DNA cytosine methylation during haematopoietic 
differentiation by analysing the genome-wide DNA methylation at single CpGs using an Illumina 
Infinium HumanMethylation 450 array. Again, we observed an excellent correlation between all 
biological replicas and a clear separation of the different maturation stages (Appendix I: Figure 3a, 
Supplementary Figure S12). Like the histone modifications, DNA methylation patterns dramatically 
changed during differentiation from CD34+ cells into the neutrophilic lineage, but no single CpG was 
differently methylated after ELF-MF exposure (Appendix I, Figure 3b,c). From these results, we 
conclude that ELF-MF exposure does not influence the formation of cell type-specific DNA 
methylation patterns.  
Although we did not observe genomic regions with significantly altered histone modifications or DNA 
methylation, we identified some genomic locations with up to 16-fold differential occupancy by 
H3K4me2, H3K27me3 marks or DNA methylation between ELF-MF and sham exposed cell 
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populations. We elaborated that these genomic locations did not reach statistical significance due to 
high variation in replicate samples. This variation occurred in the background of an overall good 
correlation between replicates in an apparently non-random manner. H3K4me2 and H3K27me3 read 
counts in all tiles revealed exposure condition-dependent effects on the variability of replicate 
samples, both in Jurkat cells and neutrophilic progenitors (Appendix I, Figure 4a,b). In Jurkat cells, we 
observed the highest increased replicate variability of H3K4me2 and H3K27me3 following low dose 
TSA, indicating that epigenetic disturbance can be measured at the level of variance between 
replicate populations (Appendix I, Figure 4c). In ELF-MF exposed Jurkat cells, we observed an 
increased replicate variability of H3K27me3 but a decreased variability of the H3K4me2 modification. 
On the other hand, in the epigenetically more plastic differentiating neutrophilic progenitors, the 
variability of both histone modifications was decreased in the ELF-MF exposed population (Appendix 
I, Figure 4d,e). Additionally, the variability of DNA methylation was also decreased in neutrophilic 
progenitors upon ELF-MF exposure (Appendix I, Figure 4f). These results suggest that ELF-MF 
exposure can affect the robustness of the establishment and/or maintenance of key epigenetic 
modifications, particularly in differentiating cell populations.  
We further investigated whether the variability of the epigenetic features is randomly distributed 
over the genome or located in specific genomic regions such as gene promoters, exons, introns and 
intergenic regions or bivalent domains identified by co-occupancy of H3K4me2 and H3K27me3 marks 
in our ChIP-seq data. In ELF-MF exposed Jurkat cells, the H3K4me2 marks were more robust while 
the H3K27me3 modifications were more variable, irrespective of the context (Appendix I, Figure 
5a,b). By contrast, H3K27me3 was clearly more variable in TSA treated Jurkat cells at promoters and 
bivalent domains, consistent with the preferential location of histone acetylation at promoters or 
enhancers (Nicholson et al., 2015). In neutrophilic progenitors, we observed the highest 
reproducibility of H3K4me2 and H3K27me3 at promoters and bivalent domains and the pronounced 
replicate variability at introns and intergenic regions. ELF-MF exposure decreased replicate variability 
of H3K4me2 at all genomic features except at bivalent domains, whereas the variability of H3K27me3 
was reduced without much preference for any of the genomic sites assessed (Appendix I, Figure 5c-
f). Additionally, we found that the variability of DNA methylation is reduced at all genomic features 
upon ELF-MF exposure (Appendix I, Figure 5g). These results indicate that ELF-MF affects the 
robustness of epigenetic marks in a partially genomic context-dependent manner, with the most 
distinctive feature being the H3K4me2 modification at bivalent domains.  
Bivalent domains are associated with transcriptionally poised chromatin and are present at 
regulatory elements of developmental genes that will be activated or repressed during 
differentiation (Bernstein et al., 2006; Boland et al., 2014). Hence, bivalent domains are highly 
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dynamic but seemingly more protected from ELF-MF impact during differentiation. Therefore, we 
investigated whether the reorganisation of the chromatin during differentiation affects the 
robustness of the epigenetic features in ELF-MF exposed neutrophilic progenitors. Upon ELF-MF 
exposure, the H3K4me2 modification was more robust at genomic locations with only the active 
mark present but not at bivalent domains, regardless of their dynamics during differentiation 
(Appendix I, Figure 6a). By contrast, we observed the most pronounced decrease of the replicate 
variability of H3K27me3 in genomic regions losing the repressive histone mark during differentiation, 
regardless of bivalency. We then examined the relationship between the differentiation dynamics of 
the histone modifications and the ELF-MF effect on their relative enrichment. We found the highest 
difference in H3K4me2 occupancy in non-bivalent tiles gaining H3K4me2, while we observed the 
highest exposure effect on H3K27me3 occupancy in tiles lost the modification during differentiation 
(Appendix I, Figure 6b). In addition to this differentiation-dependent pattern of histone modification, 
we also observed that the variability of DNA methylation of ELF-MF exposed cells is significantly 
reduced at sites losing mC during differentiation but not changed at CpGs gaining methylation 
(Appendix I, Figure 6c).  
In conclusion, our data suggest that ELF-MF exposure does not globally and deterministically 
influence epigenetic modifications of differentiated leukaemic and differentiating haematopoietic 
cells. Nevertheless, we noticed that ELF-MF may affect the robustness of epigenetic programming of 
histone modifications and DNA methylation in the course of chromatin reorganisation during 
neutrophilic granulopoiesis. Our data suggest that ELF-MF stabilizes mainly epigenetic features 
associated with open chromatin marked by H3K4me2 or in chromatin changing from a repressive to 
an active state during differentiation marked by losing H3K27me3 and/or undergoes DNA 
demethylation. 
 
 
Contribution: I conceived, performed and analysed the in vitro exposure experiments of leukaemic 
cells as well as during the neutrophilic differentiation. I analysed the cell cycle, amount of apoptotic 
cells and the different maturation stages by flow cytometry. I determined the histone modifications 
by ChIP, prepared the ChIP samples for next-generation sequencing and contributed to the 
bioinformatic analysis of the ChIP-seq data. I prepared the DNA samples for the DNA methylation 
array, did the variance analysis of the histone modifications and DNA methylation and wrote the 
manuscript in the Appendix I.   
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4.2 Dynamics of Histone Modifications and DNA Methylation during in vitro 
Granulopoiesis (Appendix II) 
During cellular differentiation, epigenetic modifications shape the chromatin structure and the DNA 
accessibility, determining the gene expression pattern required for cell lineage commitment. Active 
epigenetic features present at pluripotency genes change to a repressed state and repressed or 
poised epigenetic features of lineage-specific genes are converted to transcriptionally permitted 
states, altogether resulting in a global reorganisation of the epigenome (Boland et al., 2014; Hawkins 
et al., 2010; Kraushaar and Zhao, 2013). Regulatory epigenetic modifications include the acetylation 
and methylation of histone tails and the methylation of DNA cytosine bases (Bernstein et al., 2007; 
Cedar and Bergman, 2011), altogether establishing three main classes of chromatin; active, repressed 
and chromatin poised for gene expression. Active chromatin is marked by H3K4me2, H3K4me3 and 
H3K27 acetylation, whereas chromatin correlating with gene repression is characterized by 
H3K27me3 and H3K9me3. Poised chromatin is occupied by active as well as repressive marks and is 
preferentially located at regulatory elements of developmental genes in stem cells (Boland et al., 
2014; Hawkins et al., 2010; Kraushaar and Zhao, 2013). In gene regulatory regions with intermediate 
to high CpG content, DNA methylation negatively regulates gene expression; cytosine methylation is 
associated with chromatin compaction, absence of methylation with open chromatin (Bernstein et 
al., 2007; Nicholson et al., 2015). Epigenetic aberrations are a hallmark of cancers such as leukaemia. 
The most common leukaemia in adults is acute myeloid leukaemia, characterized by an accumulation 
of cells in progenitor stages especially neutrophilic progenitors (Krebsliga, 2016; Mehdipour et al., 
2015; Zenhäusern et al., 2003). The blocked differentiation of progenitor cells together with 
alterations in epigenetic modifiers for DNA methylation and histone modifications found in 
leukaemic cells, indicating a defect in the epigenetic control during differentiation. To understand the 
driving force of epigenetic aberration in cancerogenesis, it is important to determine the normal 
shaping of the chromatin landscape during a normal cellular differentiation. The epigenetic 
programming during human neutrophilic granulopoiesis has not been investigated systematically, 
although few studies analysed histone modifications and DNA methylation in isolated mature 
neutrophils and neutrophilic progenitors, respectively (Olins and Olins, 2005; Ronnerblad et al., 
2014). Therefore, we set out to monitor the dynamics of histone modifications and DNA methylation 
during an in vitro neutrophilic differentiation, using a well-defined in vitro system. We differentiated 
human CD34+ cord blood cells into the neutrophilic lineage for 14 days. Cells differentiated from the 
CD34+ progenitor stage mainly to a promyelocytes state within five days and into myelocytes and 
metamyelocytes within nine days of differentiation (Appendix II, Figure 1a and Supplementary 
Figure 1). 
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We addressed the dynamic pattern of DNA cytosine methylation during haematopoietic 
differentiation by analysing the genome-wide DNA methylation at single CpGs using an Illumina 
Infinium HumanMethylation 450 array (Appendix II, Figure 1). The pattern of DNA cytosine 
methylation was dramatically altered during neutrophilic granulopoiesis, with the highest changes at 
lineage commitment between CD34+ cells and neutrophilic progenitors after five days of 
differentiation. In total, we observed more CpG loci losing than gaining (FDR-adjusted P value < 0.05, 
log2 fold change [FC] > ±0.6) DNA methylation especially at lineage commitment with 3’882 and 
2’977 CpGs, respectively; only at the latest stage of differentiation comparing progenitors after nine 
and 14 days more CpGs are gaining DNA methylation (17 and 419, respectively, Appendix II, Figure 
1b). The majority of sites with DNA methylation changes are either consistently gaining or losing 
methylation during the entire differentiation (Appendix II, Figure 1c,d). At lineage commitment, CpGs 
losing DNA methylation are preferentially located at introns and outside of CpG islands (CGI) at CGI 
shelfs, whereas CpGs gaining DNA methylation are enriched at promoters and CGI (Appendix II, 
Figure 1e,f). In addition, we found that CpGs losing methylation were preferentially associated with 
genes that become activated in neutrophils, while methylation gain was observed in genes important 
in other blood lineages (Appendix II, Figure 1g). Our data therefore suggest an important regulatory 
role of DNA demethylation in neutrophilic lineage restriction. These results are in line with previous 
reports indicating a genome-wide loss of DNA methylation between GMPs and promyelocytes, and 
that myeloid-specific genes are repressed through DNA methylation in HSCs and become activated 
by DNA demethylation (Ko et al., 2010; Ronnerblad et al., 2014; Trowbridge et al., 2009).  
HSCs are characterized by a high number of bivalent domains co-occupied by active H3K4me2 and 
H3K4me3 as well as repressive H3K27me3 marks, while mature neutrophils have a high amount of 
heterochromatin containing repressive histone modifications (Cui et al., 2009; Navakauskiene et al., 
2014; Olins and Olins, 2005). During in vitro neutrophilic differentiation, we investigated the dynamic 
reorganisation of the H3K4me2 and H3K27me3 modifications by ChIP-sequencing (Appendix II, Figure 
2). We observed a fundamental and widespread reorganisation of both histone modifications at the 
transition of CD34+ cells into neutrophilic progenitors after five days, but as well later on in the 
differentiation between progenitors after five and nine days (Appendix II, Figure 2a,b,d). Overall, we 
found in both time periods of differentiation more genomic locations that are losing (log2 FC < -0.6, 
FDR-adjusted P value < 0.05) than gaining (log2 FC > 0.6, FDR-adjusted P value < 0.05) H3K4me2 
modifications (t5/t0: 11’260 and 8’358; t9/t5: 12’186 and 6’438, respectively, Appendix II, Figure 2a). 
In contrast, we revealed a higher number of regions gaining than losing H3K27me3 modifications 
(log2 FC ˃± 0.6, FDR-adjusted P value < 0.05) in both time periods during differentiation (t5/t0: 7’914 
and 6’260, t9/t5: 9’563 and 7’204, respectively, Appendix II, Figure 2b). Generally, at genomic 
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locations undergoing differentiation associated alterations in both histone modifications, H3K4me2 
marks were preferentially lost and H3K27me3 gained during differentiation (Appendix II, Figure 2c). 
Genomic locations showing H3K4me2 changes are enriched at introns, those showing H3K27me3 
changes at intergenic regions and promoters, while genomic regions with alterations in both histone 
modifications are preferentially located at gene promoters (Appendix II, Figure 2f). Also, alterations 
in H3K4me2, H3K27me3 or both histone modifications occur predominantly at genes important in 
other lineages than neutrophils (Appendix II, Figure 2g). Overall, we conclude that the majority of the 
observed histone modification changes point to an overall converting chromatin into a more 
compact state during differentiation, leaving lineage-specific genes in an active state.  
We found the highest alterations of DNA methylation and histone modifications at lineage 
commitment. To address the correlation of the different epigenetic features to each other, we 
analysed genomic locations undergoing differentiation associated changes in DNA methylation and 
histone modifications (Appendix II, Figure 3a). We determined that genomic regions with histone 
modification and DNA methylation changes are enriched at gene promoters and active enhancers, 
and they are located closer to the transcription start site than regions with only alterations of histone 
modifications (Appendix II, Figure 3b-d). During lineage commitment, moreover, genomic locations 
with changes in H3K4me2 and DNA methylation showed either loss of H3K4me2 and gain of DNA 
methylation at CpGs or gain of the active mark and loss of DNA methylation, indicating the negative 
correlation of these epigenetic marks (Appendix II, Figure 4a). By contrast, genomic locations 
undergoing H3K27me3 and DNA methylation changes at lineage commitment are predominantly 
characterized by a gain of the repressive histone mark as well as of DNA methylation. Genomic 
regions with concomitant changes in all three epigenetic features lose preferentially the active 
H3K4me2 mark and gain H3K27me3 as well as DNA methylation, indicating a general transition 
towards a more repressed chromatin state (Appendix II, Figure 4a,b). Additionally, such regions are 
located at genes important in cellular development of other lineages, including erythroid cells, 
leukocytes or natural killer cells (Appendix II, Figure 4c). We observed only two neutrophil-specific 
genes activated through a concomitant increase of H3K4me2, loss of H3K27me3 and CpG 
methylation during differentiation (Appendix II, Figure 4b,c). From these results, we conclude that 
genomic regions dynamically regulated through histone modifications and DNA methylation lose 
predominantly the active mark and increase the repressive marks, leading to gene silencing. 
Important pluripotency and developmental genes are associated with a poised chromatin state in 
HSCs, allowing a fast epigenetic adaptation during differentiation and a rapid activation or repression 
of the gene (Boland et al., 2014). To investigate the time-dependency of the epigenetic repression in 
genomic regions occupied by poised chromatin in HSCs, we analysed genomic regions repressed 
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through alterations in H3K4me2, H3K27me3 and de novo DNA methylation in both time periods of 
neutrophilic granulopoiesis (Appendix II, Figure 5). We determined that the loss of H3K4me2 
occurred to equal parts in both time periods during differentiation, whereas de novo DNA 
methylation and gain of the H3K27me3 modification occurs preferentially at lineage commitment. 
The majority of genomic regions with a poised chromatin state in CD34+ cells were preferentially 
repressed at lineage commitment through gaining of the H3K27me3 mark alone or in combination 
with de novo DNA methylation, and occasionally only by DNA methylation alone.  
Overall, our study provides novel insight into the genome-wide dynamics of histone modifications 
and DNA methylation during human granulopoiesis. We report a fundamental reorganisation of the 
chromatin landscape during granulopoiesis most pronounced at the transition of CD34+ cells into the 
neutrophilic lineage, shaping an overall more compact chromatin. The global perspective does not 
reveal context specific local chromatin dynamics that seems to be relevant for the establishment of 
cell type-specific gene expression. Directed for local pattern changes, the data suggest a regulatory 
role of DNA demethylation in the establishment of neutrophil-specific gene expression. By contrast, 
our data indicate that epigenetic repression of pluripotency and developmental genes marked by a 
poised chromatin state in CD34+ cells occurred preferentially through gaining of H3K27me3 alone or 
concomitant with de novo DNA methylation. These results suggest a role of de novo DNA methylation 
in stabilizing gene repression or subsequent long term silencing, rather than in initiating gene 
silencing. Our results are in line with previous studies indicating that myeloid-specific genes are 
poised through DNA methylation in HSCs and activated by DNA demethylation, while lymphoid-
specific genes are keep in a poised state in HSCs through H3K27me3, leading to activation by histone 
modification changes rather than DNA methylation alterations (Cedar and Bergman, 2011; Ko et al., 
2010; Oguro et al., 2010; Trowbridge et al., 2009). 
 
 
Contribution: I conceived, performed and analysed the in vitro neutrophilic granulopoiesis. I 
analysed the different maturation stages by flow cytometry. I determined the histone modifications 
by ChIP, prepared the ChIP samples for next-generation sequencing and contributed to the 
bioinformatic analysis of the ChIP-seq data. I prepared the DNA samples for the DNA methylation 
array, and did all the analysis on the observed alterations of histone modifications and DNA 
methylation and wrote the manuscript in the Appendix II. 
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4.3 Extremely-Low-Frequency Magnetic Fields and Risk of Childhood Leukaemia: A 
Risk Assessment by the ARIMMORA Consortium (Appendix III) 
ELF-MF exposure has been classified as being “possibly carcinogenic” to humans (group 2B) due to an 
association with an increased risk of childhood leukaemia in epidemiological studies, but in the 
absence of a plausible scientific rationale for an underlying mechanism (IARC, 2002). The ARIMMORA 
project funded by the European Commission aimed to explore the underlying biophysical mechanism 
by developing and applying novel experimental and computational techniques. Our investigations in 
the field of epigenetics (Appendix I), together with experts in the fields of ERK signalling, leukaemic in 
vivo models, in vivo toxicology and EMF-sensitive animal models as well as specialists in exposure 
assessment and biophysical modelling were contributing to this long collaborative project. Based on 
the results on the individual partners, the consortium performed a re-evaluation of the potential 
carcinogenicity of ELF-MF; according to IARC rules (published commentary of risk assessment in 
appendix III). 
The evaluation was based on the results of the ARIMMORA project and on recent work performed 
outside the consortiums, published until March 2015. The standardised IARC evaluation scheme was 
applied, assessing the evidence of carcinogenicity in human and in experimental animals (in vivo 
studies) separately, and classifying the cumulative evidence as sufficient, limited, inadequate or 
lacking. Additionally, mechanistic data obtained from in vitro experimentations were categorised in 
weak, moderate or strong. The combination of evidence in the three groups defines the classification 
of agent into group 1 (carcinogenic to humans), group 2A (probably carcinogenic to humans), group 
2B (possibly carcinogenic to humans), group 3 (not classifiable as to its carcinogenicity to humans) or 
group 4 (probably not carcinogenic to humans).  
The daily mean exposure levels of children is below 0.1 µT, only a small fraction of children (1-2%) is 
exposed to ELF-MF with a daily average of 3 µT or more. Recent studies established an association 
between ELF-MF and childhood leukaemia (two fold increased risk) at average exposure levels for 
24 h above 0.3 -0.4 µT, whereas no significant correlation could be found for lower exposure levels 
(Ahlbom et al., 2000; Kheifets et al., 2010; Schuz, 2011). Measurements within ARIMMORA 
confirmed these typical daily exposure levels and highlighted the importance of child’s behaviour 
around powerlines (Struchen et al., 2015). Additionally, simulation of exposure with ELF-MF of 
pregnant women revealed the highest electromagnetic field to be on the skin, fat, and subcutaneous 
adipose tissue of the foetus during all gestational ages and increased continuously with gestational 
age (Liorni et al., 2014). Within ARIMMORA, no additional epidemiological studies were performed. 
However, most recent epidemiological studies indicated a possible carcinogenicity of ELF-MF (IARC, 
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2002; SCENIHR, 2007, 2009, 2015; WHO, 2007), but doubts about methodological limitations cannot 
be ruled out. Therefore, the evaluation of the evidence of carcinogenicity was considered “limited” in 
humans by the ARIMMORA consortium.  
One goal of the ARIMMORA project was the generation of a novel mouse model for B-cell acute 
lymphoblastic leukaemia (B-ALL), the most common human childhood leukaemia. This was achieved 
by constitutively expression of the fusion gene ETV6-RUNX1 (also known as TEL-AML1) in the 
haematopoietic stem/progenitors compartment of mice (Martin-Lorenzo et al., 2015). In these 
transgenic mice, the influence of ELF-MF exposure in the development of B-ALL was analysed, by 
exposing mice throughout embryonic life and after birth until three month of age. From a total of 30 
transgenic mice exposed to ELF-MF (50 Hz, 1.5 mT, 10’ on/5’off, 20 h/day), one mouse developed 
ETV6-RUNX1-positive precursor B-ALL at 14 month of age compared to none of the 65 control 
animals. Despite these findings the consortium concluded that more studies are necessary to 
substantiate the possible adverse impact of exposure. Therefore, in combination with the published 
literature, the evidence of carcinogenicity in experimental animals was considered by the 
ARIMMORA consortium as “inadequate”.  
The weakness of previous risk assessments was the lack of support from mechanistic evidence (IARC, 
2002; SCENIHR, 2007, 2009, 2015; WHO, 2007). For many years of research, it remains difficult to 
integrate all reported effects and non-effects of ELF-MF exposure into a consistent chain of causality, 
without the identification of the underlying mechanism. Therefore, ARIMMORA intended to 
elucidate possible biological mechanism. Animal studies within ARIMMORA showed transient 
reduction of CD8+ T-cells in ELF-MF exposed (50 Hz; 10 µT, 1 mT or 10 mT) CD-1 and B6CBA mice, 
after 28 days. These observations were corroborated by findings in ELF-MF exposed ETV6-RUNX1 
transgenic mice, showing a consistent decrease in total numbers of CD8+ T-cells at 2 month of age. 
These results suggest that levels of CD8+ T-cells could serve as a biomarker for ELF-MF exposure. 
Furthermore, experiments in Lewis and Fischer rats indicated that cytokines altered by ELF-MF 
exposure (50 Hz, 0.1 mT) were involved in T-cell functions or influenced the number of T-cells. In 
vitro studies within ARIMMORA investigated the ERK signalling cascades and epigenetic regulation 
(our part). Surprisingly, ELF-MF exposure induced ERK1/2 activation in cell types at intensities as low 
as 0.15 µT and was detectable within minutes of exposure. Furthermore, ERK1/2 activation was 
decreased by co-exposure with blue light, suggesting that ELF-MF induced ERK activation could be 
controlled by the photoreceptor cytochrome. Analysis of activating and repressing histone 
modifications in exposed (50 Hz, 1 mT, 5’ on/10’ off) and sham exposed Jurkat cells did not indicate a 
consistent influence on the epigenome of ELF-MF on fully differentiated cells. Minor epigenetic 
changes were observed on activating and repressing histone marks upon ELF-MF exposure (50 Hz 
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powerline, 1 mT, 5’ on/10’ off) in differentiating haematopoietic stem cells, suggesting that ELF-MF 
exposure is able to influence the epigenome to a small extent (final results see Appendix I). As the 
functional relevance and association to carcinogenesis of the observed mechanistic data in the in vivo 
and in vitro studies within ARIMMORA remains to be clarified and no mechanism was meanwhile 
identified outside ARIMMORA, the overall mechanistic evidence can be considered moderate while 
the contribution to carcinogenesis remains weak. 
The combination of the limited evidence of carcinogenicity in humans and the inadequate evidence 
of carcinogenicity in experimental animal with only weak evidence from mechanistic studies resulted 
in the classification of ELF-MF as “IARC Group 2B” (possible carcinogenic to humans) (Appendix III, 
Figure 1).  
 
 
Contribution: I planned and performed the in vitro exposure experiments in leukaemic cells as well 
as during a haematopoietic differentiation, determined histone modifications (H3K4me2 and 
H3K27me3) by ChIP, prepared the ChIP samples for next-generation sequencing and contributed to 
the bioinformatic analysis of the ChIP-seq data. Furthermore, participated at the ARIMMORA risk 
assessment meeting at IARC and was involved in the writing of the risk assessment.  
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4.4 Supplementary Results 
4.4.1 ELF-MF exposure does not influence cell viability and cell cycle distribution in the 
leukaemic cell line REH 
Epidemiological studies determined an association between ELF-MF and leukaemia, but the 
underlying cellular mechanisms are not clear. Studies in animal and cellular models were used to 
investigate biological effects of ELF-MF exposure, yielding inconclusive information. Previous studies 
described effects of ELF-MF exposure on cellular growth rates and apoptosis (Brisdelli et al., 2014; 
Focke et al., 2010; Santini et al., 2005), but not consistently and depending on cell type or exposure 
conditions. We observed (Appendix I) that ELF-MF exposure has no influence on cell proliferation, 
cell cycle distribution and the amount of apoptotic cells when the T cell lymphoma cell line Jurkat 
was exposed for the duration of 3.5 cell cycles (50 Hz sinus, 1 mT, 5’ on/10’ off). To address a 
potential cell type dependency, we exposed another leukaemic cell line, the B cell precursor 
leukaemia REH, in the exponential growth phase to a sinusoidal intermitted ELF-MF (50 Hz sinus, 1 
mT, 5’ on/10’ off) or a sham control (< 7 µT residual field) for 144 h, corresponding to again 3.5 cell 
cycles (Figure 10a). As in all experiments, the exposure settings were blinded for the experimenter.  
REH cells proliferated exponentially during the 144 h analysed (Figure 10b). Before the exposure, 
25% and 10% of the cells in the population were in S and G2 phase, respectively (Figure 10c). After 
72 h of exposure a transient alteration of the cell cycle progression with a decrease of G1 and an 
increase of S and G2 phase cells occurred in all conditions. We measured around 95% living cells after 
72 h of ELF-MF or sham exposure, whereas after 144 h the apoptotic and dead cells increased to 9%. 
Exposure of REH cells for 3.5 cell cycles (144 h) did not significantly affect either the overall 
proliferation of the cell culture, the proportion of apoptotic cells nor the cell cycle distribution at all 
assessed time-points (Figure 10b-d).  
Together with the results in the Jurkat cells (Appendix I), we conclude that ELF-MF exposure in a 
highly controlled experimental setup, does not affect viability and proliferation of leukaemic cells. 
The discrepancy of our results to previous studies might be explained by cancer cell-specific features, 
cell type-specific sensitivity to ELF-MF intensities, different magnetic field characteristics used (static, 
dynamic, frequency and intensity) or limited exposure times (Juutilainen et al., 2006; Mangiacasale et 
al., 2001; SCENIHR, 2015; Yoon et al., 2014) 
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Figure 10: ELF-MF exposure does not alter proliferation and viability of cultured REH cells (a) Blinded for the 
operator, the leukaemic cell line REH cells was exposed to ELF-MF (50 Hz sinus, 1 mT, 5’ on/10’ off), sham (< 7 
µT residual field) for 144 h. (b) Starting with 3x105 cells/mL, the proliferation was monitored by cell counting at 
the indicated time-points. Average population doublings of independent biological replicates (n=4) in function 
of culture time were calculated and statistically analysed by ANOVA (*P < 0.05) and Student’s t-test. Error bars 
indicate SEM. (c) Cell cycle profiles were assessed by flow cytometry, before (t0) and after exposure to ELF-MF, 
or sham at the indicated time-points. Data represent the mean proportion of cells in the different cell cycle 
phases with SEM (n=4). (d) Analysis of apoptosis by flow cytometry at the indicated time-points of exposure by 
Annexin-V/PI staining, discriminating alive, apoptotic and dead/necrotic cells. Data represent mean percentage 
of cells in different states of cell viability with SEM (n=4). Flow cytometry data were analysed by FlowJo 
software and statistically analysed by χ2 test for each replica (* P < 0.05) and Student’s t-test.  
Methods 
Cell culture and ELF-MF exposure 
REH cells (B cell precursor leukaemia) were cultured in RPMI-1640 medium supplemented with 2 mM 
L-glutamine, 1 mM Na-pyruvate, 10% FCS and 0.6x penicillin/streptomycin (Sigma-Aldrich) at 37°C in 
a humidified atmosphere with 5% CO2. Fresh medium was supplied every 48 h. For ELF-MF exposure 
experiments, cells were seeded at a density of 3x105 cells/mL and grown for the indicated time 
without addition of fresh medium. The exposure system sXc-ELF (IT’IS, Zurich, Switzerland) allows for 
a well-controlled exposure with ELF-MF (Schuderer et al., 2004). The selected exposure for the 
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leukaemic cell line was sinusoidal ELF-MF (50 Hz, 1 mT, 5’ on/10’ off) or sham for approximately 3.5 
cell cycles (144 h). The electric field caused by the coil was shielded and the magnetic field uniformity 
was better than 1% (SD). Each coil was place inside a μ-metallic box and the boxes placed side by side 
in the same incubator to decouple the coils, to shield the electric and magnetic fields generated by 
the incubator and to ensure the same environmental conditions (temperature, humidity and CO2). 
The field attenuation between the coils was at least a factor of 150, i.e., the shame exposure was 
anywhere less than 7 µT compared to the uniform exposure of 1 mT. The exposure system meets the 
general criteria established in Kuster and Schoenborn (2000). Randomized assignment of ELF-MF and 
sham exposure conditions to the two chambers allows experiments blinded for the observer. 
Continuous temperature monitoring confirmed that the temperature difference between the 
exposure chambers was less than 0.1°C. 
 
Cell cycle analysis and apoptosis measurement by flow cytometry 
For the cell cycle analysis, 20-50x103 cells were fixed with cold 70% ethanol overnight. Cells were 
collected by centrifugation, resuspended in 1 mg/mL RNase A (in 200 mM Tris-HCl pH 7.5 and 200 
mM NaCl) and incubated at 37°C for 30 min. After addition of 0.5 mg/mL pepsin (in 0.2% HCl) and 
incubation for another 15 min at 37°C, the cells were stained with propidium iodide (100 µg/mL in 
PBS, pH 7.5) and incubated on ice for at least 30 min. The number of apoptotic cells in the population 
was estimated by the Annexin-V Alexa488/PI kit (Invitrogen) according to the provider’s 
recommendations. 20-50x103 cells were blocked on ice in Annexin-binding solution supplemented 
with 1% bovine serum albumin for 15 min before staining with the FITC-anti-Annexin V antibody for 
20 min at RT, followed by washing three times with Annexin-binding solution. PI (Invitrogen) or DAPI 
was added before analysing the cells. All samples were measured using a FACS cytometer (Beckton 
Dickinson) and analysed by FlowJo Software. Data were statistically analysed by χ2 test for each 
replica as well as pairwise comparison by Student’s t-test using Graphpad Prism. 
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5 Concluding Discussion and Outlook 
Cancerous tissues are characterized by genetic and epigenetic alterations. Histone modification and 
DNA methylation changes shape the chromatin structure during differentiation in a cell type-specific 
manner. Environmental factors can exert influence on this process, perturb the establishment and/or 
maintenance of cell identity, which can promote the development of cancer (Feil and Fraga, 2011; 
Shen and Laird, 2013). During my PhD studies, I investigated the effect of ELF-MF exposure, as an 
environmental factor, on epigenetic modifications in differentiating haematopoietic stem cells as 
well as in leukaemic cells.  
Exposure to ELF-MF, which represents a common situation due to electric power supply, has been 
increasingly associated with an increased risk of childhood leukaemia (IARC, 2002). However, the 
mechanisms remain elusive. As the energy content of ELF-MFs is orders of magnitudes below of what 
would be required to affect chemical bonds in DNA (Adair, 1998), we proposed that ELF-MF may 
affect the epigenome, instead of the genome, and thereby promotes cancerous transformation. 
Together with collaborators, I analysed alterations in the active H3K4me2 and repressive H3K27me3 
histone marks as well as in DNA methylation at genome scale during a well-controlled in vitro 
neutrophilic differentiation. In addition, activating and repressive histone marks were analysed in 
leukaemic Jurkat cells. We observed that after ELF-MF exposure of 3 days, the pattern of H3K4me2 
and H3K27me3 of terminally differentiated leukaemic cells is not significantly altered. The suitability 
and sensitivity of our approach was confirmed by non-toxic treatment with the histone deacetylase 
inhibitor trichostatin A, which dramatically altered the histone methylation pattern. During 
neutrophilic differentiation, ELF-MF exposure did not significantly impact histone modifications and 
DNA methylation, although the chromatin landscape undergoes a fundamental reorganisation during 
haematopoietic differentiation. These results indicate an absence of a global effect of ELF-MF 
exposure on epigenetic modifications of leukaemic cells and differentiating CD34+ cells, at least in 
our experimental setup. A previous study proposed that ELF-MF exposure can alter the genome-wide 
DNA methylation in mouse spermatocytes (Liu et al., 2015). This discrepancy to our results can be 
explained by the two different cell systems or cell type-specific responses to ELF-MF. In addition, 
ELF-MF exposure might induce spontaneous and random spermatogenesis, which is accompanied by 
extensive differentiation-dependent DNA methylation changes. It was previously reported that 
ELF-MF exposure enhances differentiation efficiency in neurons, correlating with a gain of H3K9 
acetylation at specific neuronal genes (Jung et al., 2014; Leone et al., 2014; Ma et al., 2014). In 
addition, the reprogramming efficiency of somatic cells is mediated by the histone methyltransferase 
Mll2 (Baek et al., 2014). Our haematopoietic differentiation system was controlled by the growth 
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factor G-CSF and the cytokines SCF and Flt-3 ligand, allowing a reproducible differentiation towards 
the neutrophilic lineage. We did not observe any significant alterations in the differentiation 
efficiency following ELF-MF exposure measured by the distribution of different maturation stages. 
However, at lineage commitment, we found an increase of apoptotic cells and a slight transient non-
significant alteration of cell cycle progression with an increase in S phase and a decrease in G1 phase 
cells upon ELF-MF exposure. Our in vitro differentiation starts with a heterogeneous CD34+ stem cell 
population, including haematopoietic stem cells as well as the earlier progenitor types MPP, MLP, 
CMP, GMP and MEP (Seita and Weissman, 2010). However, MLPs and MEPs are no longer committed 
to differentiate into the neutrophilic lineage and undergo apoptosis through stimulation with only 
the neutrophilic growth factor G-CSF (Doulatov et al., 2012). Therefore, the increase of apoptotic 
cells upon ELF-MF exposure could indicate a small positive selection of neutrophilic cells due to a 
weak synchronisation effect of the cell population as more non-neutrophilic precursor cells are 
removed by apoptosis. In addition, the slight accumulation of ELF-MF exposed cells in S phase may 
suggest a disturbance of S phase progression and an accumulation of cells at the intra S phase DNA 
damage checkpoint, indicating a correlation to the ELF-MF induced increase of apoptotic cells due to 
cell death induction after an incomplete DNA repair during S phase (Bertoli et al., 2013; Malumbres 
and Barbacid, 2009). This small positive selection of neutrophilic cells, however, did not notably 
affect the overall dynamics and efficiency of granulopoiesis, and the underlying global reorganisation 
of epigenetic modifications.  
Although, we did not observe any global effect of ELF-MF exposure on the epigenetic modifications, 
we observed genomic loci showing differential occupancy by H3K4me2, H3K27me3 or DNA 
methylation upon ELF-MF exposure. Hence, we found that ELF-MF exposure had an influence on the 
variability of the epigenetic modifications in the replicate samples. Treatment with TSA resulted in a 
dramatic replicate variability of the histone modifications in Jurkat cells, especially at promoters and 
bivalent domains. These variability pattern correlate with the preferred localisation of histone 
acetylation at gene promoters (Nicholson et al., 2015) and indicates that epigenetic perturbation can 
be measured at the level of sample variance. In Jurkat cells, we noticed a decreased replicate 
variability of H3K4me2 and an increased variability of H3K27me3, regardless of the genomic location. 
During neutrophilic differentiation, we observed an overall decreased replicate variability of histone 
modifications as well as DNA methylation after ELF-MF exposure. The discrepancy of the increased 
replicate variability of H3K27me3 in ELF-MF exposed Jurkat cells to the decreased variability of 
H3K4me2 in ELF-MF exposure Jurkat cells or of epigenetic modifications during differentiation could 
be explained by cancer cell-specific features (Mangiacasale et al., 2001), cell type-specific sensitivity 
to ELF-MF strength (Juutilainen et al., 2006; Yoon et al., 2014) or the different epigenetic plasticity in 
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terminal differentiated cells compared to differentiating cells. We observed a variability pattern 
depending on the chromatin state during the reorganisation of the epigenome in differentiating cells: 
epigenetic modifications of open chromatin or chromatin opening such as regions marked by 
H3K4me2, losing H3K27me3 and de novo DNA methylation during differentiation appear to be less 
variable upon ELF-MF exposure. The decreased replicate variability of histone modifications and DNA 
methylation preferential located at open chromatin or chromatin activated during differentiation 
may indicate an influence of the exposure on the establishment and/or maintenance of the 
epigenetic modifications, resulting in a stabilisation of epigenetic programming at sites of 
transcriptional activity and/or chromatin opening during differentiation. As we did not observe 
genomic locations with significantly altered histone modifications or DNA methylation analysed in a 
cell population, but observed that ELF-MF exposure can stabilise epigenetic features at open 
chromatin detected by sample variance between the replicates, we conclude that ELF-MF exposure 
has an effect on the robustness of the epigenetic modification in a stochastic manner, in only a small 
fraction of differentiating neutrophilic cells. Previous work indicated that ionizing radiation, induced 
five to 50 fold more DNA double strand breaks in decondensed than condensed chromatin (Takata et 
al., 2013; Yoshikawa et al., 2008). ELF-MFs are unlikely to directly damage DNA, but our results 
indicate as well that open or opening chromatin is more affected by ELF-MF exposure than compact 
chromatin. Another study showed that chromatin changes upon ELF-MF exposure depend on the 
initial chromatin state, meaning that relaxed chromatin becomes more compact and compact 
chromatin more open (Sarimov et al., 2011). Our haematopoietic differentiation starts with a 
heterogeneous population of expanded CD34+ cord blood cells (D'Arena et al., 1996; Engelhardt et 
al., 2002; Jobin et al., 2015) and a high replicate variance of epigenetic features, suggesting a slightly 
different initial chromatin state. ELF-MF exposure may result in the homogenisation of the epigenetic 
pattern by reducing heterogeneity in the cell population. Taken together, our results indicate that 
ELF-MF may affect the robustness of histone modifications and DNA methylation associated with 
transcriptional activity and/or chromatin opening during differentiation in a stochastic manner at 
individual cells. 
However, our methodological approach of ChIP-seq and 450k Infinium array is limited in sensitivity 
and does not allow a detection of small differences between individual cells in a heterogeneous cell 
population. By analysing the variance between the replicates, we were able to avoid these limitations 
and determine the stochastic effect of ELF-MF on individual subpopulation of cells. Nevertheless, 
variance determination is in general highly sensitive to experimental variations (Altman and 
Krzywinski, 2014), especially with small amount of replicates. In order to limit this problem, we 
reduced the technical variations as much as possible, as documented in a good correlation of the 
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read counts in genomic regions between the replicates. Also, we observed a reduced replicate 
variability upon ELF-MF exposure on histone modifications and DNA methylation analysed by two 
different methodologies, and therefore we believe that the reduced variability is biologically 
relevant. To further investigate the stochastic effect of ELF-MF exposure on the robustness of 
epigenetic modifications in individual cells in a heterogeneous cell populations, epigenetic features 
could be analysed in a single cell approach together with ChIP-seq (Hyun et al., 2015; Rotem et al., 
2015) and reduced representation bisulfite sequencing (Guo et al., 2015; Hu et al., 2016; Wang et al., 
2015).  
In summary, my data provide a proof-of-concept that ELF-MF exposure can potentially affect the 
patterns of the epigenetic code. The effect on the robustness of epigenetic modifications, appeared 
to be on a stochastic nature on individual cells, not globally detectable, are particularly notable in 
differentiating haematopoietic cells undergoing epigenetic programming. This epigenetic footprint of 
ELF-MF exposure, especially on open chromatin, is important information for further mechanistic 
studies investigating the potential mechanism underlying leukaemogenic effects of ELF-MF. In future 
studies, it will be interesting to address the epigenetic alteration of ELF-MF exposure in another 
cellular system, for instance during neuronal differentiation as previous studies investigated an 
enhanced differentiation efficiency and alterations in epigenetic features following ELF-MF exposure 
(Cheng et al., 2015; Jung et al., 2014; Ma et al., 2016; Ma et al., 2014).  
A new risk assessment in 2015 by the ARIMMORA consortium evaluated the evidence for the 
contribution of ELF-MF exposure to carcinogenesis. We were part of the ARIMMORA consortium and 
our data provided a novel insight into a possible molecular aspect of ELF-MF exposure; however, the 
functional relevance remains to be determined. Therefore, the overall conclusion of the mechanistic 
data, including all publicly available data and the data generated in the ARIMMORA project was that 
evidence of ELF-MF contribution to carcinogenesis at this point is weak. Together with the evaluation 
of the epidemiological studies (limited evidence) and studies in animal models (inadequate evidence) 
the classification of ELF-MF as possibly carcinogenic to humans was not adjusted. So far most animal 
studies included in risk assessments do not suggest that ELF-MF exposure induces tumour 
development. However, a recent study from 2016 indicated a significant co-carcinogenic effect in 
rats exposed to sinusoidal 50 Hz magnetic field in combination with an acute low-dose γ radiation 
(SCENIHR, 2015; Soffritti et al., 2016). The increasing knowledge about possible effects of ELF-MF 
exposure and their molecular mechanism, will hopefully lead to a clear evaluation of the risk to 
public health in near future.  
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Epigenetic alterations are a hallmark of cancer including acute myeloid leukaemia (AML), the most 
common leukaemia in adults. AML is characterized by an increase in progenitor cell stages, 
particularly neutrophilic progenitors (50-60%), indicating an involvement of defects in control 
mechanisms of differentiation. However, dynamic epigenetic changes during neutrophilic 
granulopoiesis that could serve as a base line for the identification of cancerous abnormalities have 
not been discussed yet. In a second part of my studies, I investigated the dynamic alterations of the 
histone modifications H3K4me2 and H3K27me3 as well as of DNA cytosine methylation during the in 
vitro neutrophilic granulopoiesis. We showed a dynamic pattern of DNA methylation during in vitro 
granulopoiesis, with more CpGs gaining methylation at the beginning, in progenitor cells after five 
and nine days, and more CpGs losing methylation in progenitors after 14 days compared to the 
earlier progenitor stages. In total, we observed more CpGs losing than gaining DNA methylation, 
most pronounced at the transition of CD34+ cells into the neutrophilic lineage. These results are in 
line with previous studies reporting predominant loss of DNA methylation in human promyelocytes 
compared to GMPs and between mature neutrophils and promyelocytes (Bocker et al., 2011; Hodges 
et al., 2011; Ronnerblad et al., 2014). Further, we found that the patterns of active and repressive 
histone modifications H3K4me2 and H3K27me3, respectively, are dramatically altered during 
granulopoiesis. In general, we observed more genomic regions gaining H3K27me3 than losing it, 
while the H3K4me2 modification is preferentially lost. Moreover, genomic regions with alterations in 
both histone modifications mainly lost the H3K4me2 modification and gained H3K27me3. These 
results indicate a general compaction and silencing of chromatin during neutrophilic differentiation. 
In line with our results, human blood neutrophils were described to be enriched for heterochromatic 
regions containing repressive histone marks and low amounts of active marks (Navakauskiene et al., 
2014; Olins and Olins, 2005). Genomic locations with changes in histone modifications and DNA 
methylation at lineage commitment were enriched at regulatory regions as promoters and active 
enhancers. We observed a dynamic regulation of the modifications at the same sites where a gain in 
H3K4me2 was generally associated with a loss in H3K27me3 and DNA demethylation, indicating a 
transcriptional activation, whereas a loss in H3K4me2 correlated with a gain in H3K27me3 and de 
novo DNA methylation, indicating transcriptional repression. We investigated that genomic locations 
with changes in all three epigenetic features investigated preferentially guide the chromatin towards 
a more repressed state and are present at genes important in other blood lineages, indicating an 
important role of concomitant alteration of histone modifications and DNA methylation in epigenetic 
repression. Additionally, we noticed that epigenetic repression of poised chromatin domains in 
CD34+ cells occurred preferentially at the point of lineage commitment between CD34+ cells and 
neutrophilic progenitors after 5 days of differentiation through a gain of H3K27me3 alone or in 
combination with de novo DNA methylation, but rarely with DNA methylation alone. These results 
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suggest that epigenetic repression of importent pluripotency genes was mainly initiated by 
H3K27me3 modifications before de novo DNA methylation and could indicate that DNA methylation 
stabilised gene repression or was involved in long-term silencing. By contrast, we observed a high 
amount of CpGs with DNA demethylation at lineage commitment present at neutrophil-specific 
genes and without simultaneous alterations at histone modifications. Therefore, our data indicate an 
important regulatory role of DNA demethylation in lineage restriction. These results are in line with 
previous studies showing that myeloid specific genes are poised through DNA methylation in HSCs 
and activated with DNA demethylation, indicated as Dnmt1 deletion in HSCs resulted in an increase 
of myeloid progenitor cells, whereas Tet2 depletion led to an impaired myeloid differentiation. On 
the other side, lymphoid specific genes are poised through H3K27me3 and activated through 
changes in histone modifications (Cedar and Bergman, 2011; Ko et al., 2010; Trowbridge et al., 2009). 
Overall our data provide an insight into the interplay between DNA methylation and histone 
modifications during neutrophilic differentiation, indicating their specific role in lineage restrictions 
and cell plasticity. In future studies it will be interesting to address the time-dependency of 
epigenetic alterations and gene expression, the correlation to heterochromatin marks like H3K9me3 
and the role of individual epigenetic modifications in the course of carcinogenesis.  
In conclusion, my studies provided novel insight into the landscape of histone modifications and DNA 
methylation in the course of a neutrophilic differentiation and how these patterns can be modified 
by ELF-MF. We observed a stochastic effect of ELF-MF exposure on the stability of epigenetic 
features, predominantly at open chromatin. These data may serve as a basis for further studies 
investigating the mechanism for ELF-MF induced leukaemogenic effects as well as for the 
establishment of biomarker panels for ELF-MF exposure assessment. Additionally, we investigated 
the regulatory role of DNA methylation and histone modifications during neutrophilic granulopoiesis. 
These data may provide information for further studies investigating chromatin epigenetic regulators 
as targets for leukaemia induced differentiation therapy, initiating the differentiation of cancerous 
cells into mature cells finally leading to cell death. 
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Abstract 
Extremely-low-frequency magnetic fields (ELF-MF) have been classified as "possibly carcinogenic" to 
humans on the grounds of an epidemiological association of ELF-MF exposure with an increased risk 
of childhood leukaemia. Underlying mechanisms, however, have remained obscure. Genome 
instability seems an unlikely reason as the energy transmitted by ELF-MF is not sufficient to damage 
DNA and induce cancer-promoting mutations. ELF-MF, however, may perturb the epigenetic code of 
genomes, which is well-known to be sensitive to environmental factors and generally deranged in 
cancers, including leukaemia. We examined the potential of ELF-MF to influence key epigenetic 
modifications in leukaemic Jurkat cells and in human CD34+ hematopoietic stem cells undergoing in 
vitro differentiation into the neutrophilic lineage. Sensitive genome-wide profiling revealed no 
statistically significant, ELF-MF dependent alterations in the patterns of active (H3K4me2) and 
repressive (H3K27me3) histone marks, nor in the formation DNA methylation patterns during 
granulopoiesis. However, ELF-MF exposure showed consistent effects on the reproducibility of these 
histone and DNA modification profiles, which appear to be of a stochastic nature but show a genomic 
context preference. The data indicate that ELF-MF exposure may stabilize H3K4me2 modifications in 
chromatin that changes from a repressive to an active state during cell differentiation. 
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Introduction 
The increasing use of electronic appliances generating electromagnetic fields in the extremely-low-
frequency range of 50 or 60 Hz (ELF-MF) has raised concerns about potential health risks. The main 
sources of ELF-MFs are in-house installations, household appliances and powerlines, resulting in 
average indoors exposure levels between 0.025 and 0.07 µT in Europe
1,2
. Based on epidemiological 
studies, associating ELF-MF exposure with an increased risk for childhood leukaemia, ELF-MF 
exposure was evaluated as being possibly carcinogenic to humans (group 2B) by the International 
Agency for Research on Cancer (IARC)
3,4
. Animal and cellular studies, performed to address biological 
effects of ELF-MF exposure and pinpoint mechanisms underlying potential health impacts, however, 
failed to come up with a consistent mechanistic explanation of these epidemiological observations
1,3
. 
Most animal studies failed to support evidence that magnetic fields can cause tumours, an exception 
being a recent study indicating a co-carcinogenic effect in rats exposed to sinusoidal 50 Hz ELF-MF in 
combination with an acute low-dose γ-ray iradiation
1,5
. 
Acute lymphoblastic leukaemia (ALL) is the most common type of childhood leukaemia, characterized 
by high accumulation of T or B lymphocytes in progenitor stages, unable to terminally differentiate
6,7
. 
Many ALLs arise from foetal genetic lesions or translocations like TEL-AML1 (ETV6-RUNX1) or MLL-
TET1 fusions in blood progenitor cells, resulting in unlimited self-renewal and failure in stage-specific 
developmental arrest
8
. Besides the foetal genetic events, the classical ‘two-hit’ model of childhood 
ALL postulates a requirement of a second hit after birth in the form of additional chromosomal or 
genetic alteration
9
. Prominent amongst these appear to be mutations in genes encoding epigenetic 
modifiers like in the methyltransferase EZH2, a subunit of the polycomb repressive complex 2, or the 
DNA methyltransferase DNMT3a
10-12
. This selection for mutations in epigenetic modifiers indicates 
that defects in the control of cell differentiation associated changes in gene expression and 
chromatin landscapes contribute to the establishment of ALL. 
Cancers generally emerge as a consequence of progressive change in genome structure and function, 
including mutation of the DNA sequence and alteration of chromatin structure and gene 
expression
13
. Genomic instability is therefore a hallmark of tumor progression
14,15
. Whether or not 
ELF-MFs have the power to induce genetic mutations is questionable as the energy deposited by ELF-
MFs is orders of magnitudes below of what would be required to affect chemical bonds in DNA
16
. 
Therefore, notwithstanding occasional reports of a genotoxic potential of ELF-MFs
17-20
, it seems 
unlikely that ELF-MF-induced genetic mutations contribute significantly to the mutagenesis in cancer. 
Another hallmark of cancers are aberrations in the cell type-specific patterns of epigenetic 
modifications. Epigenetic modifications to histone proteins and the DNA, established mainly during 
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cell differentiation, guide and stabilize cell-type-specific gene expression. This "programming" of 
genomes in differentiating cells is instructed by environmental cues and, hence, is also likely to be 
sensitive to disturbance by environmental factors
21,22
, such as MFs. Consistent with a possible impact 
of ELF-MFs exposure on epigenetic cell programming, it has been reported that ELF-MFs are able to 
alter neural differentiation
23-26
. Regulatory epigenetic modifications include the acetylation and 
methylation of histone tails and the methylation of DNA cytosine bases
27,28
, altogether establishing 
three main classes of chromatin; i.e. active, repressed and poised chromatin. Active chromatin, 
comprising highly expressed genes, is marked by trimethylation of histone 3 lysine 4 (H3K4me3), 
acetylation of histone 3 lysine 27 (H3K27ac) and unmethylated DNA cytosine, whereas chromatin 
correlating with gene repression is characterized by histone 3 trimethylated at lysine 27 (H3K27me3) 
and lysine 9 (H3K9me3) and DNA cytosine methylation (5-methylcytosine, 5mC). Transcriptionally 
poised chromatin is co-occupied by the active and repressive marks H3K4me2/3 and H3K27me3 and 
is located preferentially at developmental genes in stem cells
29
. The potential of ELF-MF exposure to 
destabilize epigenetic modifications in general and in a cancer-relevant manner has not been 
addressed systematically. Yet, it was reported to alter global levels of 5mC and the expression of DNA 
methyltransferases DNMT1 and DNMT3b in mouse spermatocytes
30
, and to increase the 
reprogramming efficiency of somatic cells by upregulation of the histone lysine methyltransferase 
Mll2, which appears to enrich H3K4me3 at pluripotent genes
31
. 
To investigate whether ELF-MFs have a potential to alter the epigenome, we analysed under highly 
controlled and standardized conditions the impact of exposure on the stability of key active 
(H3K4me2) and repressive (H3K27me3) histone modifications in a leukaemic cell line, as well as on 
the formation of cell-type-specific H3K4me2 and H3K27me3 and DNA methylation patterns in in vitro 
differentiating human cord blood cells. We profiled these modifications genome-wide and found that 
ELF-MF exposure has no specific and reproducible effects on the stability of histone and DNA 
modifications in leukaemic cells nor on the establishment of cell type-specific modifications during 
haematopoietic differentiation. Yet, the ELF-MF exposure appeared affected the reproducibility, i.e. 
the robustness, of the epigenetic marks in replicate cell populations. 
 
Results 
ELF-MF exposure does not reproducibly induce alterations in histone modifications in Jurkat cells. 
To determine if ELF-MF exposure affects the epigenetic stability of leukaemic cells, we profiled the 
genome-wide patterns of the key histone marks H3K4me2 and H3K27me3 (Figure 1) in the T cell 
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lymphoma cell line Jurkat exposed intermittently (5’ on/10’ off) to a 50 Hz sine ELF-MF at a flux 
density of 1 mT, or to a sham control (< 7 µT residual field) for 72 h (Supplementary Figure S1). 
Exposure settings were blinded throughout the experiments. We also included a treatment with the 
histone deacetylation inhibitor trichostatin A (TSA) at a sub-toxic dose of 10 nM to assess the impact 
of a known epigenetic modulator (Supplementary Figure S2). Previous studies – although not 
consistently – described effects of ELF-MF exposure on cell proliferation and apoptosis
17,32,33
, 
parameters that on their own may influence epigenetic modifications. We therefore assessed 
exposure effects on proliferation, cell cycle progression and apoptosis in our exponentially growing 
Jurkat cells. These controls showed no significant exposure effect on either of these parameters 
throughout the 3.5 cell cycle duration (72 h) of the experiment (Supplementary Figure S2). By 
contrast, TSA treatment (10 nM) resulted in a transient increase of G1 and a decrease of S and G2 
phase cells 24 hours after treatment start without, however, affecting overall cell proliferation or the 
proportion of apoptotic cells. We therefore conclude that the ELF-MF exposure condition applied did 
not affect cell viability and proliferation in our experiment. 
We then combined chromatin immunoprecipitation (ChIP) with next generation sequencing (ChIP-
seq) to quantitatively map H3K4me2 and H3K27me3 occurrence in chromatin isolated from Jurkat 
cells before exposure (t0), following ELF-MF/sham exposure for 72 h, or treated with TSA. Two ChIP-
seq replicates were generated from six biological replicates for each condition by pooling three 
samples each. About 51 million reads per Chip-seq sample were mapped to the hg19 human 
genome. H3K4me2 and H3K27me3 profiles in 500 bp genomic tiles showed a high reproducibility 
between the replica of all condition (Supplementary Figures S3 and S4). Principal component analysis 
of the data clearly separated TSA treated Jurkat cells from exposed cells. ELF-MF and sham-exposed 
cells, however, clustered together, indicating that the exposure has no global effect on H3K4me2 and 
H3K27me3 patterns (Figure 1a). Consistently, we observed a large number of 500 bp tiles showing 
significantly different enrichment in H3K4me2 and H3K27me3 modifications in TSA treated cells 
(FDR-adjusted P value < 0.05, log2 fold change [FC] > ±0.6) (Figure 1b, 1e), but no significant 
differences were apparent when comparing ELF-MF- and sham-exposed Jurkat cells (Figure 1c, 
Supplementary Figure S5). Several loci, however, showed up to three-fold differential H3K4me2 and 
H3K27me3 occupancy upon ELF-MF exposure, as illustrated for two regions within the RPTOR and 
CEP170 genes (Figure 1d). These differences, however, did not reach statistical significance. These 
results indicate that the landscape of H3K4me2 and H3K27me3 modifications in leukemic cells is 
largely unaffected by ELF-MF exposure. 
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ELF-MF exposure does not reproducibly affect global patterning of histone marks in granulopoiesis. 
As epigenetic processes are highly dynamic and likely to be sensitive to disturbance by environmental 
factors during cellular differentiation
22,34,35
, we addressed whether ELF-MF exposure affects 
differentiation-associated patterning of H3K4me2 and H3K27me3 marks. Under exposure to a 
powerline-simulating ELF-MF (50 Hz, 1 mT, 5’ on/10’ off) with parallel sham and no ELF-MF controls 
(Supplementary Figure S1), we differentiated in vitro CD34+ haematopoietic stem cells from human 
cord blood into the neutrophilic lineage by an established protocol
36
. The differentiation process was 
monitored by flow cytometry by analysing granulocytic maturation stages. 90% of cells differentiated 
from the CD34+ progenitor state to a promyelocyte (75%) or myelocyte (15%) stage within five days 
irrespective of the exposure condition (Supplementary Figure S6). By day 10, more than 50% of cells 
matured into myelocytes and metamyelocytes/neutrophils, again without notable differences 
between ELF-MF- and sham-exposed populations. Also, cell proliferation was not affected by ELF-MF 
exposure (Supplementary Figure S6). Throughout exponential growth, around 25% and 10% of cells 
in all populations were in S and G2 phase of the cell cycle, respectively (Figure 2a; Supplementary 
Figure S7). At days four and five (neutrophilic progenitor cell stage), ELF-MF exposed cultures showed 
a small reduction of G1 and a compensating increase of S phase cells when compared to sham and 
unexposed controls. Investigating potentially associated effects of the ELF-MF exposure on cell 
viability as observed previously
32,33,37,38
, we quantified the proportion of alive cells, early apoptotic, 
late apoptotic and dead cells by flow cytometry. Expansion cultures of CD34+ cells (t0) were highly 
proliferating and composed of around 95% living cells (Figure 2b; Supplementary Figure S8). 
Following induction of differentiation, the fraction of apoptotic cells increased, establishing a 
significant difference between exposure conditions at day four, where 24% of cells were apoptotic or 
dead in ELF-MF exposed cultures and 19% in sham exposed cultures (Figure 2b). Although small, 
these differences indicate that ELF-MF has the potential to induce apoptosis directly or indirectly in a 
small fraction of differentiating neutrophilic cells. The concomitant slight accumulation of ELF-MF 
exposed cells in S-phase suggest that this may be related to an ELF-MF-induced disturbance of S-
phase progression. 
To determine whether ELF-MF exposure influences the patterning of H3K4me2 and H3K27me3 
modifications, we performed ChIP-seq with chromatin of cells harvested before (t0) and after five 
days (t5) of differentiation. Two ChIP-seq replicates were generated from three independent 
differentiation experiments by pooling experiments two and three into ChIP-seq replicate two. 26 
million reads per ChIP-seq sample were mapped to the human genome and read numbers in 500 and 
1,000 bp genomic tiles were analysed. The comparison of reads per tile between samples confirmed 
a good reproducibility and clearly separated samples of CD34+ cells and neutrophilic progenitors in a 
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principal component analysis (Figure 2c, Supplementary Figures S9, S10). We first analysed the ChIP-
seq data by a likelihood-ratio test assuming fixed standard deviations to compare ELF-MF with sham- 
and non-exposed cells after five days of differentiation. This identified only few genomic regions with 
differential (FDR-adjusted P value < 0.05, log2 FC > ±0.6) H3K4me2 or H3K27me3 enrichments 
(Supplementary Figure S11), most pronounced in the comparison of ELF-MF-exposed with non-
exposed cells. Nine and 19 genomic regions showed significant differences in H3K4me2 and 
H3K27me3 enrichment, respectively, between ELF-MF and sham exposed neutrophilic progenitors. 
To address potential false positives due the statistical reasons, we adjusted the analysis by allowing 
for variable standard deviations between samples. Analyzed this way, the differences in H3K4me2 or 
H3K27me3 occupancy between ELF-MF or sham exposed cells disappeared (FDR-adjusted P 
value < 0.05, log2 FC > ±0.6) (Figure 2d). By contrast, comparing cells prior to and five days into 
differentiation yielded large numbers of tiles with significant differences in H3K4me2 and H3K27me3 
occupancy (Figure 2e), including loci like ELANE and CD34 with 3.8- and 11-fold differential 
enrichments, respectively (Figure 2f), and documenting the epigenetic reorganization occurring 
throughout neutrophilic differentiation. Notably, however, despite the lack of significant differences 
between ELF-MF and sham-exposed cells, many genomic loci showed substantial differential 
enrichments for either of the histone marks (up to 8-12 fold) (Figure 2d), as illustrated in the 
respective profiles at the UBAP2 and CLF5 loci (Figure 2g). These results show that, while the 
epigenetic landscape undergoes major alterations during neutrophilic differentiation, ELF-MF 
exposure does not reproducibly impair the global patterning of the two key histone modifications 
examined. 
Genome-wide formation of DNA methylation patterns is not affected by ELF MF exposure.  
Environmental conditions modulate epigenetic modifications not only at histones but also at the 
level of DNA
39,40
. To address whether ELF-MF affects DNA cytosine methylation during neutrophilic 
differentiation, we performed genome-wide methylation analysis at single CpG sites of CD34+ (t0) 
and day five progenitor (t5) cells, using the Illumina Infinium HumanMethylation 450 platform. We 
analysed 412,940 CpGs and observed a high correlation between all biological replicas and a clear 
separation of samples from CD34+ and neutrophilic progenitor cells in a principal component 
analysis (Figure 3a; Supplementary Figure S12). As expected, the pattern of DNA methylation 
dramatically changed during differentiation, resulting in 3,882 hypo- (log2 FC < -0.6) and 2,977 
hypermethylated (log2 FC > 0.6) sites (FDR-adjusted P value < 0.05) (Figure 3b). Yet, no CpGs were 
differentially methylated with statistical significance when ELF-MF exposed progenitor cells were 
compared with control conditions (Figure 3c; Supplementary Figure S12). These results indicate that, 
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although DNA methylation undergoes major changes during neutrophilic granulopoiesis, ELF-MF 
exposure does not influence the formation of cell-type-specific DNA methylation patterns. 
ELF-MF exposure affects the variability of epigenetic modifications between replicate experiments. 
Although we did not identify consistent alterations of histone modifications or DNA methylation 
upon ELF-MF exposure both in leukaemic cells and in differentiating neutrophilic cells, we observed a 
number of genomic loci showing up to 16-fold differential occupancy by H3K4me2 and H3K27me3 or 
DNA methylation (Figures 1c, 2d, and 3c). These differences did not reach statistical significance 
(FDR-adjusted P value < 0.05) due to a considerable variance between the data sets. Although the 
overall correlation of the ChIP-seq data was high (Supplementary Figures S3, S4, S9, and S10), a 
closer examination of the H3K4me2 and H3K27me3 read counts in all tiles revealed exposure 
condition-dependent effects on the variability of replicate samples, both in Jurkat cells and 
neutrophilic progenitors (Figure 4a, 4b). We reasoned that this differences in replicate variability may 
reflect an influence of the exposure on the establishment and/or maintenance of H3K4me2 and 
H3K27me3 modification patterns, resulting in a stochastic perturbation of epigenetic programming. 
The dramatic replicate variability of H3K4me2 and H3K27me3 marks also observed in Jurkat cells 
treated low-dose TSA, a known epigenetic modulator (Figure 4c), corroborated that epigenetic 
perturbation is indeed detectable at the level of sample variance. ELF-MF exposure, when compared 
to sham-exposed or un-exposed (t0) conditions, significantly increased the replicate variability of 
H3K27me3 modifications while reducing the variability of H3K4me2 modifications in Jurkat cell 
(Figure 4c). Consistent with the higher epigenetic plasticity of stem- and tissue progenitor cells, 
replicate variabilities of H3K4me2 and H3K27me3 modifications were more pronounced in 
populations of CD34+ hematopoietic stem cells and neutrophilic progenitors (t5) than in populations 
of Jurkat cells (Figure 4c, 4d). Here, ELF-MF exposure significantly reduced the replicate variability of 
both H3K4me2 and H3K27me3 modifications in neutrophilic progenitors (Figure 4d), and the same 
was apparent in the DNA methylation data (Figure 4f). Notably, the decrease in replicate variability in 
ELF-MF exposed cells correlated well with a more robustly directed differentiation into the 
neutrophilic lineage, as indicated by a reduced median variability of the maturation stages 
(Supplementary Figure S13). Together, these observations indicate that ELF-MF exposure can affect 
the robustness of the establishment and/or maintenance of key epigenetic modifications, particularly 
in differentiating cell populations. 
The stabilizing effect of ELF-MF on epigenetic modifications partially depends on chromatin state. 
Next, we investigate whether the variability in epigenetic modifications is randomly distributed 
across the genome or preferentially associated with certain genomic features. We intersected the 
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profiles of histone and DNA modifications with annotated gene promoters, exons, introns and 
intergenic regions and also correlated them with bivalent chromatin domains identified by co-
occupancy of active H3K4me2 and repressive H3K27me3 marks in our ChIP-seq data. In TSA treated 
Jurkat cells, H3K4me2 variability showed little dependency on genomic context while H3K27me3 was 
clearly most variable at gene promoters and in bivalent chromatin (Figure 5b), consistent with the 
preferential localisation of histone acetylation at gene promoters and enhancers
41
. ELF-MF exposure, 
however, reduced replicate variability of H3K4me2 modifications and increased variability of 
H3K27me3 modifications irrespective of the genomic context (Figure 5a,b). In neutrophilic 
progenitors, H3K4me2 and H3K27me3 modifications generally showed the highest reproducibility at 
promoters and in bivalent chromatin domains and a pronounced replicate variability particularly in 
introns and intergenic regions (Figure 5c). ELF-MF exposure decreased replicate variability of 
H3K4me2 marks at all genomic locations except in bivalent chromatin domains (Figure 5c,e; 
Supplementary Figure S13). Consistently, active gene promoters, devoid of H3K27me3, were 
significantly more stabilized by exposure than bivalent promoters, co-occupied by H3K4me2 and 
H3K27me3 modifications (Supplementary Figure S13). ELF-MF exposure also reduced the variability 
of H3K27me3 modifications, although less pronounced and without much preference for any of the 
genomic sites assessed (Figure 5d,f; Supplementary Figure S13). The variability of DNA methylation 
was also significantly decreased upon ELF-MF exposure, although without much preference for a 
particular genomic context (Figure 5g). These results indicate that ELF-MF affects the robustness of 
epigenetic marks in a partially genomic context-dependent manner, with the most distinctive feature 
being the H3K4me2 modification in active and bivalent gene promoters of differentiating cells. 
Bivalent chromatin is associated with transcriptionally poised states and often present at regulatory 
elements of developmental genes that will be activated or repressed in the course of cell 
differentiation
29,42
. As bivalent chromatin is highly dynamic but seemingly less variable and more 
protected from ELF-MF impact in differentiating neutrophilic progenitors, we investigated whether 
the robustness of H3K4me2 and H3K27me3 marks correlates with differentiation associated changes 
in chromatin status. We identified genomic tiles changing H3K4me2 or H3K27me3 modification (FDR-
adjusted P value < 0.05) during neutrophilic differentiation and categorized them into upregulated 
(log2 FC > +0.6), downregulated (log2 FC < -0.6) or not changed for either of the histone 
modifications. Then, we intersected tiles with H3K4me2 and/or H3K27me3 occupancy in neutrophilic 
progenitors with the tiles in the three categories of differentiation associated change (Figure 6a) 
Analysing these categories confirmed that ELF-MF exposure generally reduced H3K4me2 variability in 
active (H3K4me2) but not in bivalent chromatin (H3K4me2 and H3K27me3), and this effect was 
independent of the differentiation dynamics in either of the modifications (Figure 6a). By contrast, 
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ELF-MF exposure reduced the variability of H3K27me3 modification with a clear dependency on 
chromatin dynamics; it was most pronounced in tiles losing the repressive histone mark during 
differentiation, regardless the status of bivalency (Figure 6a). We then examined the relationship 
between the differentiation dynamics of the histone modifications and the ELF-MF effect on their 
relative enrichment (Figure 6b). The ELF-MF effect on H3K4me2 occupancy was strongest in tiles 
representing active chromatin (H3K4me2 only) that gained H3K4me2 during differentiation, while 
the exposure effect on H3K27me3 occupancy was highest in tiles that lost the modification during 
differentiation. To address whether effects of ELF-MF exposure on DNA methylation follow the same 
pattern, we analysed replicate variability of DNA methylation data from neutrophilic progenitors in 
CpG sites significantly hypo- (log2 FC < -0.6, FDR-adjusted P value < 0.05) or hypermethylated (log2 
FC > +0.6, FDR-adjusted P value < 0.05) or unchanged in the course of differentiation. Consistent with 
the data on H3K27me3, the ELF-MF exposure was associated with a significantly reduced variability 
of CpG methylation at sites losing 5mC during differentiation but had no effect as sites gaining 5mC. 
We also observed that the ELF-MF impact on DNA methylation levels in neutrophilic progenitors was 
less pronounced at sites that change CpG methylation during differentiation that at sites that show 
no changes (Figure 6d). These observations suggest that ELF-MF exposure stabilizes epigenetic 
modifications in regions marked by H3K4me2 that lose H3K27me3 and/or undergo DNA 
demethylation during differentiation, i.e. in chromatin that changes from a repressive to an active 
state during differentiation. 
 
Discussion 
Epidemiological studies have associated the exposure to ELF-MF with an increased risk of childhood 
leukaemia but underlying biological mechanisms have remaining elusive. The concept of cancer 
promotion through DNA damage-induced genetic mutation is widely accepted for ionizing ration but 
appears, on the basis of energetic considerations, not applicable to ELF-MF. We reasoned that 
ELF-MF exposure may affect the epigenome rather than the genome, thereby promoting cancerous 
changes in cell identity and behaviour. Our aim was to explore the possibility that ELF-MF exposure 
influences the stability and programming of key epigenetic modifications in leukemic cells and in 
differentiating hematopoietic stem cells in a way that may explain enhanced leukaemogenesis. 
The epigenome is well-known to be susceptible to environmental influences of all kinds, including the 
exposure to non-mutagenic carcinogens
21,22,34
. We showed here that the treatment of leukaemic 
Jurkat cells with a very low, sub-toxic dose of TSA, not affecting cell behaviour or phenotype in any 
notable way, destabilizes and alters patterns of the key epigenetic modifications (H3K4me2 and 
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H3K27me3) in a way readily detectable by genome-wide profiling, hence documenting the feasibility 
and sensitivity of our approach to measure subtle epigenetic aberrations. Yet, the evaluation of the 
impact of ELF-MF exposure on the profile of these marks in Jurkat cells did not reveal any specific and 
reproducible exposure-dependent alterations. We therefore conclude that in the well-controlled 
experimental setup of this study, ELF-MF exposure does not cause perturbations on the epigenetic 
landscape in a leukaemic cell line. Likewise, we observed no statistically significant alterations of 
epigenetic modifications in neutrophilic progenitors after five days of in vitro differentiation under 
ELF-MF exposure. Neither H3K4me2, nor H3K27me3, nor DNA methylation marks were influenced by 
the exposure, although extensive differentiation-associated changes in these modifications were 
clearly evident. The absence of an impact of the ELF-MF on CpG methylation levels and patterning 
during neutrophilic granulopoiesis is in contrast to a previous report, indicating changes in global 
cytosine methylation of a murine spermatocytes-derived cell line when exposed to a comparable 
ELF-MF (50 Hz, 1 mT or 3 mT, intermitted, 72 h)
30
. This discrepancy could be explained by cell type-
specific susceptibilities of the DNA methylation system to ELF-MF exposure or by a different 
permissiveness of the culture systems for the establishment of epigenetic variation in subpopulations 
of cells. Our in vitro differentiation system was tightly controlled by the growth factor G-CSF and 
cytokines, allowing specifically for growth and development of cells of the neutrophilic lineage while 
restricting the establishment of other cell-types. The minor exposure-dependent, transient 
differences in cell cycle progression and apoptosis early in the differentiating cell populations may 
indeed reflect an underlying positive selection for neutrophilic cells, which overall supported the 
formation of homogenous populations of promyelocytes and myelocytes, irrespective of the ELF-MF 
exposure. So, selection may have masked epigenetic divergence in our experiments, which may have 
been picked up more easily by the less stringent conditions in the experiments with spermatocyte-
derived cells. ELF-MF exposure of these cells might have triggered spontaneous differentiation 
responses that were tolerated in the culture and, ultimately, gave rise to detectable epigenetic 
change. Enhancement of differentiation upon ELF-MF exposure was reported in neuronal cells
23,24,43
, 
where it correlated with a gain of H3K9 acetylation at specific neuronal genes, promoting their 
activation
44
. 
Our data thus suggests that ELF-MF exposure has no specific and reproducible effect on key 
epigenetic modifications in leukaemic cells and differentiating haematopoietic cells. We cannot rule 
out potential effects on histone modifications that were not studied here or under different 
experimental conditions, .e.g. under prolonged duration or a different mode of ELF-MF exposure or 
with different cell-lines or differentiation cell culture conditions. A closer examination of the data, 
however, revealed a potential impact ELF-MF exposure on the robustness of the epigenetic 
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programming. ELF-MF exposure was generally associated with a reduced variability in ChIP-seq and 
DNA methylation data between replicate samples, the exception being H3K27me3 in Jurkat cells, 
showing increased variability upon ELF-MF exposure. Notably, the treatment of Jurkat cells with TSA, 
a known epigenetic modulator, generated similar effects on replicate variability for both histone 
modifications, suggesting that the variance in replicate data sets can be a measure for epigenetic 
robustness, which in the case of ELF-MF exposure appears to be perturbed in a stochastic manner. 
The impact of ELF-MF exposure on the reproducibility of histone and DNA modification patterns is 
likely to depend on cell-type specific epigenetic states and plasticity, as well as differential 
sensitivities to ELF-MFs
45,46,47
. For instance, it was reported that chromatin conformation changes 
following low dose ELF-MF exposure of human lymphocytes depend on the initial chromatin state
48
. 
Investigating the viscosity of chromatin, these authors found that relaxed chromatin becomes more 
condensed and compact chromatin more open upon ELF-MF exposure; i.e. that chromatin 
perturbance by ELF-MFs is context dependent. Our in vitro differentiation starts with an 
epigenetically dynamic and heterogeneous stem cell population
49-51
, as also indicated by a high 
replicate variability for H3K4me2 and H3K27me3 modifications in CD34+ cells. ELF-MF exposure then 
appears to exert a homogenizing effect on the initially variable chromatin states in the early 
differentiating cell population, hence reducing the replicate variability at later time points in 
differentiation. We found ELF-MF exposure to increase the robustness of histone modifications as 
well as DNA methylation, particularly in genomic regions marked by H3K4me2 and losing H3K27me3 
and/or DNA methylation in the course of differentiation. As H3K4me2 and unmethylated CpGs are 
associated with transcriptionally active chromatin, allowing for binding of transcription factors, the 
locus-specific pattern of reduced replicate variability upon ELF-MF exposure coincides with sites of 
transcriptional activity and/or chromatin opening during differentiation. These results therefore 
suggest that open and active chromatin is more affected by MF exposure than condensed chromatin. 
Notably, to monitor the status of our cell cultures and assess the comparability of the genomic data 
produced, we systematically measures a variety of cell growth parameters throughout all 
experiments. Previous studies reported ELF-MF exposure-dependent alterations in cell proliferation, 
cell cycle progression and apoptosis in various cancerous and non-cancerous cells
19,32,38,52,53
. We 
observed no alterations in cell proliferation in Jurkat cells and during granulopoiesis upon ELF-MF 
exposure and neither did we notice any effects on apoptosis or cell cycle progression in Jurkat cells. 
During granulopoiesis, we found small differences in cell cycle progression concomitant with an 
increased induction of apoptosis in ELF-MF exposed cultures at day four, which may have had a 
synchronizing effect on exposed cell populations and thereby contributed to the reduced replicate 
variability observed of these cultures. 
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In conclusion, we report that ELF-MF exposure has no significant effect on the epigenetic landscapes 
of leukaemic and differentiating haematopoietic cells. However, our data indicate that ELF-MF 
exposure may influence the robustness of histone modification and DNA methylation patterning in 
the course of the global chromatin reorganization associated with neutrophilic differentiation. This, 
however, did not notably affect the overall dynamics and efficiency of granulopoiesis. 
 
Methods 
Cell culture and neutrophilic differentiation. 
Culturing of cells was routinely performed at 37°C in a humidified atmosphere with 5% CO2. Jurkat 
cells (acute T cell leukaemia) were cultured in RPMI-1640 medium supplemented with 2 mM 
L-glutamine, 1 mM Na-pyruvate, 10% FCS and 0.6x penicillin/streptomycin (Sigma-Aldrich). Fresh 
medium was supplied every 48 h. For ELF-MF exposure experiments, cells were seeded at a density 
of 10
5
 cells/mL and grown for the indicated time without addition of fresh medium. As positive 
control, cells were treated with 10 nM trichostatin A (TSA). CD34-positive cells isolated from human 
cord blood of mixed donors were obtained from AllCells (Alabama, United States). CD34+ cells were 
propagated in Stemline II medium expansion medium (Stemcell technology) supplemented with 100 
ng/mL thrombopoietin, 100 ng/mL stem cell factor, 10 ng/mL Flt3-ligand (Peprotech), 5000 U/mL 
Penicillin and 5 mg/mL Streptomycin (Sigma-Aldrich) for four days (De Bruyn et al., 2003). For the 
neutrophilic differentiation, expanded CD34+ cord blood cells were seeded at cell densities of 10
5
 
cells/mL in Stemline II medium supplemented with 100 ng/mL stem cell factor, 10 ng/mL Flt3-ligand, 
100 ng/mL G-CSF (Peprotech), 5000 U/mL Penicillin and 5 mg/mL Streptomycin (Sigma-Aldrich) and 
cultured for 10 days. Every second day, fresh cell culture medium was added (1:2 dilution). 
Exposure to ELF-MF. 
The exposure system sXc-ELF (IT’IS, Zurich, Switzerland) allows for a well-controlled exposure with 
ELF-MF (Supplementary Figure S1)
54
. The selected exposure for the leukaemic cell line was sinusoidal 
ELF-MF (50 Hz, 1 mT, 5’ on/10’ off) or sham for approximately 3.5 cell cycles (72 h). The electric field 
caused by the coil was shielded and the magnetic field uniformity was better than 1% (SD). Each coil 
was place inside a μ-metallic box and the boxes placed side by side in the same incubator to 
decouple the coils, to shield the electric and magnetic fields generated by the incubator and to 
ensure the same environmental conditions (temperature, humidity and CO2). The field attenuation 
between the coils was at least a factor of 150, i.e., the shame exposure was anywhere less than 7 µT 
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compared to the uniform exposure of 1 mT. The exposure system meets the general criteria 
established in [Recommended Minimal Requirements and Development Guidelines for Exposure 
Setup of Bio-Experiments Addressing the Health Risk Concern of Wireless Communications]. 
Intermittent exposure is often chosen as it reflects in situ better than continuous exposures and it 
has also been demonstrated to enhance the response, i.e. showed the largest ELF-MF response on 
comet assay tail factors with 5’on/10’off cycles. Control exposures were done in parallel, either in a 
µ-metal shielded compartment inside the exposure incubator or in different incubator. Randomized 
assignment of ELF-MF and sham exposure conditions to the two chambers allows experiments 
blinded for the observer. Continuous temperature monitoring confirmed that the temperature 
difference between the exposure chambers was less than 0.1°C. 
Cell cycle, apoptosis measurement and identification of cell differentiation state by flow 
cytometry. 
Cell cycle profiles were analysed by propidium iodide staining as described in detail elsewhere
17
. The 
number of apoptotic cells in the population was estimated by the Annexin-V Alexa488/PI kit 
(Invitrogen) according to the provider’s recommendations. Maturation status of the differentiating 
neutrophilic cell population was analysed by immuno-detection of cell surface markers. The following 
combination of antibodies were used: PE mouse anti-human CD16b, APC mouse anti-human CD34, 
APC-Cy7 mouse anti-human CD11b, PE-Cy7 mouse anti-human CD14 (all from BD Biosciences) and 
FITC-anti-Annexin V (Invitrogen). Neutrophilic differentiation stages were identified by gating on 
subpopulations according to the expression of surface markers (Supplementary Figure S6)
55
: CD34+ 
cells (CD34+, CD11b-, CD16b-), promyelocytes (CD34-, CD11b-, CD16b-), myelocytes (CD34-, CD11b+, 
CD16b-) and metamyelocytes (CD36-, CD11b+, CD16b+). Monocytes were identified according to the 
expression of CD14+. All samples were measured using a FACS cytometer (Beckton Dickinson) and 
analysed by FlowJo Software. Data were statistically analysed by χ
2
 test for each replica as well as 
pairwise comparison by Student’s t-test using GraphPad Prism. Full methodical details are given in 
the Supplementary information. 
Base resolution DNA methylation analysis by Illumina Infinium HumanMethylation 450 array. 
Genomic DNA was extracted from frozen cell pellets by QIAamp DNA mini kit (Qiagen) according to 
the manufacturer’s instructions including an RNase-treatment step. 500 ng of genomic DNA was 
bisulfide converted using the EZ-96 DNA Methylation Kit (Zymo Research Corporation). Genome-
wide assessment of DNA methylation was done on Illumina Infinium HumanMethylation 450 
Beadchip arrays, interrogating methylation at 485,577 sites
56
. Raw signal intensities were extracted 
by the Illumina GenomeStudio software and imported into R as a methylumi object using the 
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methylumi package. Data normalization was performed applying the dasen method as described 
previously
57
. Briefly, probe-level signals for individual CpG sites were subjected to background 
adjustment, followed by quantile normalization of both typeI and typeII probes separately. Probes 
for CpG sites with signal intensities not significantly different (P < 0.05) from background 
measurements in any data sets or mapping to regions with known germline polymorphisms, to 
multiple genomic loci
58
, or to either sex chromosome were removed, yielding a total of 412,940 CpG 
after filtering. All computational and statistical analyses were performed using R and Bioconductor
59
. 
All analyses for differential methylation were performed on M-values (M = log2 
(methylated/unmethylated) as recommended
60
. Empirical Bayes methodology utilizing a moderated 
t-statistic available in limma was used to test for significant differences between the groups (Smyth, 
2004). False-discovery rate (FDR)-adjusted P values for multiple comparisons were calculated using 
the Benjamini and Hochberg approach. Differentially methylated CpGs were defined as those with 
both a false discovery rate (FDR) adjusted P value < 0.05 and log2 fold change > 0.6. Variance was 
calculated based on M-values
60
. 
Whole-genome analysis of histone modifications. 
The ChIP protocol using ChIP-validated antibodies for the H3K4 dimethylation and H3K27 
trimethylation histone modifications (Millipore) of 20-30 µg chromatin was performed as described 
previously
61
 and in the Supplementary information in detail. Single-end 50 bp reads sequencing of 
ChIP was performed at the Quantitative Genomics Facility in Basel and at Genome Technology Access 
Center (GTAC) in St. Louis (Missouri, USA), using standard protocols for library generation for the 
Illumina HiSeq platform. To maintain the blinding of ELF-MF exposure conditions during ChIP-seq and 
bioinformatics analyses, sample pooling was guided by the IT’IS foundation. In total 16 libraries were 
sequenced from H3K4me2 and H3K27me3 ChIP samples of Jurkat cells: 2 sample pools of 3 
independent exposure replicates for each condition (before exposure, sham-, ELF-MF-exposure and 
TSA treatment) and both histone modifications, resulting in around 200 Mio reads for the exposure 
conditions and 50 Mio reads for the TSA treated samples. For the analysis of primary cells during 
neutrophilic differentiation, 14 libraries were generated from H3K4me2 and H3K27me3 ChIP 
samples: one independent exposure replicate as well as one pool of two independent exposure 
replicates for each exposure condition (ELF-MF and sham) for CD34+ cells and neutrophilic 
progenitors at day°5. For the control differentiation, ChIPs of two independent replicates of 
progenitor cells were pooled. Additionally, two input controls were included, one each for CD34+ and 
progenitors cells.  
Appendix I 
16 
The analysis of ChIP-seq data was performed at the scientific computing core facility (sciCORE) of the 
University of Basel. For each library, sequence reads were aligned to the human reference genome 
assembly (hg19) using the Sequence Mapping and Alignment Tool (SMALT v 0.6.2). High quality 
alignments (bamtools filter-mapQuality ">30") were extracted. Center positions of ChIPped DNA 
fragments were approximated based on average fragment lengths and orientations of read 
alignments (http://ccg.vital-it.ch/chipseq/chip_center.php). Fragment center-positions of each 
library were used to call genomic domains for H3K4me2 or H3K27me3 with increased read densities 
applying the program “chippart” (http://ccg.vital-it.ch/chipseq/). Global domain sets were assembled 
by combining domains less than 1 kb apart with the merge function of bedtools and being present in 
at least one of the samples. Merged domain sets were subdivided into tiles of uniform lengths of 500 
and 1,000 bp. After random downsampling of high quality alignments (51 Mio and 26 Mio for Jurkat 
and HSC, respectively), the number of reads mapping within tiles (fragment center-positions) were 
extracted for each library. Tiles were further filtered for read counts above an arbitrary threshold 
above background (50 reads for H3K4me2, 30 for H3K27me3 per 500 bp tile and 100 reads for 
H3K4me2, 60 for H3K27me3 per 1,000 bp tile length) in at least one sample. In the differentiation 
experiment an additional filtering criteria of 7 read counts above the corresponding input was 
applied. Read counts within genomic tiles were tested for differences between groups of samples 
applying a generalized linear model (GLM) likelihood ratio test as implemented in the EdgeR package, 
originally developed for differential gene expression data
62
. In brief, the dispersion parameter of the 
negative binomial model was estimated for each genomic interval. Tables with read counts resulting 
from the merging, normalization and filtering were used and the log2-fold changes and P values of 
the GLM likelihood ratio test were computed under the null hypothesis that the fitted coefficients of 
negative binomial GLMs of the compared groups are equal. Domains (500 bp and 1,000 bp) with 
significant alterations were defined as those with both a false discovery rate (FDR) adjusted P value < 
0.05 and log2 fold change > ±0.6. If overlaying 500 and 1,000 bp tiles had significant alteration 500 bp 
tile was selected. 
The integrative genomics viewer was used to visualize ChIP-seq reads
63,64
. Coefficient of variation and 
the principal component coefficients were calculated based on the normalized read counts from 
EdgeR comparisons of 500 bp domain of Chip-seq datasets and analysed by R/Bioconductor. 
Intersections between H3K4me2 and H3K27me3 ChIP-seq data in 500 bp tiles indicate bivalent 
domains. Promoter, exons, introns, intergenic regions and transcription start side were defined using 
the Bioconductor package TxDb.Hsapiens.UCSC.hg19.knownGene and analysed by R/Bioconductor
59
.  
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Figures 
 
Figure 1. ELF-MF exposure does not alter global patterns of histone modifications in Jurkat cells. 
Jurcat cells were ELF-MF (50 Hz sinus, 1 mT, 5’ on/10’ off), sham exposed or treated with 10 nM 
Trichostatin A (TSA) for 72 h. Profiles of H3K4me2 and H3K27me3 modification were generated by 
ChIP-sequencing of two replica (representing pools of three biological replicates). (a) Principal 
component analysis of H3K4me2 and H3K27me3 ChIP-seq data from non-exposed (t0), ELF-MF and 
sham exposed or TSA treated cells, comparing read counts in 500 bp genomic tiles. (b,c) Comparison 
of H3K4me2 and H3K27me3 read counts within 500 bp genomic tiles between TSA treated and ELF-
MF exposed (b) or ELF-MF and sham exposed (c) cells. Shown are differences in relative enrichments 
as log2-fold change (FC) (x-axis) against the false discovery rate (FDR)-adjusted P value (likelihood 
ratio test) (y-axis). Statistically significant tiles (FC > ±0.6, FDR-adjusted P < 0.05) are highlighted in 
red (H3K4me2) or blue (H3K27me3). (d) Exemplary profiles of H3K4me2 and H3K27me3 
modifications at the RPTOR and CEP170 loci with FCs between sham and ELF-MF exposed cells of 1.8 
and 2.1, respectively, but not reaching statistical significance. (e) H3K4me2 and H3K27me3 profiles at 
the B3GALT6 and KMT2C locus, significantly different in ELF-MF and TSA treated cells. 
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Figure 2. Patterning of histone modifications during granulopoiesis is not affected by ELF-MF. 
Human CD34+ cord blood cells were differentiated in vitro to neutrophilic progenitors under ELF-MF 
(50 Hz powerline signal, 1 mT, 5’ on/10’ off) or sham exposure for 5 days. (a,b) Cell cycle profiles and 
apoptosis were assessed by flow cytometry before and at days 4, 5 and 6 of neutrophilic 
differentiation and statistically analysed by χ
2
 test on each replica (**** P < 0.001) and pairwise 
comparison by Student’s t-test. Shown are the mean percentages of cells in the G1, S, and G2 phase 
of the cell cycle (a) and of alive, early apoptotic, late apoptotic and dead/necrotic cells (b). Error bars; 
SEM of n≥2 and n=3 biological replicates, respectively. (c-g) H3K4me2 and H3K27me3 profiles of 
CD34+ cells (t0) and neutrophilic progenitors (t5) were obtained by ChIP-seq and two replicates were 
statistically analysed. (c) Principal component analysis of ChIP-seq data. (d,e) Comparison of ELF-MF 
and sham exposed neutrophilic progenitors (d) or of CD34+ and combined neutrophilic progenitor 
cells (e). Shown are differences in relative enrichments of ChIP-seq reads within 500 and 1,000 bp 
genomic tiles as log2-fold change (FC) (x-axis) against the false discovery rate (FDR)-adjusted P value 
(likelihood ratio test with variable dispersion) (y-axis). Statistically significant (FC > ±0.6, FDR-adjusted 
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P < 0.05) tiles differentially occupied by H3K4me2 and H3K27me3 are highlighted in red and blue, 
respectively. (f,g) Exemplary profiles of H3K4me2 and H3K27me3 marks at genomic loci, identified by 
a 500 bp tile (black box) with significant differences in neutrophilic progenitors and CD34+ cells (f) or 
more than 2-fold enrichment between ELF-MF and sham exposed progenitor cells (g). 
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Figure 3. The DNA methylation pattern does not change upon ELF MF exposure. DNA methylation 
of CD34+ human cord blood cells (t0) and neutrophilic progenitors (t5), in vitro differentiated under 
ELF-MF (50 Hz powerline signal, 1 mT, 5’ on/10’ off), sham or no exposure condition for five days, 
was analysed by Illumina Infinium HumanMethylation 450 array. (a) Principal component analysis of 
all samples (M-values). (b,c) Differences in elative DNA methylation levels as log2-fold change (FC) (x-
axis) are plotted against the false discovery rate (FDR)-adjusted P value (calculated by moderated t-
statistic) (y-axis) for the comparison of (b) neutrophilic progenitors at t5 (combined exposed 
progenitors) and CD34+ cells and (c) ELF-MF and sham exposed day 5 neutrophilic progenitors. CpGs 
statistically significantly (FDR-adjusted P < 0.05) hypomethylated (FC < -0.6) and hypermethylated (FC 
> 0.6) are indicated in green and dark red, respectively.  
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Figure 4. ELF-MF exposure impacts the variability of the epigenetic landscape. The squared 
coefficient of variation (CV2) of ChIP-seq read counts within 500 bp genomic tiles was determined 
based on the two replicate datasets for H3K4me2 and H3K27me3, generated from non-exposed (t0), 
ELF‑MF exposed (50 Hz sinus, 1 mT, 5’ on/10’ off, 72 h), sham exposed or Trichostatin A (10 nM, 72 
h) treated Jurkat cells, and from neutrophilic progenitors after five days of in vitro differentiation 
under ELF‑MF (50 Hz powerline, 1 mT, 5’ on/10’ off) or sham exposure. Linear comparison of CV2 
values of ELF‑MF (x-axis) and sham exposed (y-axis) Jurkat cells (a) and neutrophilic progenitor cells 
(b) for H3K4me2 and H3K27me3 marks. Global replicate variability of the two replicate ChIP-seq 
datasets for H3K4me2 and H3K27me3 in Jurkat cells (c) and in neutrophilic progenitors (d). (e) 
Variance in DNA methylation levels (M value) of the three biological replicates for CD34+ human cord 
blood cells (t0), ELF-MF and sham exposed neutrophilic progenitors after five days of in vitro 
differentiation. (c,d,e) Box-and-whisker plots illustrate median (lines) and mean (black circles) CV2 
values with interquartile ranges (boxes), 1.5x interquartile ranges (whiskers) and outliers. Data were 
statistically analysed by Wilcox rank sum test (**** P < 0.001).  
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Figure 5. Genomic context dependent effect of ELF-MF exposure on the robustness of epigenetic 
modifications. (a, b) Assessment of the variability of epigenetic modifications in ELF-MF- (50 Hz 
sinus, 1 mT, 5’ on/10’ off, 72 h) and sham-exposed or TSA (10 nM, 72 h) treated Jurkat with respect 
to genomic features indicated. (c, d) As in (a, b) but with data from neutrophilic progenitors after five 
days of in vitro differentiation under ELF-MF (50 Hz powerline, 1 mT, 5’ on/10’ off) or sham exposure. 
(a-d) The squared coefficient of variation (CV
2
) of reads in 500 bp tiles of two H3K4me2 and 
H3K27me3 ChIP-seq replicates was analysed for promoters (± 1,000 bp of TSS), exons, introns, 
intergenic regions (UCSC hg19) or bivalent domains in our data set (H3K4me2 and H3K27me3 
occupancy). Box-and-whisker plots illustrate median (lines) and mean (black circles) CV
2
 values with 
interquartile ranges (boxes), 1.5x interquartile ranges (whiskers) and outliers. P values of the 
Wilcoxon rank sum test are indicated. (e,f) Comparison of the mean variabilities of ChIP-seq reads of 
H3K4me2 and H3K27me3 tiles (CV
2
 values on y-axis) between ELF-MF and sham-exposed samples of 
neutrophilic progenitors, plotted as a function of distance to the nearest bivalent domain or intron. 
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(g) Variability of three replicates of DNA methylation assessed with respect to genomic features, 
comparing ELF-MF and sham-exposed neutrophilic progenitors. Box-and-whisker plots illustrate 
median (lines) and mean (black circles) variance with interquartile ranges (boxes), 1.5x interquartile 
ranges (whiskers) and outliers. The P values are according to Wilcoxon rank sum test. 
  
Appendix I 
29 
 
Figure 6. The chromatin state defines the stability of epigenetic features under ELF-MF exposure. 
Variability of epigenetic marks in sham and ELF-MF exposed neutrophilic progenitors, intersected 
with tiles/sites significantly (FDR-adjusted P < 0.05) changing modifications during differentiation of 
CD34+ cells to day five progenitors. (a) Median (lines) and mean (black circles) CV
2
 values (a) and 
with interquartile ranges (boxes), 1.5x interquartile ranges (whiskers) and outliers categorized 
according to tiles enriched in H3K4me2, H3K27me3 or both that either significantly change (up, log2 
fold change > 0.6; down, log2 fold change < -0.6) or remain stable (no) during differentiation. (b) As 
in (a) but for differential enrichments of histone modifications between ELF-MF and sham exposed 
samples. (c,d) Variability of DNA methylation of sham and ELF-MF exposed neutrophilic progenitors, 
intersected with CpGs significantly changing methylation (hypo, FDR-adjusted P < 0.05, log2 fold 
change < -0.6; hyper, FDR-adjusted P < 0.05, log2 fold change > 0.6) or not (no) during neutrophilic 
differentiation. Shown are median (lines) and mean (black circles) with interquartile ranges (boxes), 
1.5x interquartile ranges (whiskers) and outliers of variance (c) and log fold changes between ELF-MF 
and sham exposed samples (d). (a,c) P values indicate statistical significance level by the Wilcoxon 
rank sum test. 
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Supplementary Figures  
 
 
Supplementary Figure S1. Schematic overview of ELF-MF exposure experiments. (a) Blinded for the 
operator, the leukaemic cell line Jurkat was exposed to ELF-MF (50 Hz sinus, 1 mT, 5’ on/10’ off) and 
sham for 72 h, or treated with 10 nM trichostatin A for 72 h. (b) After the expansion of CD34+ human 
cord blood cells for 4 days, the hematopoietic stem cells (HSC) population was split into three 
experimental groups before initiating the in vitro differentiation into neutrophilic lineage for 10 days 
by the addition of G-CSF. Blinded for the experimenter, ELF-MF (50 Hz powerline, 1 mT, 5’ on/10’ off) 
or sham exposure was carried out throughout the differentiation. Control differentiations without 
ELF-MF exposure were done either in a µ-metal shielded box inside the exposure incubator or in an 
independent incubator. (c) sXcELF exposure system provided and serviced by the IT’IS foundation 
(http://www.itis.ethz.ch/services/exposure-systems/in-vitro-sxc/sxcelf/).  
  
Appendix I 
 32 
 
Supplementary Figure S2. ELF-MF exposure does not alter proliferation and survival of Jurkat cells. 
Cells were ELF-MF exposed (50 Hz sinus, 1 mT, 5’ on/10’ off), sham exposed or treated with 10 nM 
Trichostatin A (TSA) for 72 h. (a) Starting with 1x10
5
 cells/mL, the proliferation was monitored by cell 
counting at the indicated time points. Average population doublings of independent biological 
replicates (n=6) as a function of time were calculated and statistically analysed by ANOVA (*P < 0.05) 
and Student’s t-test. Error bars indicate SEM. (b) Cell cycle profiles were assessed by flow cytometry, 
before (t0) and after exposure to ELF-MF, sham or TSA at the indicated time points. Data represent 
the mean proportion of cells in the different cell cycle phases with SEM (n=5). (c) Analysis of 
apoptosis by flow cytometry of cells at the indicated time points of exposure. Annexin-V/PI staining 
was used to discriminate living, apoptotic and dead/necrotic cells. Data represent mean percentages 
of cells in different states of cell viability with SEM (n=6). Flow cytometry data were analysed by 
FlowJo software and statistically analysed by χ
2
 test for each replica (* P < 0.05) and Student’s t-test. 
(d) Average population doublings of Jurkat cells treated with 10 nM or 100 nM Trichostatin A (TSA) 
for 48 h compared to untreated cells. Indicated are error bars and SEM from two biological 
replicates. 
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Supplementary Figure S3: Correlation between H3K4me2 ChIP-seq data from Jurkat cells. Global 
profiles of H3K4me2 histone modification of Jurkat cells prior to treatment (t0), exposed to ELF-MF 
(t72 EMF; 50 Hz sinus, 1 mT, 5’ on/10’ off) and sham, or treated with 10 nM trichostatin A (TSA) for 
72 h were generated by ChIP-sequencing. For each condition, two ChIP-seq replicates were 
generated by pooling three biological replicates each. The correlation of ChIP-seq reads in 500 bp 
genomic tiles between all H3K4me2 ChIP-seq samples is illustrated by density plots (lower left) and 
correlation coefficients (R values; upper right). 
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Supplementary Figure S4. Correlation between H3K27me3 ChIP-seq data from Jurkat cells. Global 
profiles of H3K27me3 histone modification of Jurkat cells prior to treatment (t0), exposed to ELF-MF 
(t72 EMF; 50 Hz sinus, 1 mT, 5’ on/10’ off) and sham, or treated with 10 nM trichostatin A (TSA) for 
72 h were generated by ChIP-sequencing. For each condition, two ChIP-seq replicates were 
generated by pooling three biological replicates each. The correlation of ChIP-seq reads in 500 bp 
genomic tiles between all H3K27me3 Chip-seq samples is illustrated by density plots (lower left) and 
correlation coefficients (R values; upper right). 
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Supplementary Figure S5. Differences of H3K4me2 and H3K27me3 enrichment in Jurkat ChIP-seq 
samples. Jurkat cells were ELF-MF (50 Hz sinus, 1 mT, 5’ on/10’ off), sham exposed, or treated with 
10 nM Trichostatin A (TSA) for 72 h. Profiles of histone H3K4me2 and H3K27me3 modification were 
generated by ChIP-sequencing and two replica (pools of three biological replicates) were statistically 
analysed. Pairwise comparison of histone modification profiles of cells before exposure (t0), exposed 
to ELF-MF or sham, or treated with TSA. (a) Box-and-whisker plots illustrate the median values (line) 
of log2 fold changes of H3K4me2 or H3K27me3 ChIP-seq read counts within 500 bp tiles with 
interquartile ranges (boxes), 1.5x interquartile ranges (whiskers) and outliers. Differences in relative 
enrichments of H3K4me2 (b) and H3K27me3 (c) are shown as log2-fold change (FC) (x-axis) and 
plotted against the false discovery rate (FDR)-adjusted P value (calculated by likelihood ratio test) on 
the y-axis. Statistically significant tiles (FC > ±0.6, FDR-adjusted P < 0.05) are highlighted in red 
(H3K4me2) or blue (H3K27me3). 
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Supplementary Figure S6: ELF-MF exposure has no impact on lineage commitment. Exposed either 
to ELF-MF (50 Hz powerline signal, 1 mT, 5’ on/10’ off) and sham or non-exposed negative control, 
CD34+ cord blood cells were differentiated in vitro into neutrophilic lineage for 10 days. (a) Cell 
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proliferation of the differentiating cell population monitored daily by counting. Average of 
population doublings of three independent biological replica are shown as function of time and 
statistically analysed by ANOVA and Student’s t-test. (b) Proportion of living cells in neutrophilic 
differentiation stages was analysed at the time-points indicated by flow cytometry using the stem 
cell marker CD34 and the two neutrophilic markers CD11b and CD16b. Using the FlowJo software, 
the expression of these markers was used to discriminate between CD34+ cells (CD34+, CD11b-, 
CD16b-), promyelocytes (CD34-, CD11b-, CD16b-), myelocytes (CD34-, CD11b+, CD16b-) and 
metamyelocytes/neutrophils (CD36-, CD11b+, CD16b+). (c) Flow cytometric analysis of the 
population for cells differentiating into granulocytic or monocytic lineage after 4 to 6 days, 
characterized by CD14 expression. (b,c) Shown are the means of three independent replicates (two 
for the negative control) with SEM , statistically analysed by χ
2
 test for each replica (P < 0.05) and 
pairwise comparison by Student’s t-test. (d,e) Gating strategy combining the analysis of apoptosis 
and discrimination of neutrophilic differentiation stages in the alive cell fraction. (d) To obtain intact 
and single (singlet) cells, cell debris and clusters were excluded by gating on forward scatter 
(FSC)/side scatter (SSC) and on pulse-width, respectively. Single cells were separated in alive, early 
apoptotic, late apoptotic and dead/necrotic cells according to Annexin V and DAPI stainings. (e) Alive 
cells (Annexin V negative/ DAPI negative) were then analysed for CD34, CD11b, CD16b and CD14 
expression. (f) Isotype controls (grey) for each antibody used. Freshly isolated human blood 
granulocytes and monocytes were used as positive controls (black). Expressions of indicated marker 
of neutrophilic progenitor at two time-points were illustrated as examples (orange/blue). 
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Supplementary Figure S7. Analysis of the cell cycle profiles of differentiating neutrophilic cells. Cell 
cycle profiles of two independent biological replicates (a,b) from neutrophilic progenitors, sham or 
ELF-MF (50 Hz powerline signal, 1 mT, 5’ on/10’ off) exposed, were analysed by flow cytometry 4, 5 
and 6 days (t4, t5, t6) after induction of differentiation. (c) Summary and statistical analysis of cell 
cycle profiles. Mean percentage of cells in different cell cycle phases with SEM are shown. Data 
represent two biological replicates for ELF-MF and sham exposure, and one replica for the control 
differentiation. They were statistically analysed by χ
2
 test for each replica (*P < 0.05). 
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Supplementary Figure S8. Analysis of apoptosis in differentiating neutrophilic progenitors. 
Apoptosis in the haematopoietic cell population was analysed by flow cytometry before and at days 
4 to 6 of the differentiation into neutrophilic lineage for non-exposed, ELF-MF (50 Hz powerline 
signal, 1 mT, 5’ on/10’ off) and sham exposed cultures. (a) Density plots with Annexin V expression 
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on the x-axis and DAPI permeability on the y-axis indicating alive cells (Annexin V/DAPI double 
negative), early apoptotic (Annexin V+/DAPI-), late apoptotic (double positive) and dead/necrotic 
(Annexin V-/DAPI+) cells are shown. (b) Summary and statistical analysis of the apoptosis, showing 
the mean percentage and SEM of cells in the different cell viability state at the indicated time-points. 
Data of three biological replicates (only two negative control and t5) were statistically analysed by χ
2
 
test by pairwise comparison (*P < 0.05), considering significance only when observed in every 
replicate.  
  
Appendix I 
 41 
 
Supplementary Figure S9. Correlation between H3K4me2 ChIP data of neutrophilic granulopoiesis. 
Global profiles of H3K4me2 histone modification of CD34+ cord blood cells (t0), ELF-MF (50 Hz 
powerline signal, 1 mT, 5’ on/10’ off), sham or not exposed neutrophilic progenitor cells (t5) after 5 
days of differentiation were generated by ChIP-sequencing. Two ChIP-seq replicates were generated 
for each condition, except only one replicate for the non-exposed neutrophilic progenitors (a pool of 
two independent biological replicates). The correlation of ChIP-seq reads in 500 bp genomic tiles 
between all H3K4me2 ChIP-seq samples is illustrated by density plots (lower left) and correlation 
coefficients (R values; upper right). 
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Supplementary Figure S10. Correlation between H3K27me3 ChIP data of neutrophilic 
granulopoiesis. Global profiles of H3K27me3 histone modification of CD34+ cord blood cells (t0), 
ELF-MF (50 Hz powerline signal, 1 mT, 5’ on/10’ off), sham or not exposed neutrophilic progenitor 
cells (t5) after 5 days of differentiation were generated by ChIP-sequencing. Two ChIP-seq replicates 
were generated for each condition, except only one replicate for the non-exposed neutrophilic 
progenitors (a pool of two independent biological replicates). The correlation of ChIP-seq reads in 
500 bp genomic tiles between all H3K27me3 ChIP-seq samples is illustrated by density plots (lower 
left) and correlation coefficients (R values; upper right). 
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Supplementary Figure S11. Pairwise comparison of histone modifications in neutrophilic 
progenitors results in a few statistically significant alterations depending on the ELF-MF exposure 
condition. Human CD34+ cord blood cells were differentiated in vitro into the neutrophilic progenitor 
cells under ELF-MF (50 Hz powerline signal, 1 mT, 5’ on/10’ off), sham or no exposure for five days. 
H3K4me2 and H3K27me3 enrichment profiles for CD34+ cells and neutrophilic progenitors were 
generated by ChIP-seq and two replicates (one independent and a pool of two independent 
biological replicates, only one replicate for non-exposed neutrophilic progenitors) were statistically 
analysed. Shown are differences in relative enrichment of ChIP-seq reads for H3K4me2 (a) and 
H3K27me3 (b) modifications within 500 bp genomic tiles as log2-fold change (FC) (x-axis) between 
ELF-MF, sham or non-exposed neutrophilic progenitors plotted against false discovery rate (FDR)-
adjusted P value (calculated by likelihood ratio test with fixed dispersion) (Y-axis). Statistically 
significant (FC > ±0.6, FDR-adjusted P < 0.05) tiles (500 bp or additional in 1,000 bp tiles) differentially 
occupied by H3K4me2 and H3K27me3 are highlighted in red and blue, respectively. 
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Supplementary Figure S12. Analysis of cytosine methylation data from neutrophilic differentiation. 
CD34+ cord blood cells were in vitro differentiated into the neutrophilic lineage for five days, while 
exposing them to ELF-MF (50 Hz powerline signal, 1 mT, 5’ on/10’ off) and sham or not exposed 
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negative control conditions. DNA methylation of CD34+ cells (t0) and ELF-MF-, sham or not exposed 
neutrophil progenitor cells at day five (t5) was analysed by Illumina Infinium HumanMethylation 450 
array. (a) Comparison of DNA methylation levels of negative controls with ELF-MF and sham exposed 
progenitor cells at day five, plotting relative differences in log2-fold change (FC) (x-axis) against false 
discovery rate (FDR)-adjusted P value (moderated t-statistic; n=3, n=2 for negative control) (y-axis). 
(b) The correlation of DNA methylation levels (β-values) between all replicates and experimental 
conditions is illustrated by density plots and correlation coefficients (R values).  
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Supplementary Figure S13. Replicate variability of H3K4me2 and H3K27me3 marks in neutrophilic 
progenitors are locus-specific. Variability of ChIP-seq replicates for H3K4me2 and H3K27me3 
modifications of ELF-MF (50 Hz powerline, 1 mT, 5’ on/10’ off) and sham-exposed neutrophilic 
progenitors at day five of in vitro differentiation was assessed. (a) Median of the squared coefficient 
of variation (CV
2
) of reads in 500 bp tiles of two H3K4me2 and H3K27me3 ChIP-seq replicates (x-axis) 
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was correlated with the median variance of neutrophilic stages (three replicates, y-axis) in ELF-MF 
and sham exposed neutrophilic progenitors. Neutrophilic stages were analysed by flow cytometry 
discriminating CD34+ cells (CD34+, CD11b-, CD16b-), promyelocytes (CD34-, CD11b-, CD16b-), 
myelocytes (CD34-, CD11b+, CD16b-) and metamyelocytes/neutrophils (CD36-, CD11b+, CD16b+). 
(b-e) The squared coefficient of variation (CV
2
) of reads in 500 bp tiles of two H3K4me2 and 
H3K27me3 ChIP-seq replicates was assessed with respect to genomic features: promoters (± 1,000 
bp of TSS), exons, introns, intergenic regions (UCSC hg19) or bivalent domains. (b) Box-and-whisker 
plots illustrate median (lines) and mean (black circles) CV
2
 values of H3K4me2 and H3K27me3 
modification at non-bivalent (non-bi) and bivalent (bi) promoters. P values above indicate 
significance levels by Wilcoxon rank sum test. (c) Box-and-whisker plots illustrate median (lines) and 
mean (black circles) delta CV
2
 values (CV
2
 ELF-MF – CV
2
 sham) and horizontal lines indicate the 
median of all H3K4me2 or H3K27me3 tiles. P values of the Wilcoxon rank sum test indicate significant 
differences between delta CV
2
 values of all tiles and delta CV
2
 values of tiles at corresponding 
genomic feature. (d,e) Comparing ELF-MF and sham exposed samples, mean variability of ChIP-seq 
reads of H3K4me2 (d) and H3K27me3 (e) tiles (CV
2
 values on y-axis) were plotted as function of 
distance to the nearest corresponding genomic feature.  
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Supplementary Methods 
Cell cycle analysis by propidium iodide staining 
20-50x10
3
 cells were fixed with cold 70% ethanol overnight. Cells were collected by centrifugation, 
resuspended in 1 mg/mL RNase A (in 200 mM Tris-HCl pH 7.5 and 200 mM NaCl) and incubated at 
37°C for 30 min. After addition of 0.5 mg/mL pepsin (in 0.2% HCl) and incubation for another 15 min 
at 37°C, the cells were stained with propidium iodide (100 µg/mL in PBS, pH 7.5) and incubated on 
ice for at least 30 min. The DNA content was measured using a FACS cytometer (Beckton Dickinson) 
in FL2 channel (emission at 575 nm). Raw data were analysed with FlowJo software (TreeStar). Data 
were statistically analysed by χ
2
 test for each replica as well as pairwise comparison by Student’s 
t-test using GraphPad Prism. 
Apoptosis measurement by Annexin V staining 
The number of apoptotic cells in the population was estimated by the Annexin-V Alexa488/PI kit 
(Invitrogen) according to the provider’s recommendations. 20-50x10
3
 cells were blocked on ice in 
Annexin-binding solution supplemented with 1% bovine serum albumin for 15 min before staining 
with the FITC-anti-Annexin V antibody for 20 min at RT, followed by washing three times with 
Annexin-binding solution. PI (Invitrogen) or DAPI was added before analysing the cells. Samples were 
measured using a FACS cytometer (Beckton Dickinson) and analysed by FlowJo Software. Data were 
statistically analysed by χ
2
 test for each replica as well as pairwise comparison by Student’s t-test 
using GraphPad Prism. 
Identification of cell differentiation state by flow cytometry  
Maturation status of the differentiating neutrophilic cell population was analysed by flow cytometry 
detecting cell surface markers (CD34, CD11b, CD16b) by antibodies. After blocking the cells in 
Annexin-binding solution (Invitrogen) with 1% BSA on ice for 20 min, the cells were stained in 50 µL 
blocking buffer on ice for 20 min with the following combination of antibodies: PE mouse anti-human 
CD16b, APC mouse anti-human CD34, APC-Cy7 mouse anti-human CD11b, PE-Cy7 mouse anti-human 
CD14 (all from BD Biosciences) and FITC-anti-Annexin V (Invitrogen) and washed three times with 
blocking buffer. As negative control, samples were stained with an unrelated isotype-matched 
antibody (BD Biosciences, Supplementary Figure S6f). Freshly isolated monocytes and granulocytes 
from human blood, separated by a Ficoll-plaque-plus density gradient (GE Healthcare), were used as 
positive controls. Cell samples were analysed by a FACSCanto II (BD Biosciences) (Supplementary 
Figure S6d) and Flow cytometry data were determined with FlowJo software (TreeStar), with gating 
to exclude doublets and nonviable cells on the basis of pulse width and incorporation of DAPI in 
combination with Annexin V. The neutrophilic differentiation stages were identified by gating on 
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subpopulations according to the expression of surface markers (Supplementary Figure S6e)
1
: CD34+ 
cells (CD34+, CD11b-, CD16b-), Promyelocytes (CD34-, CD11b-, CD16b-), Myelocytes (CD34-, CD11b+, 
CD16b-) and Metamyelocytes (CD36-, CD11b+, CD16b+). Monocytes were identified according to the 
expression of CD14+. 
Chromatin-Immunoprecipitation (ChIP)  
Proteins bound to DNA were crosslinked by incubating cells with freshly prepared 1% methanol-free 
formaldehyde in PBS, pH 7.4 at room temperature under slow agitation for 10 min. Crosslinking was 
stopped by the addition of glycine to a final concentration of 125 mM. Cells were washed three times 
with ice-cold PBS, pelleted and snap-frozen. Cells were lysed in cold lysis buffer (1% SDS, 10 mM 
EDTA, 50 mM Tris-HCl pH 8 and 0.5% Triton-X100, 1 mM PMSF, 1x cOmplete™ Protease Inhibitor 
Cocktail [Roche]) on ice for 20 min while vortexing several times. To produce random chromatin 
fragments ranging from 250-400 base pairs in length, cell lysates were sonicated for 30 min (30 sec 
on, 30 sec off, power high) using a Bioruptor sonicator with a cooling system (diagenode) and cleared 
by centrifugation at 14,000 g at 4°C for 10 min. Chromatin concentration was estimated by 
measuring absorbance at 260 nm on a Nanodrop 1000 (Witec AG). For histone ChIPs, 20-30 µg 
chromatin were diluted 10-fold in ChIP dilution buffer (0.01% SDS, 16.7 mM Tris-HCl pH 8.0, 1.2 mM 
EDTA, 167 mM NaCl, 1.055% Triton X-100, 1 mM PMSF, 1x cOmplete™), saving 1% of the volume for 
input analysis. Diluted chromatin was pre-cleared with 20 µL of magnetic Protein G beads 
(Invitrogen) and pre-blocked with 1 mg/mL BSA and 1 mg/mL tRNA or single-stranded salmon sperm 
DNA at 4°C for 1 h, prior to incubation with 1-2 µg of the respective antibody (H3K4me2: 07-030 
Millipore; H3K27me3: 07-449 Millipore) overnight at 4°C under slow rotation. Histone-antibody-
complexes were pulled down by incubation with 40 µL of pre-blocked magnetic Protein G beads at 
4°C for 2 h, followed by serial washing with 500 µL ChIP wash buffer I (150 mM NaCl, 20 mM Tris-HCl 
pH 8.0, 2 mM EDTA, 0.1% SDS, 1% Triton X-100, 1 mM PMSF), 500 µL ChIP wash buffer II (500 mM 
NaCl, 20 mM Tris-HCl pH 8.0, 2 mM EDTA, 0.1% SDS, 1% TritonX-100, 1 mM PMSF) and 500 µL ChIP 
wash buffer III (250 mM LiCl, 1% NP40, 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 1% sodium deoxycholate, 
1 mM PMSF) at 4°C under rotation. After two additional washes with 500 µL TE buffer (10 mM Tris-
HCl pH 8, 1 mM EDTA), bound complexes were eluted by two sequential incubations with 250 µL 
elution buffer (1% SDS, 0.1 M NaHCO3) at 65°C for 10 min while shaking at 1,400 rpm. Reversal of 
crosslinking in eluates and input samples was done by incubation at 65°C for 4 h in the presence of 
200 mM NaCl. After proteinase K digestion (50 µg/mL) in the presence of 10 mM EDTA and 40 mM 
Tris-HCl pH 6.5 at 45°C for 1 h, DNA was purified by phenol/chloroform extraction and NaCl/ethanol 
precipitation and resuspended in 10 mM Tris-HCl pH 8.0.  
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Abstract 
The epigenetic information contained in histone tail modifications and DNA methylation is crucial for 
the establishment and maintenance of the cell type-specific gene expression pattern. The dramatic 
shaping of the chromatin landscape during a cellular differentiation reflects the transcriptional 
programming of a stem cell into a functional, terminally differentiated cell. Aberrations of epigenetic 
modifications are a hallmark of cancer including leukaemia and indicate a loss of cellular identity. 
Characteristics of acute myeloid leukaemia (AML) are defects in genes encoding epigenetic modifiers, 
indicating a role of dysregulated epigenetic programming in the development of cancer. To 
understand the potential perturbance of epigenetic programming during differentiation and its 
contribution to carcinogenesis, it is important to understand the physiological epigenetic pattern 
established during the differentiation process. We investigated the changes in DNA cytosine 
methylation, the activating histone mark H3K4me2 and the repressive histone mark H3K27me3 at 
genome scale in human CD34+ cord blood cells, differentiating into the neutrophilic lineage. We 
report that DNA cytosine methylation as well as histone modifications undergo fundamental changes 
during granulopoiesis especially at the transition of CD34+ cells into the neutrophilic lineage. 
Epigenetic repression of key pluripotency and developmental genes occurs through a gain of 
H3K27me3, a loss of H3K4me2 and gain of DNA methylation. Epigenetic activation of neutrophil- 
specific genes preferentially occurs through DNA demethylation without coincidental alterations at 
histone modifications. Overall, our data provide insight into the dynamics of the landscape of 
epigenetic histone modifications and DNA methylation in the human myeloid system, illustrating 
their regulatory role in lineage restrictions and cell plasticity.  
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Introduction 
Cellular homeostasis and function, including the controlled interaction with the environment, not 
only depends on the genetic code but also and primarily on the epigenetic information contained in 
histone tail modifications and DNA methylation. While virtually all cells of a multicellular organism 
contain the same genetic code, epigenetic modifications shape the chromatin landscape and DNA 
accessibility, determining the gene expression pattern required for cell lineage commitment 
(Bernstein et al., 2007; Cedar and Bergman, 2011). Acetylation and methylation of specific residues in 
the histone tails are the most prominent histone modifications whereas the epigenetic modification 
of DNA comprises the methylation of cytosine (5mC) at CpG sequences (Bernstein et al., 2007; 
Kouzarides, 2007; Nicholson et al., 2015). The pattern of epigenetic modification changes as genomes 
undergo functional adaptation during differentiation (Dambacher et al., 2013). The epigenetic 
control mechanisms establish three main classes of chromatin: active, repressed and chromatin 
poised for gene expression. Active chromatin, containing highly expressed genes is occupied by 
histone 3 lysine 4 tri-methylation (H3K4me3), H3K4me2 and H3K27 acetylation, while chromatin 
associated with gene repression is marked by H3K27me3 and H3K9me3. Chromatin poised for gene 
expression is occupied by active as well as repressive epigenetic features including H3K4me2, 
H3K4me3 and H3K27me3 modifications and is preferentially located at developmental genes in stem 
cells (Boland et al., 2014; Cantone and Fisher, 2013; Dambacher et al., 2013). In gene regulatory 
regions with intermediate to high CpG content, DNA methylation negatively regulates gene 
expression; cytosine methylation is associated with chromatin compaction, absence of methylation 
with open chromatin (Bernstein et al., 2007; Nicholson et al., 2015). Hence, in organismal 
development, epigenetic mechanisms establish chromatin stages allowing cell type-specific gene 
expression and cell lineage restrictions.  
Aberrations in the epigenetic information as well as genetic mutations are hallmarks of cancer, but 
may also be a driving force of cancerogenesis. Acute myeloid leukaemia (AML) is the most common 
leukaemia in adults and is characterised by a high accumulation of myeloid progenitor cells, among 
them about 50-60% being neutrophilic progenitors (Seiter, 2016; Zenhäusern et al., 2003). Many 
AMLs arise from foetal genetic lesions or chromosomal translocations generating fusion proteins 
such as PML–RARα, AML1–ETO and mixed lineage leukaemia (MLL) (Florean et al., 2011; Kelly and 
Gilliland, 2002; Martens and Stunnenberg, 2010). Additionally, recent studies on AML uncovered the 
presence of somatic mutations in genes encoding modifier of DNA methylation (e.g. DNMTs, TET2) 
and histone modifications (e.g. EZH2, MLL), illustrating a significant epigenetic contribution to 
leukaemogenesis (Conway O'Brien et al., 2014; Dohner, 2002; Ernst et al., 2010; Figueroa et al., 2010; 
Greenblatt and Nimer, 2014; Ley et al., 2010; Mizuno, 2001; Nicholson et al., 2015). As cellular 
Appendix II 
4 
differentiation is based on activation or repression of specific genes, accompanied by global 
rearrangement of chromatin and epigenetic modifications, the blocked differentiation of progenitor 
cells and mutations in epigenetic modifiers in AML may indicate a defect in the epigenetic control 
mechanism of differentiation. 
Maintaining the blood system, human haematopoiesis occurs in the bone marrow where multipotent 
haematopoietic stem cells (HSCs) differentiate into all different types of blood cells. Around two-
thirds of the haematopoietic activity in the bone marrow produces monocytes and granulocytes, 
especially neutrophilic granulocytes with a daily production of 10
11
 cells (Borregaard, 2010). 
Neutrophils are the most abundant white blood cell in the circulation and key players in the innate 
immune system. Stimulation of HSCs with the granulocyte-colony stimulating factor (G-CSF) results in 
the production of neutrophils through a regulated differentiation process with distinct intermediate 
states: myeloblasts, promyelocytes, myelocytes and metamyelocytes (Amulic et al., 2012; 
Borregaard, 2010). Neutrophilic granulopoiesis is disturbed and blocked in 50-60% of AML, resulting 
in the accumulation of progenitors, which suggests a defect in control mechanisms of granulopoiesis 
as cause for leukaemogenesis. Yet, no study investigated the dynamic epigenetic transitions 
occurring during human neutrophilic granulopoiesis. It was shown in isolated cells, however, a gain of 
DNA methylation in neutrophils when compared to HSCs, dynamically regulated throughout 
differentiation with the most pronounced changes occurring at points of lineage restrictions. 
Myeloid-specific genes were shown to be repressed by DNA methylation in HSCs and undergo 
programmed active demethylation upon myeloid differentiation, apparent at common myeloid 
progenitor states (CMPs) (Cedar and Bergman, 2011; Ko et al., 2010; Trowbridge et al., 2009). This 
demethylation is followed by an increase of genome-wide DNA methylation in granulocyte-
macrophage progenitors (GMPs) compared to CMPs, and again a decrease of methylation in 
promyelocytes and further neutrophilic differentiation states (Alvarez-Errico et al., 2015; Ronnerblad 
et al., 2014). Concomitantly, chromatin of neutrophils was shown to be characterized by a high 
amount of heterochromatin containing different repressive histone modifications like H3K9me3, 
H3K27me3 or H3K20me3 and low amounts of active histone modifications such as H3K4me3 and 
H3K4me2 (Navakauskiene et al., 2014; Olins and Olins, 2005). 
To investigate the programming of epigenetic modifications during neutrophilic granulopoiesis, we 
studied the changes of active and repressive histone modifications as well as DNA methylation during 
an in vitro differentiation of human neutrophilic granulocytes. We generated genome-wide profiles 
of histone modifications (H3K4me2 and H3K27me3) and DNA cytosine methylation. We report that 
the epigenetic code undergoes fundamental changes during granulopoiesis most pronounced at the 
stage of lineage commitment, shaping an overall more compact chromatin. Our data show that the 
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activation of neutrophil-specific genes preferentially occurs through DNA demethylation without 
coincident alterations at histone modifications. By contrast, the epigenetic repression of important 
pluripotency and developmental genes occurs through a gain of H3K27me3 with concomitant loss of 
H3K4me2 and de novo DNA methylation. 
 
Results 
CpG methylation changes are most pronounced at the beginning of in vitro neutrophilic 
granulopoiesis. 
To analyse the changes of the epigenetic modifications during granulopoiesis, CD34+ cells isolated 
from human cord blood were in vitro differentiated into the neutrophilic lineage by the addition of 
the growth factor G-CSF and the cytokines stem cell factor and Flt3-ligand (Tura et al., 2007) (Figure 
1a). We performed three differentiation experiments to address whether extremely-low-frequency 
magnetic field (ELF-MF) exposure affects cell differentiation associated chromatin reorganisation 
(Supplementary Figure S1) (Manser et al., in preparation). As ELF-MF exposure did not impact the 
programming of DNA methylation and histone modifications during granulopoiesis, we used the data 
of the different exposure conditions as replicates for the analysis of differentiation dependent 
epigenetic reorganisation. After five days of differentiation, 90% of the cells differentiated to the 
promyelocyte (75%) or myelocyte (15%) state (Supplementary Figure S1b). By day nine, 60% of cells 
matured into myelocytes (40%) and metamyelocytes/neutrophils (20%), while 50% of cells 
differentiated into myelocytes and 25% into metamyelocytes/neutrophils within 14 days of 
differentiation. To address the dynamic changes of cytosine methylation during granulopoiesis, we 
performed genome-wide methylation analysis of single CpG sites in CD34+ cells (t0) and neutrophilic 
progenitors after five (day 5 progenitors, t5), nine (t9) and 14 (t14) days of differentiation, using the 
Illumina Infinium HumanMethylation 450 platform (Figure 1). The hierarchical clustering of the 
412’940 CpGs analysed in all samples (three replicates for CD34+ cells, eight replicates each for 
neutrophilic progenitors) documented the high reproducibility of the biological replicates 
(Supplementary Figure S2a). Principal component analysis revealed a clear separation of the 
maturation stages (Supplementary Figure S2b). Specific genes expressed in neutrophilic granulocytes 
(MPO, ELANE, PRTN3) lost DNA methylation at CpG sites, whereas stem cell genes (GATA2, CD34) 
gained DNA methylation at CpG sites during differentiation (Supplementary Figure S3), consistent 
with previous results (Ronnerblad et al., 2014). The pattern of cytosine DNA methylation was 
dramatically altered during differentiation from CD34+ cells (t0) into day 5 progenitors, resulting in 
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3’882 and 2’977 significantly changed (FDR-adjusted P < 0.05) CpG sites losing (log2 FC < -0.6) and 
gaining (log2 FC > 0.6) methylation, respectively (Figure 1b). Comparing neutrophilic progenitors with 
the preceding time-point, we observed 1’800 sites losing and 267 sites gaining methylation in 
day nine progenitors, whereas in progenitors after 14 days of differentiation 17 CpGs gained and 419 
CpGs lost methylation (Figure 1b). Investigating the dynamics of changes of DNA methylation 
throughout the in vitro differentiation, we observed that CpGs with DNA methylation changes 
consistently either loss or gain methylation throughout the entire differentiation process (Figure 1c). 
The majority of CpGs hypomethylated in neutrophilic progenitors after nine and 14 days (80% and 
100%) already lost methylation in early progenitors, while a majority of sites gaining methylation did 
so during the first five days of differentiation (Figure 1d). Loss of DNA methylation in early 
progenitors after 5 days occurs at CpG sites with a high DNA methylation content, while gain of DNA 
methylation occurs preferentially at CpG sites with low or median DNA methylation levels 
(Supplementary Figure S3d). To evaluate the findings of our in vitro differentiation with previous data 
showing a genome-wide loss of DNA methylation between CMPs and promyelocytes isolated from 
the bone marrow (Ronnerblad et al., 2014), we compared sites with DNA methylation changes 
between in vitro generated progenitors after five days of differentiation (75% promyelocytes) and 
CD34+ cells with those of isolated promyelocytes compared to CMPs. We observed an overlap of 
46% in CpGs losing and 7% in CpGs gaining DNA methylation (Supplementary Figure S3a). These 
results indicate a good reproducibility of DNA methylation alterations at sites losing methylation in 
our in vitro differentiation. 
During cellular differentiation, changes in DNA methylation are preferentially observed at CpG rich 
gene regulatory regions, including promoters, CpG islands (CGI) and CGI shores (Boland et al., 2014; 
Doi et al., 2009; Irizarry et al., 2009; Smith and Meissner, 2013). To investigate whether de novo 
methylation or methylation loss observed in neutrophilic progenitors are preferentially associated 
with certain genomic features, we intersected sites of methylation changes with annotated gene 
promoters (1’000 bp up- and downstream of transcription start site [TSS]), exons, introns and 
intergenic regions as well as with CpG islands, CGI shores (0-2 kb outside CGI), CGI shelf (2-4 kb 
outside CGI) and open sea (> 4 kb outside CGI, Figure 1e,f). In day 5 progenitors, CpGs lost 
methylation were often present at introns (40%) and intergenic regions (28%) but less frequently at 
promoters (23%), while CpGs gained methylation were preferentially found at promoters (44%, 
Figure 1e). CpGs changing methylation in progenitor cells after nine days of differentiation compared 
to progenitors after five days, were most prominently located at intron (39% loss and 45% gain) and 
promoter (29% loss and 27% gain) regions. Analysing all CpGs, we observed that CGIs are enriched 
for non-methylated CpGs, CGI shores show methylated and non-methylated CpGs, while CGI shelf 
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and open sea are preferentially methylated, irrespective of the differentiation states (Supplementary 
Figure S4). During five days of differentiation, gain of DNA methylation occurred preferentially at 
CpGs in CGIs whereas CGI shelves showed a clear trend for methylation loss, while CGI shores and 
open sea showed both gains and losses of methylation (Figure 1f). By contrast, at nine days of 
differentiation methylation gain is observed only at CGI, whereas CpGs outside of CGI are enriched 
for methylation loss. Notably, we observed the highest numbers of sites with DNA methylation 
changes outside of CGIs at open sea (t5/t0: 3’643 and t9/t5: 1’311 sites) or CGI shores (t5/t0: 1’304 
and t9/t5: 350 sites). To investigate a possible regulatory role of these genomic sites, we intersected 
sites with DNA methylation changes of day five progenitors with the location of genes in the human 
genome and analysed the respective ontology (Figure 1g). CpGs lost methylation correlated with 
genes important in neutrophils (e.g. ELANE, CTSG), while CpGs gained methylation occurred mainly at 
genes important in other blood lineages as neutrophils (e.g. TNF, IL1B, SELL). 
Overall, these results indicate that changes of the DNA methylation pattern during in vitro 
neutrophilic differentiation occur most widespread at the transition of multipotent cells into the 
neutrophilic lineage, at lineage commitment. Methylation loss is more pronounced than methylation 
gain and occurs preferentially at neutrophil-specific genes, indicating a role of DNA demethylation in 
the regulation of cell plasticity of neutrophils.  
H3K4me2 and H3K27me3 modifications undergo fundamental changes during in vitro neutrophilic 
granulopoiesis. 
Terminally differentiated human blood neutrophils are characterized by a high amount of 
transcriptionally non-permissive chromatin containing repressive histone modifications such as 
H3K9me3, H3K27me3 or H3K20me3 and a low amounts of active histone modifications such as 
H3K4me2 and H3K4me3 (Navakauskiene et al., 2014; Olins and Olins, 2005). By contrast, HSCs 
contain typically a relatively large fraction of bivalent chromatin marked by active H3K4me2, 
H3K4me3 and repressive H3K27me3 (Cedar and Bergman, 2011; Cui et al., 2009). To investigate the 
dynamic alterations of histone modifications during neutrophilic differentiation, we performed 
chromatin immunoprecipitation (ChIP) for the histone modifications H3K4me2 and H3K27me3, 
combined with next generation sequencing (ChIP-seq), in chromatin isolated from CD34+ cells and 
neutrophilic progenitors after five and nine days of differentiation (Figure 2). For all these points, we 
generated biological and technical replicates (CD34+: two, t5: five and t9: three). Reads mapped to 
the hg19 human genome were randomly downsampled to generate 26 million mapped reads per 
Chip-seq sample that were then analysed in 500 bp and 1’000 bp genomic tiles. The comparison of 
H3K4me2 and H3K27me3 profiles of all samples showed a good reproducibility in the replicates and a 
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clear separation and clustering of samples of the different maturation stages (Supplementary Figure 
S5). Comparing early day five progenitors with CD34+ cells, we observed a total of 19’618 tiles 
significantly (FDR-adjusted P value < 0.05, log2 FC > ± 0.6) changed levels of H3K4me2, while 18’624 
tiles were significantly altered in H3K4me2 between progenitors after 5 and 9 days (Figure 2a). The 
profile of H3K27me3 revealed significant changes (FDR-adjusted P value < 0.05, log2 FC > ± 0.6) in 
14’174 and 16’767 tiles in the same comparisons (Figure 2b). In both time periods, we found more 
tiles losing (log2 FC < -0.6) than gaining (log2 FC > 0.6) H3K4me2 modifications (t5/t0: 11’260 and 
8’358; t9/t5: 12’186 and 6’438, respectively). By contrast, we observed a higher number of tiles 
gaining than losing H3K27me3 modification in both time periods during differentiation (t5/t0: 7’914 
and 6’260, t9/t5: 9’563 and 7’204, respectively). To address the occurrence of the dynamic 
programing of the histone modifications, we intersected tiles with changes in H3K4me2 and 
H3K27me3 modifications of both time frames with each other. We observed that genomic locations 
with alterations in of both histone modifications were preferentially losing H3K4me2 and gaining 
H3K27me3 modifications during the first five days of in vitro differentiation (90% of tiles) and also 
when comparing neutrophilic progenitors after nine and five days (75% of tiles) (Figure 2c, 
Supplementary Figure S6a). Following the individual H3K4me2 tiles throughout the nine days of 
differentiation, we determined that 6’689 tiles lost H3K4me2 during the first five days and also the 
following four days, while 1’866 tiles gained H3K4me2 in both stages during differentiation (Figure 
2d). By contrast, we revealed 3’289 tiles with a gain of H3K27me3, while 1345 tiles lost H3K27me3 in 
both stages during differentiation. For instance, the CD34 locus representing a pluripotency gene 
with an activated chromatin state with only H3K4me2 present in CD34+ cells (t0) is progressively 
losing H3K4me2 and accumulating the repressive H3K27me3 mark (Figure 2e, Supplementary Figure 
S6b,c). By contrast, the ELANE locus, a gene specific for the neutrophil lineage, is repressed in CD34+ 
cells and occupied by low amounts of H3K4me2 and high amounts of H3K27me3 marks. Consistently, 
a gain of H3K4me2 and a loss of H3K27me3 were observed during neutrophilic differentiation.  
To investigate whether certain genomic features are preferentially associated with alterations of 
histone modifications in neutrophilic progenitors, we intersected differentially occupied genomic 
tiles with annotated gene promoters, exons, introns and intergenic regions (Figure 2f). In both time 
periods during differentiation, alterations in H3K4me2 modifications preferentially occurred at 
introns (t5/t0: 45% and t9/t5:42%) and less frequently in promoter regions (t5/t0: 18% and t9/t5: 
30%), whereas changes in H3K27me3 are most prominent at intergenic regions (t5/t0: 40% and 
t9/t5: 38%) and promoters (t5/t0: 30% and t9/t5: 28%). Tiles with changes in H3K4me2 and 
H3K27me3 modifications are highly enriched at promoters in neutrophilic progenitors after five and 
nine days of differentiation (t5/t0: 48% and t9/t5: 52%). To investigate the functional role of these 
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genomic sites showing changes in histone modifications, we intersected them with the location of 
genes on the human genome (Figure 2g). The genes regulated by alterations in H3K4me2, H3K27me3 
and both histone marks during granulopoiesis fell into the functional networks of related to the 
blood lineages, but were preferentially associated with different lineages than neutrophils. Overall, 
we conclude that the landscape of H3K4me2 and H3K27me3 reveal a fundamental chromatin 
reorganisation during in vitro neutrophilic granulopoiesis. Overall, we observed more tiles losing than 
gaining H3K4me2, while more genomic regions gain H3K27me3 than lost it. In particular, tiles with 
changes in both histone modifications preferentially lost H3K4me2 and gained H3K27me3. This 
implicates that these changes guiding the chromatin to a more compact state and allow for the 
establishment of cellular identity after lineage commitment of stem cells.  
Genomic sites undergoing changes in DNA methylation and histone modifications are enriched for 
promoters and active enhancers. 
We observed that the epigenetic code of histone modifications and DNA methylation undergoes the 
highest alterations at lineage commitment. To investigate whether histone and DNA methylation 
changes correlate, we intersected tiles with alterations of H3K4me2 and H3K27me3 with sites of DNA 
methylation changes between day 5 progenitors and CD34+ cells (Figure 3). Comparing tiles with 
H3K4me2 alterations, we observed that 10% are additional altered in H3K27me3, 3% in CpG sites and 
less than 1% where further changed in H3K27me3 and DNA methylation sites (Figure 3a). Tiles with 
H3K27me3 alterations were preferentially concomitant changed in H3K4me2 (17%), only 2% have 
DNA methylation changes and 1% were additionally altered in H3K4me2 and CpG methylation. 
Comparing sites with DNA methylation, 13% have alterations in H3K4me2 and 7% in H3K27me3, 
whereas 2% of all sites are additionally altered in H3K4me2 and H3K27me3 modifications. 
To investigate whether sites with simultaneous changes in histone modifications and DNA 
methylation at lineage commitment are preferentially associated with certain genomic features, we 
intersected them with annotated gene promoters, exons, introns and intergenic regions, and 
calculated their distance to the nearest TSS (Figure 3b,c). In early neutrophilic progenitors, H3K4me2 
modifications changes occurred to 20% at promoters, H3K27me3 changes to 30% and sites with 
changes in both histone modifications to 48% (Figure 2f). By contrast, genomic locations with 
changes in DNA methylation and histone modifications were enriched at promoters and less frequent 
at introns and intergenic regions (Figure 3b). We observed that genomic locations with changes in 
DNA methylation and H3K4me2 occurred to 28% at promoters, whereas sites with simultaneous 
changes in H3K27me3 and DNA methylation to 53% and sites with changes in all three features to 
52%. Additionally, genomic locations with simultaneous changes in histone modifications and DNA 
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methylation are on average closer located to the nearest TSS than locations with only alterations of 
histone modifications (4’400 bp and 7’700 bp for H3K4me2, 850 bp and 6’800 bp for H3K27me3, and 
920 bp and 1’100 bp for sites with changes in both histone modifications, respectively, Figure 3c).  
Beside promoters, active and poised enhancers are important regulatory elements involved in cell-
fate transitions and cell identity; they are marked by a unique signature of histone modifications and 
are enriched for DNase I hypersensitivity sites (Creyghton et al., 2010; Heintzman et al., 2007; Rada-
Iglesias et al., 2011). To investigate the appearance of alterations in DNA methylation or histone 
modifications at enhancers, we intersected genomic locations with alterations in the epigenetic 
features with active (H3K4me1, deoxyribonuclease [DNase], H3K27acetylation [H3K27ac]) and poised 
enhancers (H3K4me1, DNase, no H3K27ac) in CD34+ cells (published data from Roadmap 
Epigenomics et al., 2015) (Figure 3d). We observe that genomic locations simultaneously changed in 
histone modifications and DNA methylation are significantly enriched at active enhancers compared 
to locations with only alterations in histone modifications (15% and 6% for H3K4me2, 17% and 4% for 
H3K27me3, and 15% and 5% for sites with changes in both histone modifications, respectively). The 
same comparisons with poised enhancers showed that genomic locations with changes in both 
histone modifications are less present at poised enhancers (9% and 12%) whereas H3K27me3 
alteration are enriched at poised enhancers (17% and 8%), no significant difference observed at 
locations with H3K4me2 alterations (8% and 6%). Additionally, we determined the location of active 
and poised enhancers with alterations in the epigenetic features relative to the nearest TSS 
(Supplementary Figure S7). Regardless of DNA methylation changes, active and poised enhancers 
showing changes in H3K4me2 are further apart from the TSS, while active enhancer showing 
H3K27me3 alterations or changes in both histone modifications are closer to the TSS compared to 
sites with alterations in histone modifications but not located at enhancers. At poised enhancers, 
genomic locations showing changes in H3K27me3 are closer to the TSS, regardless of alterations in 
DNA methylation, while locations showing alteration in all three epigenetic features are further apart 
from the TSS compared to sites with alterations in histone modifications and DNA methylation but 
not located at enhancers. 
Our data demonstrate that genomic locations undergoing epigenetic changes in histone 
modifications and DNA methylation are enriched at promoters and active enhancers, confirming 
their regulatory role during differentiation.  
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Most sites with coincident changes in histone modifications and DNA methylation change 
chromatin into a repressed state. 
H3K4me2 is present at actively transcribed genes, whereas H3K27me3 as well as DNA methylation 
correlate with gene repression. During cell differentiation, active epigenetic features present at 
pluripotency genes change to a repressed state and repressed or poised epigenetic features of 
lineage-specific genes are activated, resulting in a global reorganisation of the epigenome (Boland et 
al., 2014; Hawkins et al., 2010; Kraushaar and Zhao, 2013). We observed a substantial reorganisation 
of histone modifications and DNA methylation during granulopoiesis and determined locations 
showing coordinated changes in both types of epigenetic features at lineage commitment. To 
address the directional interactions of these epigenetic changes at lineage commitment with each 
other, we compared relative alterations in histone modifications and DNA methylation at the same 
genomic locations (Figure 4). Genomic locations with changes in H3K4me2 and DNA methylation 
show either loss of H3K4me2 and gain of methylation at CpGs (393 sites) or gain of H3K4me2 and 
loss of methylation at CpGs (316 site, Figure 4a), indicating the negative correlation of these 
epigenetic marks. By contrast, sites with simultaneous alterations in H3K27me3 and DNA 
methylation are predominantly characterised by a gain of the H3K27me3 modification as well as of 
DNA methylation at CpGs (223 sites), while only a few sites lose H3K27me3 methylation (33 sites), 
indicating their preferred positive correlation. Moreover, locations with coincident alterations in 
H3K4me2, H3K27me3 and DNA methylation preferentially lose H3K4me2 and gain DNA methylation 
(143 sites, red), whereas the same sites preferentially gain H3K27me3 and DNA methylation (135 
sites, blue; Figure 4a, right panel). These correlations between alterations in DNA methylation and 
active or repressive histone modifications are as well indicated in the % of simultaneous changes of 
each active and repressive epigenetic feature (Supplementary Figure S8).  
We determined in total 150 genomic locations with significant alterations in H3K4me2, H3K27me3 as 
well as DNA methylation in early neutrophilic progenitors compared to CD34+ cells. Their pattern of 
changes can be divided in four different groups (Figure 4b). Six sites gain H3K4me2 modification, lose 
H3K27me3 as well as DNA methylation, indicating a transcriptional activation during differentiation 
(group 1). A loss of both histone modifications in combination with a gain of DNA methylation is 
observed at eight sites (group 2). One single site loses H3K4me2, gains H3K27me3 and loses DNA 
methylation (group 4). However, most locations (135 regions, group 3) lose H3K4me2 and gain 
H3K27me3 as well as DNA methylation, indicating a general transition towards a more repressed 
chromatin state. To investigate the functional role of these dynamic genomic locations, we 
intersected them with genes on the human genome (Figure 4c). We observed two genes associated 
with epigenetic alterations of group 1, indicating activation during differentiation. Both are cell type-
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specific genes in neutrophils; ELANE is encoding a neutrophil elastase and PRTN3 encodes for a 
neutrophil proteinase. By contrast, 57 genes are associated with group 3 changes, indicating gene 
repression (Supplementary Table 1). These are genes with a role in cellular development, particularly 
in blood development of multiple lineages beside granulocytes, including erythroid cells, leukocytes 
or natural killer cells (Figure 4c). Four genes are of the group 2 (HSPB6, MARVELD2, RABL6) and 4 
(MDM4) type. They are silenced during differentiation and are not expressed in fully mature 
neutrophils (RNA-seq of Ronnerblad et al., 2014). From these results, we can conclude that key 
regulatory genes important for lineage specificity of neutrophils, haematopoietic stem cells or other 
blood lineages are activated or silenced after entering the granulocytic lineage with the help of 
alterations in histone modifications and DNA methylation. 
Epigenetic repression occurs through H3K27me3 alone or together with de novo methylation of 
CpGs. 
Genes important for development, morphogenesis and cell signalling are often associated with a 
poised chromatin state in pluripotent human embryonic stem cells, multipotent stem cells like HSCs 
or in progenitor cells. This provides a plasticity of a fast epigenetic adaptation during cell 
differentiation, resulting in the rapid activation or repression of genes (Bernstein et al., 2006; Boland 
et al.). To investigate the interplay of H3K27me3 and de novo DNA methylation in epigenetic 
repression of poised chromatin in CD34+ cells, we analysed their time-dependent change during 
differentiation (Figure 5). We first determined sites showing significant alterations in H3K4me2, 
H3K27me3 and DNA methylation during nine days of differentiation, and then associated these with 
locations occupied by poised chromatin in CD34+ cells and investigated sites with concomitant 
changes in H3K4me2, H3K27me3 and DNA methylation (Supplementary Figure S9). Finally, we 
analysed at which step during differentiation and through what epigenetic change repression 
occurred. A total of 35’489 and 23’396 tiles significantly (FDR-adjusted P value < 0.05, log2 FC > ±0.6) 
changed the levels of H3K4me2 and H3K27me3 modifications between CD34+ cells and neutrophilic 
progenitors after 9 days, respectively (Figure 5a). Additionally, we observe 11’026 and 7’196 
significantly (FDR-adjusted P value < 0.05) changed CpGs losing (log2 FC < -0.6) and gaining 
(log2 FC > 0.6) DNA methylation, respectively (Figure 5b). 
We observed in total 212 locations with a poised chromatin state in CD34+ cells and changing levels 
of H3K4me2, H3K27me3 and DNA methylation during nine days of neutrophilic differentiation. To 
address the time-dependency of these epigenetic changes during differentiation, we investigated the 
relative alterations of H3K4me2, H3K27me3 and DNA methylation of these sites in the first five days 
and in the following four days of differentiation (Figure 5c). We observed 197 locations that lost 
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H3K4me2 and gained H3K27me3 as well as CpG methylation during both time periods of 
differentiation, indicating a transition into a more repressed chromatin state, while only two 
locations gained H3K4me2 and lost H3K27me3 and DNA methylation, correlating with activated 
chromatin. By analysing the timing of epigenetic repression during differentiation at the identified 
197 sites, we observed that more locations are significantly (FDR-adjusted P value < 0.05, 
log2 FC > 0.6) gaining H3K27me3 (t5/t0: 148 and t9/t5: 43) or DNA methylation (t5/t0: 88 and t9/t5: 
two) in the first part of differentiation than in the second one, H3K4me2 loss occurs preferentially in 
the second part of the differentiation (t5/t0: 89 and t9/t5: 164 tiles, Figure 5d). To address the first 
sequence of epigenetic events of epigenetic repression during nine days of differentiation, we 
clustered their changes in the same locations in each time period separately (Figure 5e). Significant 
loss of H3K4me2 modification occurred to equal parts in both time periods during differentiation, 
whereas de novo DNA methylation occurred only in the first part and gain of H3K27me3 modification 
preferentially in the first part but as well later on (Figure 5e, Supplementary Figure S9). 82 locations 
of the total 197 sites converted to a repressive state through gaining H3K27me3 with or without 
H3K4me2 loss in the first part of differentiation. 66 locations underwent repression in the first part of 
differentiation through gaining H3K27me3 modification with concomitant de novo DNA methylation. 
Only 8 locations were repressed through DNA methylation in the first part and gain of H3K27me3 in 
the second part of the differentiation, while 14 sites are repressed only through DNA methylation in 
the first part. These results suggest that during in vitro neutrophilic granulopoiesis, epigenetic 
repression of poised chromatin at HSCs occurs preferentially at lineage commitment through gaining 
of the H3K27me3 mark alone or in combination with DNA methylation, and occasionally only by DNA 
methylation alone. At some sites DNA methylation proceeds H3K27me3 modification. 
 
Discussion 
Aberrations of epigenetic modifications are a hallmark of cancer including acute myeloid leukaemia. 
However, to understand the potential perturbance of epigenetic programming during differentiation 
and its contribution to carcinogenesis, it is important to understand the physiological epigenetic 
pattern established during the differentiation process. Most previous studies investigating epigenetic 
features during myeloid development, including granulocytes were performed with isolated mouse 
or human progenitor cells or fully mature neutrophils (Bocker et al., 2011; Olins and Olins, 2005; 
Ronnerblad et al., 2014). To investigate the epigenetic programming during neutrophilic 
granulopoiesis, we performed genome-wide DNA methylation and histone modification (H3K4me2 
and H3K27me3) analysis in in vitro differentiating CD34+ cells. We report that neutrophilic 
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granulopoiesis is accompanied by a global reorganisation of epigenetic modifications with the highest 
alterations occurring at the transition of CD34+ cells into the neutrophilic lineage, overall generating 
a more compact chromatin state. Additionally, lineage specific epigenetic activation occurred 
preferentially through DNA demethylation and repression through H3K27me3 and DNA methylation.  
DNA methylation is dynamically regulated during granulopoiesis with more CpGs gaining methylation 
at the beginning, in progenitor cells after five and nine days, and more CpGs losing methylation in 
progenitors after 14 days compared to the earlier progenitor stages. In total, we observed more 
CpGs losing methylation than gaining it and this was most pronounced at the transition of CD34+ 
cells into the neutrophilic lineage. Recent work showed a loss of DNA methylation in mature 
neutrophils compared to HSCs, and between GMPs and promyelocytes as well as between 
promyelocytes and mature neutrophils (Alvarez-Errico et al., 2015; Bocker et al., 2011; Hodges et al., 
2011; Ronnerblad et al., 2014). As day 5 progenitors of in vitro differentiation consist to 75% of 
promyelocytes, our results are consistent with these observed. Also, sites of DNA methylation 
changes at CGIs were preferentially gaining methylation in neutrophilic progenitors. CGIs are mainly 
non-methylated in neutrophilic progenitors as in most cell types (Smith and Meissner, 2013), 
therefore these results indicate that CpGs at CGIs undergo de novo methylation during in vitro 
differentiation. By contrast, sites with DNA methylation changes located in CGI shelves preferentially 
lose methylation in neutrophilic progenitors after five days, whereas CpGs with methylation changes 
located in CGI shores gaining or losing methylation. The preferred loss or gain of methylation at 
different CpGs is in agreement with the general DNA methylation pattern of these genomic locations. 
CGI shelves are enriched for methylated CpGs in neutrophilic progenitors or other cell types, 
negatively correlated with the preferred loss of methylation, whereas CGI shores show an overall 
bimodal pattern of methylation with methylated and non-methylated CpGs (Ronnerblad et al., 2014; 
Zhang et al., 2015). We observed the highest number of CpGs changing methylation in CGI shores or 
open sea, indicating that DNA methylation appears to be more dynamic outside of CGI during 
granulopoiesis as previously observed with differentiation systems (Meissner et al., 2008).  
The active histone modification H3K4me2 and the repressive mark H3K27me3 revealed high 
alterations at lineage commitment and later during differentiation. In total, we observed more 
regions gaining H3K27me3 than losing it, while the H3K4me2 modification is preferentially lost. 
Additionally, genomic locations showing level changes in both histone modifications during 
differentiation preferentially lose H3K4me2 and gain H3K27me3 modification. Overall, the 
alterations of histone modifications guide the chromatin into a more compact structure in 
neutrophilic progenitors compared to CD34+ cells. This observation is in line with previous results 
reporting that human blood neutrophils are enriched for heterochromatin containing repressive 
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histone modifications as H3K9me3, H3K27me3 and low amounts of active histone modification, 
including H3K4me2 and H3K4me3 (Navakauskiene et al., 2014; Olins and Olins, 2005). We observed 
only a small fraction of genomic locations regulated through a gain of H3K4me2 and a loss of 
H3K27me3, generating an activated chromatin state. Previous studies indicated that neutrophil-
specific genes are kept in a transcriptionally poised state in HSCs with high levels of H3K4me2, 
H3K27me3 and low H3K4me3 marks and get activated through a gain of H3K4me3, a loss of 
H3K27me3 and only a small increase of H3K4me2 (Attema et al., 2007; Orford et al., 2008; Tang et 
al., 2014). These results indicate that activation occurs mainly through H3K4me3 and that H3K4me2 
is involved in maintenance of the activation potential required for differentiation and to prime loci 
for rapid activation by converting H3K4me2 to H3K4me3. This specific gene-priming mechanism may 
explain that we observe only a small amount of regions gaining H3K4me2 and losing H3K27me3 
during neutrophilic granulopoiesis. Although both activating histone modifications, H3K4me2 and 
H3K4me3, are present at most genes, H3K4me3 is particularly highly enriched at promoters of active 
transcript genes (Bernstein et al., 2005; Sims and Reinberg, 2006). This indicates that a loss of 
H3K4me2 at gene promoters during neutrophilic granulopoiesis is not only associated with gene 
repression, but probably as well with gene activation through the conversion to H3K4me3.  
Genomic locations with changes in H3K4me2, H3K27me3 and DNA methylation at lineage 
commitment are preferentially getting transcriptionally repressed. They are marked by a loss of 
H3K4me2 and a gain of H3K27me3 as well as DNA methylation, and are present at genes important 
for other blood lineages. Only two important neutrophil-specific genes are activated during 
differentiation with a gain of H3K4me2 and a loss of H3K27me3 as well as DNA methylation. These 
results indicate that the repression of important developmental or pluripotency genes is fulfilled by 
histone modifications in combination with DNA methylation to guide the chromatin into the right cell 
state. Additionally, we observed that epigenetic repression of poised chromatin states in HSCs occurs 
preferentially at lineage commitment through a gain of H3K27me3 alone or in combination with DNA 
methylation, but rarely with DNA methylation alone. These results indicate that H3K27me3 
modification initiates the epigenetic repression before de novo DNA methylation at most of the 
observed locations. The delay of DNA methylation at poised genes that become repressed might 
illustrate that DNA methylation is not the primary operator of expression changes but has rather a 
role in stabilising gene repression or is involved in subsequent long term silencing (Rose and Klose, 
2014; Vento-Tormo et al., 2015). Additionally, a previous study reported that the polycomb group 
protein EZH2 present at sites of H3K27me3 methylation is important for the recruitment of DNMT3a 
and DNMT3b, linking DNA methylation to sites of H3K27me3 modification (Vire et al., 2006). On the 
other side, myeloid-specific genes are repressed by DNA methylation in HSCs and undergo 
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programmed active demethylation initiating myeloid differentiation; Dnmt1 deletion in HSCs resulted 
in an increase of myeloid progenitor cells, whereas Tet2 depletion leads to an impaired myeloid 
differentiation (Cedar and Bergman, 2011; Ko et al., 2010; Trowbridge et al., 2009). During 
granulopoiesis, we observed a high amount of CpG sites losing methylation at the transition of HSCs 
into the neutrophilic lineage, particularly at neutrophil-specific genes, indicating their activation 
through DNA demethylation. Additionally, CpGs losing methylation in neutrophilic progenitors after 
five days of differentiation were preferentially not accompanied by a gain of H3K4me2 or changes of 
H3K27me3, indicating that DNA demethylation is the driver of gene activation at these neutrophil-
specific genes. By contrast, lymphoid-specific genes are marked by the polycomb-mediated, 
repressive H3K27me3 modification in HSCs and get activated through removal of H3K27me3 (Oguro 
et al., 2010). We observed that some lymphoid-specific genes as well as pluripotency genes are 
regulated through a gain of H3K27me3, a loss of H3K4me2 and a gain of CpG methylation, indicating 
gene repression. Genomic locations that get activated with simultaneous alterations in DNA 
methylation and histone modifications H3K4me2 and H3K27me3 were rare. Additionally, we observe 
that only a few genomic locations with bivalent histone modifications in HSCs known to be present at 
developmental genes, are activated through the loss of the repressive H3K27me3 marks. 
Conclusively, our results indicate that neutrophil-specific genes are preferentially activated through 
DNA demethylation and not regulated through H3K4me2 and H3K27me3. 
Overall, our study provides novel insight into the genome-wide dynamics of histone modifications 
and DNA methylation during human granulopoiesis. It illustrates that the highest epigenetic changes 
occur at lineage commitment. Our data indicate that epigenetic repression of genomic regions with a 
poised chromatin state at HSCs occurs through a gain of H3K27me3 mark alone or in combination 
with DNA methylation, but rarely with DNA methylation alone. Additionally, epigenetic activation of 
neutrophil-specific genes preferentially occurs through DNA demethylation without coincidental 
alterations in histone modifications H3K4me2 and H3K27me3. 
 
Methods 
Cell culture and neutrophilic differentiation. 
CD34-positive cells isolated from human cord blood of mixed donors were obtained from AllCells 
(Alabama, United States). CD34+ cells were propagated in Stemline II medium expansion medium 
(Stemcell technology) supplemented with 100 ng/mL thrombopoietin, 100 ng/mL stem cell factor, 
10 ng/mL Flt3-ligand (Peprotech), 5000 U/mL Penicillin and 5 mg/mL Streptomycin (Sigma-Aldrich) 
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for four days (De Bruyn et al., 2003). For the neutrophilic differentiation, expanded CD34+ cord blood 
cells were seeded at cell densities of 10
5
 cells/mL in Stemline II medium supplemented with 
100 ng/mL stem cell factor, 10 ng/mL Flt3-ligand, 100 ng/mL G-CSF (Peprotech), 5000 U/mL Penicillin 
and 5 mg/mL Streptomycin (Sigma-Aldrich) and cultured for 14 days. Every second day, fresh cell 
culture medium was added (1:2 dilution). During neutrophilic differentiation, cells were exposed to a 
powerline-simulating ELF-MF (50 Hz, 1 mT, 5’ on/10’ off), to the sham control (< 7 µT residual field) 
or not-exposed as descripted in Manser et al. (in preparation). The different exposure conditions 
were considered as replicates for the analysis of the differentiation dependent epigenetic 
reorganisation. 
Identification of Cell Differentiation State by Flow Cytometry. 
Maturation status of the differentiating neutrophilic cell population was analysed by flow cytometry 
detecting cell surface markers (CD34, CD11b, CD16b) by antibodies. After blocking the cells in 
Annexin-binding solution (Invitrogen) with 1% BSA on ice for 20 min, the cells were stained in 50 µL 
blocking buffer on ice for 20 min with the following combination of antibodies: PE mouse anti-human 
CD16b, APC mouse anti-human CD34 and APC-Cy7 mouse anti-human CD11b (all from BD 
Biosciences) and FITC-anti-Annexin V (Invitrogen) and washed three times with blocking buffer. As 
negative control, samples were stained with an unrelated isotype-matched antibody (BD 
Biosciences). Freshly isolated monocytes and granulocytes from human blood, separated by a Ficoll-
plaque-plus density gradient (GE Healthcare), were used as positive controls. Cell samples were 
analysed by a FACSCanto II (BD Biosciences) and Flow cytometry data were determined with FlowJo 
software (TreeStar), with gating to exclude doublets and nonviable cells on the basis of pulse width 
and incorporation of DAPI in combination with Annexin V. The neutrophilic differentiation stages 
were identified by gating on subpopulations according to the expression of surface markers 
(Elghetany, 2002): CD34+ cells (CD34+, CD11b-, CD16b-), Promyelocytes (CD34-, CD11b-, CD16b-), 
Myelocytes (CD34-, CD11b+, CD16b-) and Metamyelocytes (CD36-, CD11b+, CD16b+). More details 
were described elsewhere (Manser et al., in preparation).  
Base resolution DNA methylation analysis by Illumina Infinium HumanMethylation 450 array. 
Genomic DNA was extracted from frozen cell pellets by QIAamp DNA mini kit (Qiagen) according to 
the manufacturer’s instructions including an RNase-treatment step. 500 ng of genomic DNA was 
bisulfide converted using the EZ-96 DNA Methylation Kit (Zymo Research Corporation). Genome-
wide assessment of DNA methylation was done on Illumina Infinium HumanMethylation 450 
Beadchip arrays, interrogating methylation at 485’577 sites (Sandoval et al., 2014). Raw signal 
intensities were extracted by the Illumina GenomeStudio software and imported into R using the 
Appendix II 
18 
methylumi package as a methylumi object. Data normalization was performed applying the dasen 
method as described previously (Touleimat, 2012). Briefly, probe-level signals for individual CpG sites 
were subjected to background adjustment, followed by quantile normalization of both typeI and 
typeII probes separately. Probes for CpG sites with signal intensities not significantly different 
(P<0.05) from background measurements in any data sets or mapping to regions with known 
germline polymorphisms, to multiple genomic loci (Price et al., 2013), or to either sex chromosome 
were removed, yielding a total of 412’940 CpG after filtering.  
All computational and statistical analyses were performed using R and Bioconductor (Gentleman et 
al., 2004). All analyses for differential methylation were performed on M-values (M = log2 
(methylated/unmethylated) as recommended (Du et al., 2010). Empirical Bayes methodology 
utilizing a moderated t-statistic available in limma was used to test for significant differences 
between the groups (Smyth, 2004). False-discovery rate (FDR)-adjusted P values for multiple 
comparisons were calculated using the Benjamini and Hochberg approach. Differentially methylated 
CpGs were defined as those with both a false discovery rate (FDR) adjusted P value < 0.05 and log2 
fold change > 0.6. Promoter, exons, introns, intergenic regions and transcription start side were 
defined using the Bioconductor package TxDb.Hsapiens.UCSC.hg19.knownGene analysed by 
R/Bioconductor. Based on public datasets of DNA methylation profiles (Illumina Infinium 
HumanMethylation 450 Beadchip arrays) of human promyelocytes and CMPs, sites with DNA 
methylation changes (FDR adj. P value < 0.05 & delta b-value > 0.17) were calculated as descripted in 
publication (Ronnerblad et al., 2014). Gene annotations were defined using the Bioconductor 
package org.Hs.eg.db. The functional analyses were generated through the use of QIAGEN’s 
Ingenuity Pathway Analysis (IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity). 
Chromatin-Immunoprecipitation (ChIP). 
Proteins bound to DNA were crosslinked by incubating cells with freshly prepared 1% methanol-free 
formaldehyde in PBS, pH 7.4 at room temperature under slow agitation for 10 min. Crosslinking was 
stopped by the addition of glycine to a final concentration of 125 mM. Cells were washed three times 
with ice-cold PBS, pelleted and snap-frozen. Cells were lysed in cold lysis buffer (1% SDS, 10 mM 
EDTA, 50 mM Tris-HCl pH 8 and 0.5% Triton-X100, 1 mM PMSF, 1x cOmplete™ Protease Inhibitor 
Cocktail [Roche]) on ice for 20 min while vortexing several times. To produce random chromatin 
fragments ranging from 250-400 base pairs in length, cell lysates were sonicated for 30 min (30 sec 
on, 30 sec off, power high) using a Bioruptor sonicator with a cooling system (diagenode) and cleared 
by centrifugation at 14’000 g at 4°C for 10 min. Chromatin concentration was estimated by 
measuring absorbance at 260 nm on a Nanodrop 1000 (Witec AG). For histone ChIPs, 20-30 µg 
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chromatin were diluted 10-fold in ChIP dilution buffer (0.01% SDS, 16.7 mM Tris-HCl pH 8.0, 1.2 mM 
EDTA, 167 mM NaCl, 1.055% Triton X-100, 1 mM PMSF, 1x cOmplete™), saving 1% of the volume for 
input analysis. Diluted chromatin was pre-cleared with 20 µL of magnetic Protein G beads 
(Invitrogen) and pre-blocked with 1 mg/mL BSA and 1 mg/mL tRNA or single-stranded salmon sperm 
DNA at 4°C for 1 h, prior to incubation with 1-2 µg of the respective antibody (H3K4me2: 07-030 
Millipore; H3K27me3: 07-449 Millipore) overnight at 4°C under slow rotation. Histone-antibody-
complexes were pulled down by incubation with 40 µL of pre-blocked magnetic Protein G beads at 
4°C for 2 h, followed by serial washing with 500 µL ChIP wash buffer I (150 mM NaCl, 20 mM Tris-HCl 
pH 8.0, 2 mM EDTA, 0.1% SDS, 1% Triton X-100, 1 mM PMSF), 500 µL ChIP wash buffer II (500 mM 
NaCl, 20 mM Tris-HCl pH 8.0, 2 mM EDTA, 0.1% SDS, 1% TritonX-100, 1 mM PMSF) and 500 µL ChIP 
wash buffer III (250 mM LiCl, 1% NP40, 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 1% sodium deoxycholate, 
1 mM PMSF) at 4°C under rotation. After two additional washes with 500 µL TE buffer (10 mM Tris-
HCl pH 8, 1 mM EDTA), bound complexes were eluted by two sequential incubations with 250 µL 
elution buffer (1% SDS, 0.1 M NaHCO3) at 65°C for 10 min while shaking at 1’400 rpm. Reversal of 
crosslinking in eluates and input samples was done by incubation at 65°C for 4 h in the presence of 
200 mM NaCl. After proteinase K digestion (50 µg/mL) in the presence of 10 mM EDTA and 40 mM 
Tris-HCl pH 6.5 at 45°C for 1 h, DNA was purified by phenol/chloroform extraction and NaCl/ethanol 
precipitation and resuspended in 10 mM Tris pH 8.0. QPCR with target specific primers (see 
Supplementary Table 2) was performed using Rotor-gene SYBR Green (Qiagen) with a Rotor-Gene Q 
thermocycler (Qiagen). Statistical analysis was performed on Graphpad Prism Software by unpaired 
Student’s t-test. 
Whole-Genome Analysis of Histone Modifications. 
Single-end 50 bp reads sequencing of ChIP was performed at Genome Technology Access Center 
(GTAC) in St. Louis (Missouri, USA) using standard protocols for library generation for the Illumina 
HiSeq platform. In total 20 libraries were generated from H3K4me2 and H3K27me3 ChIP samples of 
the neutrophilic differentiation stages: two ChIP-seq replicates of CD34+ cells, five for progenitor 
cells after five days and three of progenitor cells after nine days for each histone modification 
(Manser et al., in preparation). Additionally, three input controls were included, one each for CD34+ 
cells, progenitors after five days and progenitors after nine days.  
The analysis of ChIP-seq data was performed at the scientific computing core facility (sciCORE) of the 
University of Basel. For each library, sequence reads were aligned to the human reference genome 
assembly (hg19) using the Sequence Mapping and Alignment Tool (SMALT v 0.6.2). High quality 
alignments (bamtools filter-mapQuality ">30") were extracted. Center positions of ChIPped DNA 
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fragments were approximated based on average fragment lengths and orientations of read 
alignments (http://ccg.vital-it.ch/chipseq/chip_center.php). Fragment center-positions of each 
library were used to call genomic domains for H3K4me2 or H3K27me3 with increased read densities 
applying the program “chippart” (http://ccg.vital-it.ch/chipseq/). Global domain sets were assembled 
by combining domains less than 1 kb apart with the merge function of bedtools and being present in 
at least one of the samples. Merged domain sets were subdivided into tiles of uniform lengths of 500 
and 1’000 bp. After random downsampling to about 26 million high quality alignments, the number 
of reads mapping within tiles (fragment center-positions) were extracted for each library. Tiles were 
further filtered for read counts above an arbitrary threshold above background (50 reads for 
H3K4me2, 30 for H3K27me3 per 500 bp tile and 100 reads for H3K4me2, 60 for H3K27me3 per 1’000 
bp tile length) in at least one sample. As additional filtering criteria, 7 read counts above the 
corresponding input were applied. Read counts within genomic tiles were tested for differences 
between groups of samples applying a generalized linear model (GLM) likelihood ratio test as 
implemented in the EdgeR package, originally developed for differential gene expression data 
(Robinson et al., 2010). In brief, the dispersion parameter of the negative binomial model was 
estimated for each genomic interval. Tables with read counts resulting from the merging, 
normalization and filtering were used and the log2-fold changes and P values of the GLM likelihood 
ratio test were computed under the null hypothesis that the fitted coefficients of negative binomial 
GLMs of the compared groups are equal. Domains (500 bp and 1’000 bp) with significant alterations 
were defined as those with both a false discovery rate (FDR) adjusted P value < 0.05 and log2 fold 
change > ±0.6. If overlaying 500 and 1’000 bp tiles had significant alteration, 500 bp tile was selected. 
The integrative genomics viewer was used to visualize ChIP-seq reads (Robinson et al., 2011; 
Thorvaldsdottir et al., 2013). 
Based on public datasets for primary haematopoietic stem cells from the Roadmap Epigenomics 
project (H3K4me1, E035-H3K4me1.narrowPeak; H3K27ac, E050-H3K27ac.narrowPeak; Dnase1, E051-
DNase.all.peaks), active enhancers were determined by occupation of H3K4me1, DNase and 
H3K27ac, poised enhancers as H3K4me1 and DNase, but no H3K27ac present. Intersections between 
H3K4me2 and H3K27me3 ChIP-seq data in 500 bp tiles indicate sites with alterations in both histone 
modifications. Promoter, exons, introns, intergenic regions and transcription start side were defined 
using the Bioconductor package TxDb.Hsapiens.UCSC.hg19.knownGene analysed by R/Bioconductor. 
Gene annotations were defined using the Bioconductor package org.Hs.eg.db. The functional 
analyses were generated through the use of QIAGEN’s Ingenuity Pathway Analysis (IPA® , QIAGEN 
Redwood City, www.qiagen.com/ingenuity).  
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Figures 
 
Figure 1: DNA methylation changes are most pronounced at the beginning of in vitro neutrophilic 
granulopoiesis. DNA methylation of CD34+ human cord blood cells (t0) and neutrophilic progenitors 
after five (t5), nine (t9) and 14 days (t14) of in vitro differentiation was analysed by Illumina Infinium 
HumanMethylation 450 array. (a) After the expansion of CD34+ human cord blood cells for four days, 
the CD34+ cell population was in vitro differentiated into neutrophilic lineage for 14 days by the 
addition of G-CSF. (b) Relative DNA methylation levels in log2-fold change (FC) on the x-axis are 
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plotted against the false discovery rate (FDR)-adjusted P-value (moderated t-statistic) on the y-axis 
for the comparison of neutrophilic progenitors after five days and CD34+ cells, neutrophilic 
progenitors after nine and five days, and progenitors after 14 and nine days. CpGs statistically 
significantly (FDR-adjusted P < 0.05) losing (FC < -0.6) and gaining (FC > 0.6) DNA methylation in these 
comparisons are indicated in green and dark red, respectively. (c) Comparing relative DNA 
methylation of log2-fold change (FC) between CD34+ and neutrophilic progenitor cells after five days 
(x-axis) with progenitors after five and nine days (y-axis) as well as between progenitors after five 
and nine days (x-axis) with progenitors after nine and 14 days (y-axis). Amount of CpG sites with 
significant alterations in both stages are indicated. (d) Intersections between CpGs gaining and losing 
methylation in the different neutrophilic progenitors after five, nine and 14 days, respectively. 
Illustrated is the number of CpGs in the corresponding category and the % of CpGs in only one 
category. (e) Relative occurrence of CpGs changing DNA methylation in different neutrophilic 
progenitors after five and nine days compared to earlier stages in gene promoters, exon, intron and 
intergenic regions. (f) Relative DNA methylation of log2-fold change (FC) in neutrophilic progenitors 
after five and nine days at CpG Islands (CGI), CGI shore (0-2 kb away from CGI), CGI shelf (2-4 kb away 
from CGI) and open sea. CpGs statistically significantly (FDR-adjusted P < 0.05, FC > ± 0.6) differently 
methylated at different features are indicated in black. (g) Functional analysis of CpGs gaining and 
losing DNA methylation by Ingenuity Pathway Analysis. Displayed are the top haematological system 
development and function features and their probability of overlain calculated by a right-tailed Fisher 
Exact Test. 
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Figure 2: H3K4me2 and H3K27me3 modifications undergo fundamental changes during in vitro 
neutrophilic granulopoiesis. Human CD34+ cord blood cells were differentiated in vitro into the 
neutrophilic lineage for nine days. H3K4me2 and H3K27me3 profiles of CD34+ cells (t0) and 
neutrophilic progenitors after five (t5) and nine days (t9) were generated by ChIP-sequencing. 
Replicates (two replicates for t0, five for t5 and three for t9) were statistically analysed comparing 
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CD34+ and neutrophilic progenitor cells after five days or neutrophilic progenitors after five and nine 
days. Statistically significant (log2 fold change > ±0.6, FDR-adjusted P < 0.05) 500 and 1’000 bp tiles 
differentially occupied by H3K4me2 and H3K27me3 are highlighted in red and blue, respectively. 
Relative enrichments of H3K4me2 (a) and H3K27me3 (b) ChIP-seq reads in log2-fold change (FC) on 
the x-axis are plotted against false discovery rate (FDR)-adjusted P-value (likelihood ratio test) on the 
y-axis. (c) Tiles with significant alterations at both histone modifications. Indicated are the relative 
enrichments of log2 fold change with positive values in red and negative ones in blue. Tiles with the 
same epigenetic regulation are grouped and their relative occurrence is indicated. (d) Comparing 
relative enrichments of H3K4me2 and H3K27me3 ChIP-seq reads in log2-fold change (FC) between 
CD34+ and neutrophilic progenitor cells after five days (x-axis) and neutrophilic progenitors after five 
and nine days (y-axis). Number of tiles with significant alterations in both stages are indicated. (e) 
Profiles of H3K4me2 and H3K27me3 marks at the ELANE and CD34 loci. (f) Relative occurrence of 
tiles significantly altered in H3K4me2 (red), H3K27me3 (blue) or both (black) epigenetic marks in 
gene promoters, exon, intron and intergenic regions. (g) Functional analysis of tiles with significant 
histone alterations by Ingenuity Pathway Analysis. Displayed are the top haematological system 
development and function features and their probability of overlain calculated by a right-tailed Fisher 
Exact Test. 
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Figure 3: Genomic sites undergoing changes in DNA methylation and histone modifications are 
enriched for promoters and active enhancers. Intersections between sites with significant (log2 FC > 
±0.6, FDR-adjusted P < 0.05) alterations in H3K4me2, H3K27me3 and DNA methylation between 
CD34+ cells and five day progenitors of in vitro differentiation were investigated. (a) Relative 
occurrence of sites significantly changed in H3K4me2, H3K27me3 or DNA methylation with 
coincident alterations in H3K4me2, H3K27me3 or DNA methylation. (b) Relative occurrence of tiles 
significantly altered in H3K4me2 (red), H3K27me3 (blue) or both (black) histone modifications in 
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combination with sites of DNA methylation changes in gene promoters, exon, intron and intergenic 
regions. (c) Distance to the nearest transcription start site (TSS) of sites significantly altered in 
histone modifications alone or in combination with DNA methylation. Distance is illustrated as log10 
value (bp) on the x-axis and density on the y-axis. Dashed vertical lines illustrate median. (d) Relative 
occurrence of sites significantly altered in histone modifications alone or in combination with DNA 
methylation at active and poised enhancers in CD34+ cells (black). Data were statistically analysed by 
Fisher’s exact test (*** P < 0.001, * P < 0.05). 
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Figure 4: Most sites with coincident changes in histone modifications and DNA methylation change 
chromatin into a repressed state. Sites significantly altered in histone modifications (H3K4me2, 714 
sites [red]; H3K27me3, 256 sites [blue] or in both, 150 sites) and DNA methylation between CD34+ 
cell and neutrophilic progenitors after five days of differentiation. (a) Relative differences of DNA 
methylation (x-axis) and histone modifications (y-axis) in log2 fold change. Number of sites with 
different modifications levels are indicated in red (H3K4me2) and blue (H3K27me3). (b) Comparison 
of relative enrichments of epigenetic modifications at sites showing level changing in H3K4me2, 
H3K27me3 and DNA methylation (150 sites) between CD34+ cells and neutrophilic progenitors after 
5 days of differentiation. Indicated are log2 fold changes with positive (red) and negative values 
(blue). Four differently affected groups are indicated. (c) Genes in group 1 (H3K4me2 up, 
H3K27me3 down, 5mC down), 2 (H3K4me2 down, H3K27me3 down, 5mC up) and 4 (H3K4me2 down, 
H3K27me3 up, 5mC up) are shown in the upper panel. Genes in group 3 (H3K4me2 down, 
H3K27me3 up, 5mC up) and their ontology is shown in the lower panel. Indicated are the top 
haematological system development and function features and their probability of overlain 
calculated by a right-tailed Fisher Exact Test. 
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Figure 5: Epigenetic repression occurs through H3K27me3 alone or together with de novo 
methylation of CpGs. Sites of H3K4me2, H3K27me3 (two replicates for t0, three for t9) and DNA 
methylation (three replicates for t0, eight for t9) were statistically analysed comparing CD34+ cells 
and neutrophilic progenitor cells after nine days. (a) ChIP-seq reads within 500 and 1’000 bp genomic 
tiles in log2-fold change (FC) on the x-axis are plotted against false discovery rate (FDR)-adjusted 
P-value (likelihood ratio test) on the y-axis. Statistically significant (log2 fold change > ±0.6, FDR-
adjusted P < 0.05) 500 and 1’000 bp tiles differentially occupied by H3K4me2 and H3K27me3 are 
highlighted in red and blue, respectively. (b) Relative DNA methylation levels in log2-fold change (FC) 
on the x-axis are plotted against the false discovery rate (FDR)-adjusted P-value (moderated t-
statistic) on the y-axis. CpGs statistically significantly (FDR-adjusted P < 0.05) losing (FC < -0.6) and 
gaining (FC > 0.6) DNA methylation are indicated in green. (c) Sites (212 sites) with a poised 
chromatin state in CD34+ cells and changing levels of H3K4me2, H3K27me3 and DNA methylation 
between CD34+ cells and neutrophilic progenitors after nine days. The sites are correlated with the 
epigenetic changes of the same genomic sites between CD34+ cells and progenitors after five days or 
progenitors after five and nine days. Indicated are the relative enrichments of log2 fold change with 
positive values in red and negative ones in blue. (d, e) Sites (197 sites) significantly losing H3K4me2, 
gaining H3K27me3 modification and DNA methylation in neutrophilic progenitors after nine days 
compared to CD34+ cells. Shown are the relative enrichments of these sites off all three epigenetic 
features between progenitors after five days and CD34+ cells or progenitors after nine and five days 
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(d) and their correlation to each other (e). Significantly altered tiles (log2 fold change > ±0.6, FDR-
adjusted P < 0.05) are indicated in red (H3K4me2), blue (H3K27me3) and green (DNA methylation), 
non-significant in grey.  
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Supplementary Figures  
 
Supplementary Figure S1: In vitro neutrophilic differentiation procedure. (a) In vitro differentiation 
of CD34+ human cord blood cells into the neutrophilic lineage for 14 days under ELF-MF exposure 
and control conditions. After the expansion of CD34+ human cord blood cells for four days, the 
CD34+ cell population was split into three experimental groups before initiating the in vitro 
differentiation into neutrophilic lineage for 14 days by the addition of G-CSF. ELF-MF (50 Hz 
powerline, 1 mT, 5’ on/10’ off) or sham exposure was performed throughout the differentiation. (b) 
Proportion of alive cells in the population in distinct neutrophilic differentiation stages was analysed 
at the indicated time-points by flow cytometry, using the stem cell marker CD34 and the two 
neutrophilic markers CD11b and CD16b. Using the FlowJo software, the expression of these markers 
was used to discriminate between CD34+ cells (CD34+, CD11b-, CD16b-), promyelocytes (CD34-, 
CD11b-, CD16b-), myelocytes (CD34-, CD11b+, CD16b-) and metamyelocytes/neutrophils (CD36-, 
CD11b+, CD16b+). Shown are the means of eight replicates in total (ELF-MF: three, sham: three, no 
exposure: two). 
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Supplementary Figure S2: Correlation of Cytosine methylation data of neutrophilic granulopoiesis. 
Global profiles of DNA methylation in CD34+ cord blood cells (t0, three replicates), neutrophilic 
progenitors after five (eight replicates) and nine days (eight replicates) of differentiation were 
generated by Illumina Infinium HumanMethylation 450 array. (a) The correlation of DNA methylation 
levels (β -values) between all replicates and experimental conditions is illustrated by a heatmap with 
euclidean clustering analysed by RStudio/Bioconductor. (b) Principal component analysis of all 
samples (M-values) analysed by RStudio/Bioconductor. 
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Supplementary Figure S3: Dynamic DNA methylation changes during neutrophilic granulopoiesis. 
(a) Intersections of differently methylated CpGs (FDR-adjusted P < 0.05, log2 FC < -0.6) between 
neutrophilic progenitors after five days and CD34+ cells with sites of DNA methylation changes 
between isolated promyelocytes and common myeloid progenitors from Ronnerblad et al. (2014). 
Indicated are overlays of all CpGs gaining or losing DNA methylation (b, c) DNA methylation changes 
at CpG sites at the MPO, ELANE, PRTN3, Gata 2 and CD34 locus. Indicated are the changes in beta-
values of all CpGs with significant (FDR-adjusted P < 0.05, log2 FC < -0.6) methylation changes 
identified in each gene. Each dot represents one CpG. (d) Dynamic DNA methylation changes of CpGs 
with methylation changes in neutrophilic progenitors after five days compared to CD34+ cells. 
Illustrated are the distributions of the beta-values in CD34+ cells, progenitors after five and nine days 
of the CpGs. Horizontal line indicates median.  
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Supplementary Figure S4: Distribution of DNA methylation at CpG islands. Distribution of DNA 
methylation levels (beta values) at CpG island (CGI, a), CGI shores (0-2 kb away from CGI, b), CGI shelf 
(2-4 kb away from CGI, c) and open sea (d) in CD34+ cells and neutrophilic progenitors after five, nine 
and 14 days.  
Appendix II 
39 
 
Supplementary Figure S5: Correlation between H3K4me2 or H3K27me3 ChIP samples of 
neutrophilic granulopoiesis. Global profiles of H3K4me2 and H3K27me3 histone modification of 
CD34+ cord blood cells (t0, 2 replicates), neutrophilic progenitors after five (t5, five replicates) and 
nine days (t9, 3 replicates) of differentiation were generated by ChIP-sequencing. Correlation of ChIP-
seq reads in 500 bp tiles of all ChIP-seq replicates is illustrated as a heatmap with euclidean 
clustering. Included are statistically significant (log2 fold change > ±0.6, FDR-adjusted P < 0.05) 500 
bp tiles differently occupied by H3K4me2 between progenitors after 5 days and CD34+ cells (a) and 
all observed H3K27me3 tiles (b). (c) Principal component analysis samples of all (left) and significant 
(t5 compared to t0, log2 fold change > ±0.6, FDR-adjusted P < 0.05, right) H3K4me2 ChIP-seq 
samples. (d) Principal component analysis samples of all H3K27me3 ChIP-seq samples. Data were 
analysed by RStudio/Bioconductor. 
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Supplementary Figure S6: Alterations in histone modifications during neutrophilic granulopoiesis. 
Human CD34+ cord blood cells were differentiated in vitro into the neutrophilic progenitor cells for 
nine days. (a) H3K4me2 and H3K27me3 profiles of CD34+ cells (t0) and neutrophilic progenitors after 
five (t5) and nine days (t9) were generated by ChIP-sequencing. Statistically significant (log2 fold 
change > ±0.6, FDR-adjusted P < 0.05) 500 and 1’000 bp tiles differentially occupied by H3K4me2 and 
H3K27me3 were investigated. Number of tiles with significant alteration in H3K4me2 (red) and 
H3K27me3 (blue) alone or in both histone modifications (colours with white stripes) are indicated 
with gain (dark red/dark blue) or loss of the epigenetic feature. ChIP-qPCR of H3K4me2 (b) and 
H3K27me3 (c) modifications in CD34+ cells and neutrophilic progenitors after five and nine days of in 
vitro differentiation for 3 biological replicates. Illustrated are the mean relative enrichment (inputtarget 
[%]/inputcontrol [%]) with standard error. Prdx3 and GGA2 were used as normalizer. P values are 
according to unpaired Student’s t- test (*** P < 0.001, ** P < 0.01). 
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Supplementary Figure S7: Genomic location of enhancers occupied by epigenetic changes. Distance 
to the nearest transcription start site (TSS) of sites significantly changing histone modifications level 
alone or in combination with DNA methylation and located at active (a) or poised (b) enhancers in 
CD34+ cells or not. Distance is illustrated as log10 value (bp) on the x-axis and density on the y-axis. 
Dashed vertical lines illustrate median.  
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Supplementary Figure S8: Correlation of H3K4me2, H3K27me3 and DNA methylation changes. 
Intersections between sites with significant (log2 FC > ±0.6, FDR-adjusted P < 0.05) alterations in 
H3K4me2, H3K27me3 and DNA methylation levels between CD34+ cells and neutrophilic progenitors 
after five days of in vitro differentiation were investigated. Relative occurrence of sites significantly 
increased or decreased in H3K4me2 (a), H3K27me3 b) or DNA methylation (c) with coincident 
alterations in H3K4me2, H3K27me3 or DNA methylation. 
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Supplementary Figure S9: Dynamics of epigenetic changes during neutrophilic granulopoiesis. 
Intersections between sites with significant (log2 FC > ±0.6, FDR-adjusted P < 0.05) alterations in 
H3K4me2, H3K27me3 as well as DNA methylation between CD34+ cells and neutrophilic progenitors 
after nine days of in vitro differentiation were investigated. (a) Relative occurrence of sites 
significantly changed in H3K4me2, H3K27me3 or DNA methylation with coincident alterations in 
H3K4me2, H3K27me3 or DNA methylation. (b) Sites (197) significantly losing H3K4me2, gaining 
H3K27me3 as well as DNA methylation in neutrophilic progenitors after nine days compared to 
CD34+ cells. Indicated are the relative enrichments off all three epigenetic features at these sites 
between progenitors after five days and CD34+ cells or progenitors after nine and five days. 
Clustered are the H3K4me2 or the H3K27me3 and DNA methylation changes. Significantly altered 
tiles (log2 fold change > ±0.6, FDR-adjusted P < 0.05) are indicated in red (H3K4me2), blue 
(H3K27me3) and green (DNA methylation), non-significant in grey. 
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Supplementary Tables 
Supplementary Table 1: Genes occupied by group 3 epigenetic alterations in neutrophilic progenitor 
cells after five days of differentiation compared to CD34+ cells. 
 
Genes occupied by H3K4me2 down / H3K27me3 up / 5mC up (group 3) 
ATP10A 
C7orf50 
CARD11 
CASC15 
CD7 
CLDN5 
DPF1 
DPF1 
EGFL7 
ESAM 
EXD3 
F2RL1 
GAL3ST3 
GATA2 
GNG4 
HLCS 
HOXA10 
HOXA10-AS 
HOXA10-HOXA9 
HOXA-AS3 
HOXB3 
HOXB5 
HOXB6 
HOXB-AS1 
HOXB-AS3 
IFT140 
KCNJ12 
KIAA1217 
LTBP3 
MDK 
MECOM 
MEIS1 
MIB2 
MOB2 
NKX2-3 
PLXNB2 
PRKCH 
PTRF 
RAI1 
REC8 
ROBO3 
SCN1B 
SDR42E1 
SKIDA1 
SOCS2 
ST3GAL4 
STIL 
TAL1 
TCAF1 
THRB-AS1 
TMEM204 
TMEM25 
WT1 
ZNF503-AS2 
ZNF662 
ZNRF3 
ZNRF3-AS1 
 
Supplementary Table 2: Primer used for ChIP-qPCR 
 
Name Orientation Sequence (5’ – 3’) Length 
Prdx3_3’end_qPCR Forward CTAGCCAGCCACCAAGATGT 20 
Prdx3_3’end_qPCR Reverse CCCATGTGTATCTGCACCTTC 21 
GGA2_3’end_qPCR Forward CCTGGTCTTGGCAGATGATA 20 
GGA2_3’end_qPCR Reverse ATGCCTCTGTCCCAATTCTG 20 
pCD34_qPCR Forward GGTACTCACGCAGCAAACTC 20 
pCD34_qPCR Reverse TCCTGGCCAAGCCGAGTA 18 
pCD16b_qPCR Forward CCATCCCTTTGTGGGAGTCT 20 
pCD16b_qPCR Reverse ACTCCAGTGTGGCATCATGT 20 
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